
<html lang="en"     class="pb-page"  data-request-id="ff13c796-8678-4d21-9509-82dd1fcb4659"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2010.53.issue-4;article:article:10.1021/jm901802n;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Clinical Evaluation of 1-{N-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a Thrombin Inhibitor with an Oxyguanidine P1 Motif" /></meta><meta name="dc.Creator" content="Tianbao  Lu" /></meta><meta name="dc.Creator" content="Thomas  Markotan" /></meta><meta name="dc.Creator" content="Shelley K.  Ballentine" /></meta><meta name="dc.Creator" content="Edward C.  Giardino" /></meta><meta name="dc.Creator" content="John  Spurlino" /></meta><meta name="dc.Creator" content="Kathryn  Brown" /></meta><meta name="dc.Creator" content="Bruce E.  Maryanoff" /></meta><meta name="dc.Creator" content="Bruce E.  Tomczuk" /></meta><meta name="dc.Creator" content="Bruce P.  Damiano" /></meta><meta name="dc.Creator" content="Umesh  Shukla" /></meta><meta name="dc.Creator" content="David  End" /></meta><meta name="dc.Creator" content="Patricia  Andrade-Gordon" /></meta><meta name="dc.Creator" content="Roger F.  Bone" /></meta><meta name="dc.Creator" content="Mark R.  Player" /></meta><meta name="dc.Description" content="We have identified RWJ-671818 (8) as a novel, low molecular weight, orally active inhibitor of human α-thrombin (Ki = 1.3 nM) that is potentially useful for the acute and chronic treatment of venou..." /></meta><meta name="Description" content="We have identified RWJ-671818 (8) as a novel, low molecular weight, orally active inhibitor of human α-thrombin (Ki = 1.3 nM) that is potentially useful for the acute and chronic treatment of venou..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 26, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901802n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901802n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901802n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901802n" /></link>
        
    
    

<title>Discovery and Clinical Evaluation of 1-{N-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a Thrombin Inhibitor with an Oxyguanidine P1 Motif | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901802n" /></meta><meta property="og:title" content="Discovery and Clinical Evaluation of 1-{N-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a Thrombin Inhibitor with an Oxyguanidine P1 Motif" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0010.jpeg" /></meta><meta property="og:description" content="We have identified RWJ-671818 (8) as a novel, low molecular weight, orally active inhibitor of human α-thrombin (Ki = 1.3 nM) that is potentially useful for the acute and chronic treatment of venous and arterial thrombosis. In a rat deep venous thrombosis model used to assess antithrombotic efficacy, oral administration of 8 at 30 and 50 mg/kg reduced thrombus weight by 87 and 94%, respectively. In an anesthetized rat antithrombotic model, where electrical stimulation of the carotid artery created a thrombus, 8 prolonged occlusion time 2- and 3-fold at 0.1 and 1.0 mg/kg, iv, respectively, and more than doubled activated clotting time and activated partial thromboplastin time at the higher dose. This compound had excellent oral bioavailability of 100% in dogs with an estimated half-life of approximately 3 h. On the basis of its noteworthy preclinical data, 8 was advanced into human clinical trials and successfully progressed through phase 1 studies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901802n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901802n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901802n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901802n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901802n&amp;href=/doi/10.1021/jm901802n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1843-1856</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm9016976" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm900464j" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/jm100354s"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Clinical Evaluation of 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a Thrombin Inhibitor with an Oxyguanidine P1 Motif</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tianbao++Lu">Tianbao Lu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Markotan">Thomas Markotan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shelley+K.++Ballentine">Shelley K. Ballentine</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edward+C.++Giardino">Edward C. Giardino</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Spurlino">John Spurlino</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathryn++Brown">Kathryn Brown</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+E.++Maryanoff">Bruce E. Maryanoff</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+E.++Tomczuk">Bruce E. Tomczuk</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+P.++Damiano">Bruce P. Damiano</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Umesh++Shukla">Umesh Shukla</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++End">David End</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patricia++Andrade-Gordon">Patricia Andrade-Gordon</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roger+F.++Bone">Roger F. Bone</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+R.++Player">Mark R. Player</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Tel: 215-628-7860. Fax: 215-540-4616. E-mail: <a href="/cdn-cgi/l/email-protection#94f9e4f8f5edf1e6d4fde0e7bafefafebaf7fbf9"><span class="__cf_email__" data-cfemail="2845584449514d5a68415c5b06424642064b4745">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901802n&amp;href=/doi/10.1021%2Fjm901802n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1843–1856</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 26, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 December 2009</li><li><span class="item_label"><b>Published</b> online</span>26 January 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 February 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901802n" title="DOI URL">https://doi.org/10.1021/jm901802n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1843%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTianbao%2BLu%252C%2BThomas%2BMarkotan%252C%2BShelley%2BK.%2BBallentine%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D4%26contentID%3Djm901802n%26title%3DDiscovery%2Band%2BClinical%2BEvaluation%2Bof%2B1-%257BN-%255B2-%2528Amidinoaminooxy%2529ethyl%255Damino%257Dcarbonylmethyl-6-methyl-3-%255B2%252C2-difluoro-2-phenylethylamino%255Dpyrazinone%2B%2528RWJ-671818%2529%252C%2Ba%2BThrombin%2BInhibitor%2Bwith%2Ban%2BOxyguanidine%2BP1%2BMotif%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1856%26publicationDate%3DFebruary%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901802n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1780</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">23</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901802n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Clinical Evaluation of 1-{N-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a Thrombin Inhibitor with an Oxyguanidine P1 Motif&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Tianbao&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Markotan&quot;},{&quot;first_name&quot;:&quot;Shelley&quot;,&quot;last_name&quot;:&quot;K. Ballentine&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;C. Giardino&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Spurlino&quot;},{&quot;first_name&quot;:&quot;Kathryn&quot;,&quot;last_name&quot;:&quot;Brown&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;E. Maryanoff&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;E. Tomczuk&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;P. Damiano&quot;},{&quot;first_name&quot;:&quot;Umesh&quot;,&quot;last_name&quot;:&quot;Shukla&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;End&quot;},{&quot;first_name&quot;:&quot;Patricia&quot;,&quot;last_name&quot;:&quot;Andrade-Gordon&quot;},{&quot;first_name&quot;:&quot;Roger&quot;,&quot;last_name&quot;:&quot;F. Bone&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;R. Player&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;1843-1856&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901802n&quot;},&quot;abstract&quot;:&quot;We have identified RWJ-671818 (8) as a novel, low molecular weight, orally active inhibitor of human α-thrombin (Ki = 1.3 nM) that is potentially useful for the acute and chronic treatment of venous and arterial thrombosis. In a rat deep venous thrombosis model used to assess antithrombotic efficacy, oral administration of 8 at 30 and 50 mg/kg reduced thrombus weight by 87 and 94%, respectively. In an anesthetized rat antithrombotic model, where electrical stimulation of the carotid artery created a thrombus, 8 prolonged occlusion time 2- and 3-fold at 0.1 and 1.0 mg/kg, iv, respectively, and more than doubled activated clotting time and activated partial thromboplastin time at the higher dose. This compound had excellent oral bioavailability of 100% in dogs with an estimated half-life of approximately 3 h. On the basis of its noteworthy preclinical data, 8 was advanced into human clinical trials and successfully progressed through phase 1 studies.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901802n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901802n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901802n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901802n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901802n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901802n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901802n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901802n&amp;href=/doi/10.1021/jm901802n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901802n" /></input><a href="/doi/pdf/10.1021/jm901802n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901802n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901802n%26sid%3Dliteratum%253Aachs%26pmid%3D20102150%26genre%3Darticle%26aulast%3DLu%26date%3D2010%26atitle%3DDiscovery%2Band%2BClinical%2BEvaluation%2Bof%2B1-%257BN-%255B2-%2528Amidinoaminooxy%2529ethyl%255Damino%257Dcarbonylmethyl-6-methyl-3-%255B2%252C2-difluoro-2-phenylethylamino%255Dpyrazinone%2B%2528RWJ-671818%2529%252C%2Ba%2BThrombin%2BInhibitor%2Bwith%2Ban%2BOxyguanidine%2BP1%2BMotif%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D4%26spage%3D1843%26epage%3D1856%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We have identified RWJ-671818 (<b>8</b>) as a novel, low molecular weight, orally active inhibitor of human α-thrombin (<i>K</i><sub>i</sub> = 1.3 nM) that is potentially useful for the acute and chronic treatment of venous and arterial thrombosis. In a rat deep venous thrombosis model used to assess antithrombotic efficacy, oral administration of <b>8</b> at 30 and 50 mg/kg reduced thrombus weight by 87 and 94%, respectively. In an anesthetized rat antithrombotic model, where electrical stimulation of the carotid artery created a thrombus, <b>8</b> prolonged occlusion time 2- and 3-fold at 0.1 and 1.0 mg/kg, iv, respectively, and more than doubled activated clotting time and activated partial thromboplastin time at the higher dose. This compound had excellent oral bioavailability of 100% in dogs with an estimated half-life of approximately 3 h. On the basis of its noteworthy preclinical data, <b>8</b> was advanced into human clinical trials and successfully progressed through phase 1 studies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Thromboembolic diseases remain a leading cause of morbidity and mortality in the developed world. Venous thromboembolism (VTE)<a class="ref internalNav" href="#fn1" aria-label="a">a</a> affects more than 2 million people in the United States each year, progressing to pulmonary embolism in approximately 600 000 of these patients and becoming fatal in 200 000.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> VTE is the third leading cause of cardiovascular-related death, after myocardial infarction and stroke.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Nonvalvular atrial fibrillation is among the most common dysrhythmia seen in clinical practice and is responsible for up to 100 000 ischemic strokes annually in the United States and more than a million worldwide.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p"><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: ACT, activated clotting time; aPTT, activated partial thromboplastin time; argatroban, (2<i>R</i>,4<i>R</i>)-1-[(2<i>S</i>)-5(diaminomethylideneamino)-2-[[(3<i>R</i>)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methyl-piperidine-2-carboxylic acid; BOP, benzotriazole-1-yl-oxy-tris-(dimethylamino)-phosphonium hexafluorophosphate; CYP, cytochrome P450; DTI, direct thrombin inhibitor; DVT, deep venous thrombosis; ECAT, electrical current-induced arterial thrombosis; fXa, factor Xa; hERG, human ether-a-go-go related gene; HLM, human liver microsome; PAR, protease-activated receptor; PT, prothrombin time; RGD, arginine-glycine-aspartic acid; RLM, rat liver microsome; VTE, venous thromboembolism.</p></div></div><div class="NLM_p">The conditions amenable to treatment with anticoagulants are broad, reflecting the importance of thrombosis in pathophysiology. They include the following: primary prevention of acute myocardial infarction, stroke, and cerebral ischemia; treatment of unstable angina; prevention of occlusion following percutaneous transluminal coronary angioplasty and coronary artery bypass grafting; prevention of reocclusion after acute coronary intervention using intravascular stents; prevention of systemic thrombosis after heart valve replacement or atrial fibrillation; and treatment and prevention of all forms of VTE [deep venous thrombosis (DVT), pulmonary embolism, and disseminated intravascular coagulation], secondary myocardial infarction, and restenosis.</div><div class="NLM_p">Anticoagulants have great promise for the prophylaxis of arterial and venous thrombotic disorders. Injectable agents have been in use since unfractionated heparin became commercially available in the 1940s. Low molecular weight heparins were developed in the early 1990s. The first direct thrombin inhibitor (DTI) was introduced in 1998, and the first synthetic indirect factor Xa (fXa) inhibitor, fondaparinux, became available in 2001. However, until very recently, oral agents have been limited to vitamin K antagonists such as warfarin. Vitamin K antagonists are highly efficacious but suffer from a slow onset of action, genetic variations of metabolism, complex food and drug interactions, and the costly requirement of monitoring for dose adjustments. Thus, there is a significant unmet need for new oral anticoagulants with rapid onset of action and predictable pharmacokinetics and pharmacodynamics.</div><div class="NLM_p last">The central role of the serine protease thrombin in thrombosis and hemostasis<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> makes it an attractive target for antithrombotic therapy. As a key enzyme in the blood coagulation pathway, thrombin acts on substrates such as fibrinogen, factor V, factor VIII, factor XI, and factor XIII to induce or accelerate the formation of thrombi.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Thrombin very efficiently initiates fibrin formation and activates factor XIII, a transglutaminase that catalyzes the formation of cross-links between fibrin monomers. In addition, thrombin effectively promotes platelet activation via enzymatic cleavage of the amino terminus of protease-activated receptors (PARs) on the platelet surface (PAR-1, PAR-3, and PAR-4), unveiling a tethered receptor ligand mechanism, which in turn activates the receptor to elicit platelet activation. For example, mice deficient in PAR-4 demonstrate reduced thrombus formation at sites of arterial injury.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In contrast, through its interaction with thrombomodulin, thrombin activates protein C, initiating negative feedback of the coagulation cascade. Activated protein C inactivates factors Va and VIIIa and regulates fibrinolysis via activation of a fibrinolysis inhibitor.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Antithrombin is the physiological inhibitor of thrombin; however, thrombin bound to a fibrin clot is inaccessible to the actions of antithrombin. Thrombin, via activation of PARs, is also a modulator of endothelial and smooth muscle cell proliferation and migration. It induces inflammatory responses, acting as a chemotactic to peripheral blood monocytes and as a stimulator of neutrophil adhesion.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Thus, a potent inhibitor of thrombin has potential as an effective antithrombotic drug in both venous and arterial environments. Herein, we describe a series of potent pyrazinone thrombin inhibitors, which culminated in the discovery and clinical evaluation of <b>8</b>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34865" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34865" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthetic Chemistry</h3><div class="NLM_p">Preparation of the P1 intermediate <b>4</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) started with the reaction of (2-hydroxy-ethyl)-carbamic acid benzyl ester with <i>N</i>-hydroxyphthalimide to afford <b>1</b>, which was deprotected with methylamine to give oxyamine <b>2</b>. Guanylation of <b>2</b> provided the bis-BOC intermediate <b>3</b>, which was deprotected to afford key intermediate oxyguanidine <b>4</b> in 49% overall yield beginning with the alcohol.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-Hydroxyphthalimide, PPh<sub>3</sub>, DEAD, room temperature, 10 h. (b) MeNH<sub>2</sub>, EtOH/THF, room temperature, 1 h. (c) [<i>N</i>,<i>N</i>′-Di(<i>tert</i>-butoxycarbonyl)]amidinopyrazole, room temperature, 10 h. (d) 10% Pd/C, H<sub>2</sub>(g), EtOH/THF, room temperature, 30 min.</p></p></figure><div class="NLM_p">Reaction of 3-halo-6-substituted pyrazinone intermediates <b>5</b><a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a> and <b>6</b><a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) with the appropriate alkylamine in refluxing toluene followed by saponification provided the 3-alkylamino-6-substituted pyrazinone acetic acids. The coupling of the acid and oxyguanidine intermediate <b>4</b> was accomplished with benzotriazole-1-yl-oxy-tris-(dimethylamino)-phosphonium hexafluorophosphate (BOP). The crude coupling product was purified by normal phase chromatography and then deprotected by treatment with trifluoroacetic acid. Subsequent purification of the product by normal phase chromatography followed by recrystallization of the HCl salt from ethanol provided <b>7</b>−<b>18</b>. To obtain the 3-alkylamino-6-chloropyrazinone acetic acids, coupling of the amine took place with 3-bromopyrazinone acetic acid ester <b>19</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) in refluxing toluene followed by chlorination using <i>N</i>-chlorosuccinimide, and subsequent saponification afforded <b>20</b>. Installation of the P1 oxyguanidine then took place in an analogous manner as described for <b>7</b>−<b>18</b>. Methylation of the oxyguanidine on the proximal nitrogen was accomplished using iodomethane to yield <b>22</b>.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PhMe, 60 °C, 3 h. (b) (i) Dioxane/1 N NaOH(aq), room temperature, 1.5 h; (ii) 10% HCl(aq). (c) Castro's reagent, TEA, DMF, room temperature, 18 h. (d) DCM, TFA, room temperature, 8 h.</p></p></figure><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PhMe, reflux, 12 h and then room temperature, 5 days. (b) NCS, DCE, reflux, 2.5 h. (c) (i) dioxane/1 N NaOH(aq), room temperature, 18 h; (ii) 10% HCl(aq). (d) Castro's reagent, TEA, DMF, room temperature, 3 days. (e) DCM, TFA, room temperature, 24 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Ligand Design</h3><div class="NLM_p">Many early approaches to thrombin inhibitors relied upon the active site recognition motif <span class="smallcaps smallerCapital">d</span>-Phe-Pro-Arg, which mimics a portion of the natural substrate.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Each inhibitor may be thought of as being composed of three components: a basic P1 substituent, a central group that acts as a scaffold and/or S2 binding fragment, and an aryl substituent, P3. Modeling studies<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> involving the docking of a similar inhibitor Ac-Ala-Pro-Val-TFMK (trifluoromethylketone) into the active site of human neutrophil elastase suggested that it might be possible to alter the alanine α-carbon hybridization from sp<sup>3</sup> to sp<sup>2</sup> and construct a hydrocarbon bridge from it to the adjacent proline. This modification, combined with cleavage and deletion of two carbons of the proline ring, results in a substituted pyridone that retains many of the important hydrogen bond recognition elements of the tripeptides. However, many 3-amino-2-pyridones show inherent chemical instability due to the electron-rich nature of the pyridone ring.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Stabilization of the heterocycle has been addressed in three ways: insertion of a strongly electron-withdrawing substituent such as CF<sub>3</sub> at the 4-position, derivatization of the 3-amino group as a sulfonamide, or addition of a nitrogen to convert the pyridone into a pyrazinone core.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> These strategies, particularly the conversion to a pyrazinone core, are applicable to thrombin inhibitors and have been used to design compounds with a balance of thrombin affinity and physical properties that permit desirable pharmacokinetics.</div><div class="NLM_p last">Arginine- or guanidine-based P1 groups provide molecules with high affinity by virtue of a strong salt bridge interaction with Asp189 in the S1 specificity pocket. The strong basicity of such groups, however, often causes low oral bioavailability due to poor intestinal absorption. In addition, some inhibitors with aminocyclohexane P1s display in vivo toxicity, the severity of which is a direct function of the p<i>K</i><sub>a</sub> of the aminocyclohexane.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> To address these problems, we have previously reported on a series of thrombin inhibitors exhibiting a novel oxyguanidine moiety, which serves as an arginine surrogate of the arginine-glycine-aspartic acid (RGD) type thrombin inhibitors.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The oxyguanidine possesses a greatly reduced p<i>K</i><sub>a</sub> of 7.0−7.5 versus 13−14 for guanidine, and this distinguishing characteristic is reflected in favorable in vitro permeability and pharmacokinetics. The current series combines the features of the pyrazinone core with the oxyguanidine moiety.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Structure−Activity Study</h3><div class="NLM_p">We conducted a survey of a variety of lipophilic P3 substituents on the pyrazinone core. The effects of methyl, chloro, and cyano substitution on the 6-position of the pyrazinone ring were also addressed. A range of compounds (<b>7</b>−<b>18</b>, <b>21</b>, and <b>22</b>) were assessed for the inhibition of human α-thrombin and the key enzyme trypsin (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Insights emerged regarding the effect of P3 group substitution on thrombin binding and on selectivity with respect to trypsin. 2-(4-Fluorophenyl)ethyl compound <b>9</b> (<i>K</i><sub>i</sub> = 13 nM) was essentially equipotent to <b>11</b> (<i>K</i><sub>i</sub> = 15 nM), a 2,4-difluoro-substituted analogue; however, 3,4-difluoro-substitution, as in <b>10</b>, decreased the potency 3-fold (<i>K</i><sub>i</sub> = 47 nM). The substitution pattern more significantly affected the selectivity of this set of compounds against trypsin, however: <b>10</b>, <b>9</b>, and <b>11</b> were 18-, 120-, and 230-fold more potent for thrombin than for trypsin. The same preference for monosubstitution as compared to 3,4-substitution was seen in methoxy derivatives <b>13</b> and <b>14</b>, which exhibited <i>K</i><sub>i</sub> values of 11 and 120 nM, respectively. Although it has been hypothesized that electron-withdrawing substituents on P3 decrease electron density in the aromatic ring and thereby enhance the σ−π edge-to-face interaction of the ring with the protein at electron-rich Trp215,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> in this series, such a change was not beneficial, as demonstrated by the 4-trifluoromethyl analogue <b>12</b> (<i>K</i><sub>i</sub> = 47 nM). Further comparing compounds with different inductive effects at the 4-position, the trend in <i>K</i><sub>i</sub> values was OMe (<b>13</b>) < F (<b>9</b>) < CF<sub>3</sub> (<b>12</b>) < ethyl (<b>15</b>) (11, 13, 47, and 66 nM, respectively). The potencies of these substitutions are likely due to their presence only at the 4-position, allowing a slight structural rearrangement of the binding pocket to accommodate the fit. Compound <b>14</b>, the 3,4-dimethoxy analogue, is even less potent (<i>K</i><sub>i</sub> = 120 nM) as it requires even more structural adjustment at the P3 site.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of P1−P3 Substitution on Thrombin (thr) and Trypsin (tryp) Inhibition (<i>K</i><sub>i</sub>) of <b>7</b>−<b>18</b>, <b>21</b>, and <b>22</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0011.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center" char=".">compd</th><th align="center">R</th><th align="center">Y</th><th align="center">R<sup>1</sup></th><th align="center" char=".">thr <i>K</i><sub>i</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (nM)</th><th align="center" char=".">tryp <i>K</i><sub>i</sub> (nM)</th></tr></thead><tbody><tr valign="top"><td align="char" char="."><b>7</b></td><td align="left">2,2-difluoro-2-phenylethyl</td><td align="left">CN</td><td align="left">H</td><td align="char" char=".">2.3</td><td align="char" char=".">105</td></tr><tr valign="top"><td align="char" char="."><b>8</b></td><td align="left">2,2-difluoro-2-phenylethyl</td><td align="left">Me</td><td align="left">H</td><td align="char" char=".">1.3</td><td align="char" char=".">128</td></tr><tr valign="top"><td align="char" char="."><b>9</b></td><td align="left">2-(4-fluorophenyl)ethyl</td><td align="left">Me</td><td align="left">H</td><td align="char" char=".">13</td><td align="char" char=".">1600</td></tr><tr valign="top"><td align="char" char="."><b>10</b></td><td align="left">2-(3,4-difluorophenyl)ethyl</td><td align="left">Me</td><td align="left">H</td><td align="char" char=".">47</td><td align="char" char=".">850</td></tr><tr valign="top"><td align="char" char="."><b>11</b></td><td align="left">2-(2,4-difluorophenyl)ethyl</td><td align="left">Me</td><td align="left">H</td><td align="char" char=".">15</td><td align="char" char=".">3400</td></tr><tr valign="top"><td align="char" char="."><b>12</b></td><td align="left">2-(4-trifluoromethylphenyl)ethyl</td><td align="left">Me</td><td align="left">H</td><td align="char" char=".">47</td><td align="char" char=".">2800</td></tr><tr valign="top"><td align="char" char="."><b>13</b></td><td align="left">2-(4-methoxyphenyl)ethyl</td><td align="left">Me</td><td align="left">H</td><td align="char" char=".">11</td><td align="char" char=".">3000</td></tr><tr valign="top"><td align="char" char="."><b>14</b></td><td align="left">2-(3,4-dimethoxyphenyl)ethyl</td><td align="left">Me</td><td align="left">H</td><td align="char" char=".">120</td><td align="char" char=".">3100</td></tr><tr valign="top"><td align="char" char="."><b>15</b></td><td align="left">2-(4-ethylphenyl)ethyl</td><td align="left">Me</td><td align="left">H</td><td align="char" char=".">66</td><td align="char" char=".">2200</td></tr><tr valign="top"><td align="char" char="."><b>16</b></td><td align="left">2-(5-indanyl)ethyl</td><td align="left">Me</td><td align="left">H</td><td align="char" char=".">44</td><td align="char" char=".">2500</td></tr><tr valign="top"><td align="char" char="."><b>17</b></td><td align="left">2-(1-naphthyl)ethyl</td><td align="left">Me</td><td align="left">H</td><td align="char" char=".">12</td><td align="char" char=".">500</td></tr><tr valign="top"><td align="char" char="."><b>18</b></td><td align="left">2,2-diphenylethyl</td><td align="left">Me</td><td align="left">H</td><td align="char" char=".">6.8</td><td align="char" char=".">420</td></tr><tr valign="top"><td align="char" char="."><b>21</b></td><td align="left">2,2-difluoro-2-phenylethyl</td><td align="left">Cl</td><td align="left">H</td><td align="char" char=".">1.7</td><td align="char" char=".">370</td></tr><tr valign="top"><td align="char" char="."><b>22</b></td><td align="left">2-(4-methylphenyl)ethyl</td><td align="left">Me</td><td align="left">Me</td><td align="char" char=".">37</td><td align="char" char=".">2500</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> values are averaged from multiple determinations (<i>n</i> ≥ 3), and the standard deviations are <20% of the mean.</p></div></div></div><div class="NLM_p">Analogues with larger hydrophobic substituents, such as 2,2-diphenylethyl (<b>18</b>, <i>K</i><sub>i</sub> = 6.8 nM), 2-(1-napthyl)ethyl (<b>17</b>, <i>K</i><sub>i</sub> = 12 nM), and 4-methylphenyl (<b>22</b>, <i>K</i><sub>i</sub> = 37 nM) maintained potency, as they may project out of the P3 pocket into solvent. Compounds <b>18</b> and <b>17</b> concurrently displayed 62- and 4-fold selectivity over trypsin, respectively. 2-(5-Indanyl)ethyl (<b>16</b>, <i>K</i><sub>i</sub> = 44 nM) was approximately as potent as other 3,4-disubstituted phenyl analogues such as <b>10</b> and <b>14</b>. Compound <b>22</b> also featured a methyl group at the proximal nitrogen of the oxyguanidine (α to the oxygen), which did not negatively impact potency or selectivity over trypsin (68-fold) (vide infra).</div><div class="NLM_p">The addition of a <i>gem</i>-difluoromethyl group on the benzylic position of the P3 moiety not only conferred greater thrombin affinity but also higher metabolic stability, as that position was shown to be one important site of oxidative metabolism.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> This phenomenon was exemplified by <b>7</b>, <b>8</b>, and <b>21</b>. They were among the most potent compounds studied, with <i>K</i><sub>i</sub> values of 2.3, 1.3, and 1.7 nM, respectively. In human liver microsomal (HLM) preparations, the half-lives of each of these three compounds exceeded 100 min (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Without this modification to attenuate the metabolic liability, half-lives shortened considerably, ranging from 16.6 min for <b>12</b> to 85.8 min for <b>10</b>. Within that range, most HLM <i>t</i><sub>1/2</sub> values were between 20 and 30 min.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Rat and Human Microsomal Stability, Caco-2 Flux, and Recombinant CYP3A4 Inhibition of <b>7</b>−<b>18</b>, <b>21</b>, and <b>22</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char=" " /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th colspan="2" align="center" char="."><i>t</i><sub>1/2</sub> (min)</th><th align="center" char=" "> </th><th align="center" char="."> </th></tr><tr valign="top"><th align="center">compd</th><th align="center" char=".">RLM stability</th><th align="center" char=".">HLM stability</th><th align="center" char=" ">Caco-2 <i>P</i><sub>app</sub> (A→B/B→A) (×10<sup>−6</sup> cm/s)</th><th align="center" char=".">CYP3A4 inhibition (μM)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>7</b></td><td align="char" char=".">>100</td><td align="char" char=".">>100</td><td align="char" char=" ">0.5, 2.26</td><td align="char" char=".">>10</td></tr><tr valign="top"><td align="left"><b>8</b></td><td align="char" char=".">>100</td><td align="char" char=".">>100</td><td align="char" char=" ">1.37, 6.45</td><td align="char" char=".">>10</td></tr><tr valign="top"><td align="left"><b>9</b></td><td align="char" char=".">16.7</td><td align="char" char=".">40.1</td><td align="char" char=" ">0.55, 1.48</td><td align="char" char=".">5.9</td></tr><tr valign="top"><td align="left"><b>10</b></td><td align="char" char=".">13.8</td><td align="char" char=".">85.8</td><td align="char" char=" ">0.92, 1.84</td><td align="char" char=".">2.1</td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="char" char=".">14.4</td><td align="char" char=".">57.6</td><td align="char" char=" ">0.5, 1.91</td><td align="char" char=".">2.9</td></tr><tr valign="top"><td align="left"><b>12</b></td><td align="char" char=".">44.7</td><td align="char" char=".">16.6</td><td align="char" char=" ">0.74, 3.32</td><td align="char" char=".">3.0</td></tr><tr valign="top"><td align="left"><b>13</b></td><td align="char" char=".">32.9</td><td align="char" char=".">19.1</td><td align="char" char=" ">0.28, 3.18</td><td align="char" char=".">3.5</td></tr><tr valign="top"><td align="left"><b>14</b></td><td align="char" char=".">>10</td><td align="char" char=".">34.1</td><td align="char" char=" ">0.87, 0.36</td><td align="char" char=".">6.7</td></tr><tr valign="top"><td align="left"><b>15</b></td><td align="char" char=".">52.3</td><td align="char" char=".">24.5</td><td align="char" char=" ">0.29, 10.3</td><td align="char" char=".">3.4</td></tr><tr valign="top"><td align="left"><b>16</b></td><td align="char" char=".">32.6</td><td align="char" char=".">22.8</td><td align="char" char=" ">0.67, 4.29</td><td align="char" char=".">4.7</td></tr><tr valign="top"><td align="left"><b>17</b></td><td align="char" char=".">38.8</td><td align="char" char=".">24.4</td><td align="char" char=" ">0.32, 11.81</td><td align="char" char=".">0.96</td></tr><tr valign="top"><td align="left"><b>18</b></td><td align="char" char=".">8.3</td><td align="char" char=".">25.9</td><td align="char" char=" ">0.14, 12.98</td><td align="char" char=".">1.2</td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="char" char=".">17.7</td><td align="char" char=".">>100</td><td align="char" char=" ">0.5, 3.04</td><td align="char" char=".">1.5</td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="char" char=".">24.8</td><td align="char" char=".">59.2</td><td align="char" char=" ">0.27, 0.6</td><td align="char" char=".">3.5</td></tr></tbody></table></div></div><div class="NLM_p">Substitution in the 6-position of the pyrazinone ring improved potency via interaction with the Tyr-Pro-Pro-Trp insertion loop near the S2 pocket of thrombin. In the past, substituents such as methyl appeared to be metabolically labile,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> although given the high rat liver microsome (RLM) and HLM half-lives, particularly of <b>8</b>, that does not appear to be the case throughout this series. Compound <b>21</b>, which contains a 6-Cl substitution on the pyrazinone, was 1.7 nM against thrombin and 370 nM against trypsin. 6-Cyano and 6-methyl groups (<b>7</b> and <b>8</b>), despite decreasing trypsin selectivity (<i>K</i><sub>i</sub> = 105 and 128 nM, respectively), maintained high affinity for thrombin (<i>K</i><sub>i</sub> = 2.3 and 1.3 nM, respectively). The electron-withdrawing Cl and CN and the hydrophobic methyl were all well-tolerated within the relatively hydrophobic section of protein in the S2 insertion loop.</div><div class="NLM_p">The crystal structure of <b>8</b> reveals the archetypical binding mode for the series of pyrazinone compounds. Initial difference electron density maps, calculated from atomic coordinates after positional and temperature factor refinement without the inhibitor, clearly revealed the positions of the inhibitor as well as additional solvent molecules that were not included in the difference Fourier calculation. The central pyrazinone scaffold makes hydrogen bonds with the backbone NH and CO of Gly216 as a peptide mimetic (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a,b; PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LDX">3LDX</a>). The methyl substitution projects into the pocket formed by His57, Tyr60A, and Trp60D, mostly filling this pocket, and there is space for the slightly larger substitutions of Cl or CN with minimal rearrangement required. The amide NH also contributes a hydrogen bond to the backbone of the protein (Ser214) to complete the scaffold interactions.</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Hydrogen-bonding interactions of <b>8</b> with thrombin (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LDX">3LDX</a>). The atoms are colored by atom type. Primary interactions are shown as dotted lines, and secondary shell interactions are shown as thin solid lines. (b) Accessible surface representation of thrombin is shown with the surface colored by atom type with <b>8</b> shown as a stick representation. (c) Accessible surface representation of thrombin with the inhibitor (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T4U">1T4U</a>) shown as a stick figure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The oxyguanidine binds in an asymmetric mode to Asp189. Additional hydrogen bonds are made with the backbone carbonyl of Gly219 and two water molecules to fully coordinate the oxyguanidine moiety. Water 49 is fully coordinated making hydrogen bonds with oxygen and one of the terminal guanidine nitrogens as well as with the backbone carbonyl of Gly216. Water 3 is associated with the proximal nitrogen and the other terminal nitrogen of the guanidine. The use of water molecules to bridge hydrogen-bonding interactions with the hydrogen atom of the proximal nitrogen allows flexibility in this region of the molecule. An alternate symmetrical binding mode of an orcinol-based inhibitor with the hydrogen of the proximal nitrogen flipped was seen in a previously reported oxyguanidine structure (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>c; PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T4U">1T4U</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This flexibility, along with the use of water-bridged hydrogen bonding, explains the ability to substitute a methyl group for the hydrogen atom on the proximal nitrogen (<b>22</b>) without a significant loss of affinity.</div><div class="NLM_p">Selectivity for thrombin versus trypsin is important because of the central location of trypsin in the gut and its likely role in protease-mediated feedback control of endogenous pancreatic enzyme secretion.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Recognizing that the S1 pockets of thrombin and trypsin are identical with the exception of residue 190, which is alanine and serine, respectively, one possible approach would take advantage of the slightly larger size of the pocket in thrombin by decreasing the number of hydrophilic groups and increasing the hydrophobic surface area until the limit of the pocket is reached.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Sanderson et al., utilizing this strategy, have disclosed affinity and trypsin selectivity data for related series of pyrazinone thrombin inhibitors.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> A lead compound, featuring an 2-amino-6-methyl pyridine at P1, had a <i>K</i><sub>i</sub> of 0.8 nM for thrombin and 1800 nM for trypsin. Other P1 groups have also been employed as follows: imidazopyridazines, 5-linked indoles, and azaindoles<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (the affinity of the three isomers correlates with the acidity of the conjugate acid), azoles,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> imidazole acetamides,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and aminopyridines.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p last">In addition, Reiner et al. have reported pyrazinone thrombin inhibitors embodying three classes of monocyclic P1 arginine surrogates: (1) (hetero)aromatic amidines, amines, and hydroxylamines; (2) 2-aminopyrazines; and (3) 2-aminopyrimidines and 2-aminotetrahydropyrimidines.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Those containing benzylamine and thiophene were often single digit nanomolar in potency for thrombin but triple digit nanomolar for trypsin; however, those containing aminopyrimidines or aminopyrazines were considered inactive for trypsin, thus more selective.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Advanced in Vitro Evaluation</h3><div class="NLM_p">Our exploration of the space occupied by P3 led to <b>7</b>, <b>8</b>, and <b>21</b>, which were 42-, 32-, and 217-fold selective versus trypsin, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>8</b> did have slight inhibitory potential for tissue type plasminogen activator (tPA, <i>K</i><sub>i</sub> = 2.4 μM) and fXa (<i>K</i><sub>i</sub> = 3.3 μM); however, the compounds were inactive (>26 μM) against many other important enzymes, that is, factor VIIa, urokinase, chymotrypsin, cathepsin G, human leukocyte elastase, kallikrein, chymase, and plasmin. Of these, <b>7</b> had slight inhibitory potential for fXa (<i>K</i><sub>i</sub> = 6.5 μM).</div><div class="NLM_p">Further in vitro evaluation of <b>7</b>, <b>8</b>, and <b>21</b> was undertaken to assess the metabolic stability, permeability, and recombinant cytochrome P450 (CYP) inhibition of these three lead compounds as compared to others in the series (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Test compounds were equilibrated with RLMs and HLMs at 37 °C, NADPH was added to initiate the reaction, and aliquots were withdrawn and quenched at 0, 15, 30, and 60 min. The percent of parent compound remaining in the incubation mixture was plotted as a function of time. The elimination half-lives of <b>7</b> and <b>8</b> associated with the disappearance of test article were determined to be >100 min in both species, suggesting that <b>7</b> and <b>8</b> are not susceptible to rapid metabolism by this mechanism. The half-life for <b>21</b> was >100 min in HLMs but dropped to 17.7 min in RLMs.</div><div class="NLM_p">Permeability was measured by movement of compound through Caco-2 cell monolayers grown on collagen-coated, microporous, polycarbonate membranes. Compound <b>7</b> exhibited low absorption potential, having movement from apical to basolateral (A to B) of 0.5 × 10<sup>−6</sup> cm/s and from B to A of 2.26 × 10<sup>−6</sup> cm/s, while the absorption potential for <b>8</b> was considered high (A to B = 1.37 × 10<sup>−6</sup> cm/s and B to A = 6.45 × 10<sup>−6</sup> cm/s). The absorption potential for <b>21</b> was similar to that of <b>7</b> (A to B = 0.5 × 10<sup>−6</sup> cm/s and B to A = 3.04 × 10<sup>−6</sup> cm/s).</div><div class="NLM_p last">The HLM CYP inhibition assay was performed using cDNA-expressed human enzymes of the P450 isoforms most commonly responsible for the metabolism of drugs and associated drug−drug interactions. Of particular interest was the CYP3A4 isoform, as a few compounds in the series, including <b>21</b>, demonstrated 3A4 inhibition ≤3 μM. The values for <b>7</b> and <b>8</b>, however, were both >10 μM, and there was no significant inhibition of any other P450 enzyme isoform tested.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Pharmacokinetics</h3><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> summarizes the results of the plasma protein binding (PPB) and rat and dog pharmacokinetic studies for <b>7</b>, <b>8</b>, and <b>21</b>. PPB was low (49, 67, and 88%, respectively). Compound <b>7</b>, when administered to dogs at 10 mg/kg po, displayed a <i>C</i><sub>max</sub> of 3.3 μM, a half-life of 3.9 h, and an oral bioavailability of 57%. At the same dose level and route of administration of <b>8</b>, the <i>C</i><sub>max</sub> was 5.7 μM, the half-life was 2.6 h, and the oral bioavailability was 100%. In contrast, the values for <b>21</b> were 1.6 μM, 2.1 h, and 60%, respectively.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Human Plasma Protein Binding (hPPB), in Vitro Anticoagulant Potency (2× aPTT), and Rat and Dog Pharmacokinetic Parameters of <b>7</b>, <b>8</b>, and <b>21</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center" char="."> </th><th align="center" char="."> </th><th align="center" char="."> </th><th colspan="3" align="center" char=".">rat</th><th colspan="3" align="center" char=".">dog</th></tr><tr valign="top"><th align="center" char=".">compd</th><th align="center" char=".">hPPB (%)</th><th align="center" char=".">2× aPTT (nM)</th><th align="center" char="."><i>C</i><sub>max</sub> (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th align="center" char="."><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th align="center" char="."><i>F</i> (%)</th><th align="center" char="."><i>C</i><sub>max</sub> (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th align="center" char="."><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top"><td align="char" char="."><b>7</b></td><td align="char" char=".">49</td><td align="char" char=".">342</td><td align="char" char=".">0.2</td><td align="char" char=".">1.6</td><td align="char" char=".">11</td><td align="char" char=".">3.3</td><td align="char" char=".">3.9</td><td align="char" char=".">57</td></tr><tr valign="top"><td align="char" char="."><b>8</b></td><td align="char" char=".">67</td><td align="char" char=".">510</td><td align="char" char=".">3.3<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td align="char" char=".">3.3</td><td align="char" char=".">23</td><td align="char" char=".">5.7</td><td align="char" char=".">2.6</td><td align="char" char=".">103</td></tr><tr valign="top"><td align="char" char="."><b>21</b></td><td align="char" char=".">88</td><td align="char" char=".">565</td><td align="char" char=".">0.2</td><td align="char" char=".">3.7</td><td align="char" char=".">9</td><td align="char" char=".">1.6</td><td align="char" char=".">2.1</td><td align="char" char=".">60</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Dose = 10 mg/kg unless otherwise noted in fasted animals.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">po half-life.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Dose = 30 mg/kg.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Anticoagulant and Antithrombotic Studies</h3><div class="NLM_p">On the basis of the results of the aforementioned in vitro and in vivo studies, <b>7</b> and <b>8</b> were chosen for continued assessment. Activated partial thromboplastin time (aPTT) is a global clotting test sensitive to plasma concentration variations in several clotting factors, particularly factors I, V, VII, IX, and XII of the intrinsic and common pathways, and is measured as follows: Blood samples are buffered by sodium citrate at a final concentration of 0.105−0.109 M and treated with phospholipids, surface activators, and calcium to shorten clotting time and initiate the coagulation reactions. A coagulometer is then used to measure the optical density of the mixture and record the time required to reach the threshold density at which a clot is said to have formed. Therapies prolonging aPTT from 1.5 to 2.5 (generally 2-fold) times the midpoint of the control range are associated with a reduction in the risk of recurrent thrombosis. Measurements of aPTT can be sensitive to the exact nature of the reagents used as well as sample storage/preparation protocols. Nevertheless, both prolonged and shortened aPTT values can have significant clinical implications with respect to bleeding and hypercoagulation, respectively. In the present study, fresh whole blood from humans, dogs, and rats was centrifuged to obtain plasma, and <b>8</b> was added to the plasma in concentrations from 0.001 to 100 μM. After a short stabilization period, the samples were placed in an ACL 100 microsampler coagulation analyzer to determine clotting times in seconds. In human-, rat-, and dog-spiked plasma, <b>8</b> doubled aPTT coagulation time at concentrations of 0.51 ± 0.08, 0.85 ± 0.12, and 2.03 ± 0.48 μM, respectively. Compound <b>7</b> doubled aPTT coagulation time at a concentration of 0.34 ± 0.02 μM in human plasma.</div><div class="NLM_p">To further define the antithrombotic efficacy of <b>7</b> and <b>8</b>, an electrical current-induced arterial thrombosis (ECAT) model in rats was used to evaluate the ability of the compounds to prolong time to occlusion.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Because arterial thrombosis in humans usually occurs in areas of medium to high blood flow and high sheer stress with a triggering factor of vascular injury such as atherosclerotic plaque rupture, the ECAT model may have strong pathophysiological relevance to human disease. Wong et al.<a onclick="showRef(event, 'cit25c'); return false;" href="javascript:void(0);" class="ref cit25c">(25c)</a> utilized scanning electron microscopy to confirm vessel wall injury at the site of electrical stimulation in this model: The de-endothelialized layer of the vessel showed both platelet and fibrin deposition, likely due to activation of the coagulation cascade by exposed tissue factor. Intravenous administration of <b>7</b> at doses of 0.03, 0.1, 0.3, and 1.0 mg/kg resulted in a prolongation of time to occlusion from a control of 11 ± 1 to 15.3 ± 3.2, 19.3 ± 3.8, 24.9 ± 2.6, and 30 ± 0 min, respectively, while <b>8</b> (iv) resulted in a prolongation of time to occlusion to 18.4 ± 7.1, 20.7 ± 3.7, 14.7 ± 5.0, and 30 ± 0 min, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). aPTT was also prolonged in a dose-related manner (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). For <b>8</b>, the increases in aPTT from a control of 21 ± 2 s were 23 ± 1, 31 ± 4, 35 ± 8, and 66 ± 42 s, respectively. A doubling of aPTT occurred at a dose of between 0.3 to 1.0 mg/kg, which was associated with plasma concentrations of <b>8</b> between 0.12 and 0.31 μM. For <b>7</b>, the increases in aPTT were 28 ± 2, 30 ± 2, 37 ± 9, and 47 ± 4 s, respectively. A doubling of aPTT also occurred at a dose of between 0.3 and 1.0 mg/kg, which was associated with plasma concentrations of <b>7</b> between 0.085 and 0.38 μM. In this model, <b>7</b> and <b>8</b> were 10-fold more potent than the reference DTI (2<i>R</i>,4<i>R</i>)-1-[(2<i>S</i>)-5(diaminomethylideneamino)-2-[[(3<i>R</i>)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methyl-piperidine-2-carboxylic acid (argatroban) and equipotent to one another by dose.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Time to carotid artery occlusion as a function of dose for <b>7</b> and <b>8</b> in the rat ECAT model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. aPTT as a function of dose for <b>7</b> and <b>8</b> in the rat ECAT model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An arteriovenous shunt procedure was employed as a suitable model to test the antithrombotic efficacy of the two lead thrombin inhibitors against a thrombus of mixed platelet/fibrin/red blood cell composition. In this model, a thrombus forms on a section of silk thread placed in an extracorporeal shunt between the femoral artery and the vein.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Imaging studies<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> using a <sup>99</sup>Tc-labeled platelet glycoprotein IIb/IIIa receptor antagonist have shown that the deposition on the thrombogenic surface mimics a high-shear, platelet-rich thrombus indicative of arterial conditions, and the platelet-poor tail mimics that of a venous thrombus stemming from a platelet-poor, low-shear environment. Studies consisting of seven shunt periods in dogs starting at 2 h postdrug and repeating every 30 min were performed. The thrombus weight was measured after each shunt period, and bleeding times and coagulation times were measured at 2, 3, 4, and 5 h and compared to control values.</div><div class="NLM_p">Thrombus formation (thrombus weight) by <b>7</b> was inhibited 38 ± 9 to 45 ± 12%, while for <b>8</b> inhibition ranged from 40 ± 13 to 73 ± 2% (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) during the 3 h testing period starting at 2 h postoral dosing. There were no significant changes in bleeding times as compared to vehicle experiments. Compound <b>8</b> administered orally at 3 mg/kg had no overt side effects in three out of three dogs during the 1 h period before they were anesthetized. aPTT was increased 1.6-fold for <b>8</b> at 1 h postoral dose as compared to 1.4-fold for <b>7</b>. Plasma concentrations at the 1 h time point were 0.87 ± 0.3 μM for <b>8</b> as compared to 0.48 ± 0.16 μM for <b>7</b>.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Antithrombotic effect of <b>7</b> and <b>8</b> after an oral dose of 3 mg/kg in the canine arteriovenous shunt model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further define the intravenous and oral antithrombotic efficacy of <b>8</b>, a rat deep vein thrombosis model was used to evaluate the compound's ability to inhibit venous thrombus formation (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> All experimental animal models of venous thrombosis include a trigger of the thrombogenic state, which is most often composed of two components of Virchow's triad: hypercoaguability, reduced blood flow, and vessel wall injury. Hypercoaguability is induced by treatment with an agent such as tissue factor or thromboplastin. Blood flow reduction can be achieved by complete stasis, in which case the concentration of blood components and antithrombotic agent is constant within the occluded segment. Reduced blood flow may also result from a partial stasis, which allows flow of test compound and blood components around the formed thrombus. Vessel wall injury plays a major role in the partial stasis paradigm or can be generated separately by means of ferric chloride or saline. Intravenous administration of <b>8</b> resulted in a 66 and 98% inhibition in thrombus weight at the 0.3 and 1 mg/kg dose, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) as well as dose-related changes in coagulation times. Oral administration of 30 and 50 mg/kg resulted in 87 and 94% inhibition of thrombus weight as well as dose-related changes in coagulation.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Effect of <b>8</b> on Thrombus Weight, aPTT, and Plasma Concentration in the Rat DVT Model</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char=" " /></col><col align="char" char=" " /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center" char=".">dose/route (mg/kg)</th><th align="center" char="±">mean thrombus weight (mg/100 g body weight ± SEM)</th><th align="center" char=".">decrease in thrombus weight vs vehicle (%)</th><th align="center" char=" ">aPTT</th><th align="center" char=" ">plasma concentration (μM)</th></tr></thead><tbody><tr valign="top"><td align="char">vehicle</td><td align="char" char="."> </td><td align="char" char="±">21.8 ± 0.4 (4)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td align="char" char="."> </td><td align="char" char=" ">ND<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> </td><td align="char" char=" "> </td></tr><tr valign="top"><td align="char">argatroban</td><td align="char" char=".">1.0, iv</td><td align="char" char="±">1.7 ± 0.3 (5)</td><td align="char" char=".">92</td><td align="char" char=" ">56 ± 7</td><td align="center" char=" ">ND</td></tr><tr valign="top"><td align="char"><b>8</b></td><td align="char" char=".">0.1, iv</td><td align="char" char="±">24.7 ± 3.0 (3)</td><td align="char" char=".">0</td><td align="center" char=" ">35</td><td align="char" char=" ">0.31 ± 0.21</td></tr><tr valign="top"><td align="char"> </td><td align="char" char=".">0.3, iv</td><td align="char" char="±">7.5 ± 2.4 (5)</td><td align="char" char=".">66</td><td align="char" char=" ">46 ± 8</td><td align="char" char=" ">0.54 ± 0.07</td></tr><tr valign="top"><td align="char"> </td><td align="char" char=".">1.0, iv</td><td align="char" char="±">0.5 ± 0.5 (3)</td><td align="char" char=".">98</td><td align="char" char=" ">49 ± 8</td><td align="char" char=" ">0.80 ± 0.06</td></tr><tr valign="top"><td align="char"><b>8</b></td><td align="char" char=".">10.0, po</td><td align="char" char="±">23.0 ± 1.8 (5)</td><td align="char" char=".">0</td><td align="char" char=" ">33 ± 3</td><td align="char" char=" ">0.10 ± 0.05</td></tr><tr valign="top"><td align="char"> </td><td align="char" char=".">30.0, po</td><td align="char" char="±">2.9 ± 0.6 (6)</td><td align="char" char=".">87</td><td align="char" char=" ">41 ± 6</td><td align="char" char=" ">0.76 ± 0.20</td></tr><tr valign="top"><td align="char"> </td><td align="char" char=".">50.0, po</td><td align="char" char="±">1.3 ± 0.2 (3)</td><td align="char" char=".">94</td><td align="char" char=" ">39 ± 6</td><td align="char" char=" ">0.73 ± 0.10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Number of animals in parentheses.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">ND, not determined.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Cardiovascular Safety</h3><div class="NLM_p">As part of an assessment of cardiovascular safety, <b>8</b> was evaluated in vitro for its effects on the human ether-a-go-go related gene (hERG) potassium channel. In the direct hERG channel binding assay, <b>8</b> demonstrated 50% inhibition of <sup>3</sup>H-astemizole binding at 10 μM. However, in an assay measuring percent inhibition of the Ikr-like current in hERG-transfected human embryonic kidney cells, <b>8</b> had only a minimal effect, showing a mean value of 9 ± 2%, which suggests that it has limited functional activity and should not cause QT interval prolongation.</div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> summarizes the effects of <b>7</b> and <b>8</b> on hemodynamics and electrocardiographic intervals in anesthetized guinea pigs at doses of 0.1, 0.3, 1, 3, and 10 mg/kg. At 10 mg/kg iv, <b>7</b> increased the QT interval 21% from baseline, and QTc, PR, and QRS intervals were lengthened by 10, 13, and 6%, respectively. Compound <b>8</b> had no significant effects on mean arterial pressure through 10 mg/kg (the apparent decrease was due to nondose-dependent blood pressure decreases in one animal) and no effect on heart rate except for a moderate decrease at 10 mg/kg. QT interval, QTc, PR interval, and QRS duration were not significantly affected by <b>8</b> at any dose evaluated. Furthermore, at concentrations up to 10 μM, <b>8</b> had no chronotropic or inotropic effects in the isolated right atrium of the guinea pig. Therefore, <b>8</b> was deemed to have the more favorable profile and was chosen for continued in vivo assessment.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Effects of <b>7</b> and <b>8</b> on Hemodynamics and ECG Intervals in Anesthetized Guinea Pigs</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="left"> </th><th align="left"> </th><th align="char" char="±">baseline</th><th align="char" char=".">0.1 mg/kg</th><th align="char" char=".">0.3 mg/kg</th><th align="char" char=".">1 mg/kg</th><th align="char" char=".">3 mg/kg</th><th align="char" char=".">10 mg/kg</th></tr></thead><tbody><tr valign="top"><td rowspan="3" align="left">MAP<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (mm Hg)</td><td align="left"><b>8</b></td><td align="char" char="±">51 ± 4</td><td align="char" char=".">4 ± 2</td><td align="char" char=".">5 ± 2</td><td align="char" char=".">5 ± 2</td><td align="char" char=".">2 ± 2</td><td align="char" char=".">−12 ± 9</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="char" char="±"> </td><td align="char" char=".">0</td><td align="char" char=".">−5</td><td align="char" char=".">−10</td><td align="char" char=".">−15</td><td align="char" char=".">−21</td></tr><tr valign="top"><td align="left">vehicle</td><td align="char" char="±">47 ± 12</td><td align="char" char=".">3 ± 5</td><td align="char" char=".">−2 ± 9</td><td align="char" char=".">−2 ± 6</td><td align="char" char=".">−3 ± 3</td><td align="char" char=".">−2 ± 4</td></tr><tr valign="top"><td rowspan="3" align="left">heart rate (beats/min)</td><td align="left"><b>8</b></td><td align="char" char="±">219 ± 6</td><td align="char" char=".">0 ± 1</td><td align="char" char=".">2 ± 2</td><td align="char" char=".">1 ± 1</td><td align="char" char=".">−2 ± 1</td><td align="char" char=".">−11 ± 2</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="char" char="±"> </td><td align="char" char=".">−5</td><td align="char" char=".">−9</td><td align="char" char=".">−12</td><td align="char" char=".">−17</td><td align="char" char=".">−21</td></tr><tr valign="top"><td align="left">vehicle</td><td align="char" char="±">242 ± 12</td><td align="char" char=".">−1 ± 2</td><td align="char" char=".">−4 ± 6</td><td align="char" char=".">−2 ± 7</td><td align="char" char=".">−4 ± 5</td><td align="char" char=".">−6 ± 5</td></tr><tr valign="top"><td rowspan="3" align="left">QT (ms)</td><td align="left"><b>8</b></td><td align="char" char="±">176 ± 3</td><td align="char" char=".">1 ± 1</td><td align="char" char=".">2 ± 2</td><td align="char" char=".">2 ± 1</td><td align="char" char=".">5 ± 1</td><td align="char" char=".">9 ± 1</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="char" char="±"> </td><td align="char" char=".">4</td><td align="char" char=".">9</td><td align="char" char=".">11</td><td align="char" char=".">14</td><td align="char" char=".">21</td></tr><tr valign="top"><td align="left">vehicle</td><td align="char" char="±">175 ± 18</td><td align="char" char=".">2 ± 1</td><td align="char" char=".">2 ± 2</td><td align="char" char=".">3 ± 2</td><td align="char" char=".">6 ± 3</td><td align="char" char=".">8 ± 4</td></tr><tr valign="top"><td rowspan="3" align="left">QTc (ms)</td><td align="left"><b>8</b></td><td align="char" char="±">336 ± 4</td><td align="char" char=".">1 ± 0</td><td align="char" char=".">2 ± 1</td><td align="char" char=".">3 ± 1</td><td align="char" char=".">3 ± 2</td><td align="char" char=".">2 ± 1</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="char" char="±"> </td><td align="char" char=".">4</td><td align="char" char=".">4</td><td align="char" char=".">5</td><td align="char" char=".">5</td><td align="char" char=".">10</td></tr><tr valign="top"><td align="left">vehicle</td><td align="char" char="±">353 ± 9</td><td align="char" char=".">−3 ± 5</td><td align="char" char=".">0 ± 9</td><td align="char" char=".">2 ± 9</td><td align="char" char=".">2 ± 8</td><td align="char" char=".">4 ± 7</td></tr><tr valign="top"><td rowspan="3" align="left">PR (ms)</td><td align="left"><b>8</b></td><td align="char" char="±">72 ± 3</td><td align="char" char=".">2 ± 2</td><td align="char" char=".">7 ± 5</td><td align="char" char=".">7 ± 3</td><td align="char" char=".">6 ± 5</td><td align="char" char=".">4 ± 7</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="char" char="±"> </td><td align="char" char=".">2</td><td align="char" char=".">1</td><td align="char" char=".">6</td><td align="char" char=".">8</td><td align="char" char=".">13</td></tr><tr valign="top"><td align="left">vehicle</td><td align="char" char="±">68 ± 2</td><td align="char" char=".">3 ± 3</td><td align="char" char=".">4 ± 2</td><td align="char" char=".">2 ± 2</td><td align="char" char=".">1 ± 2</td><td align="char" char=".">0 ± 2</td></tr><tr valign="top"><td rowspan="3" align="left">QRS (ms)</td><td align="left"><b>8</b></td><td align="char" char="±">27 ± 4</td><td align="char" char=".">0 ± 0</td><td align="char" char=".">0 ± 0</td><td align="char" char=".">−2 ± 1</td><td align="char" char=".">−1 ± 2</td><td align="char" char=".">0 ± 3</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="char" char="±"> </td><td align="char" char=".">3</td><td align="char" char=".">2</td><td align="char" char=".">2</td><td align="char" char=".">3</td><td align="char" char=".">6</td></tr><tr valign="top"><td align="left">vehicle</td><td align="char" char="±">36 ± 1</td><td align="char" char=".">−2 ± 3</td><td align="char" char=".">−3 ± 3</td><td align="char" char=".">−4 ± 3</td><td align="char" char=".">−5 ± 3</td><td align="char" char=".">−4 ± 3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Mean arterial pressure.</p></div></div></div><div class="NLM_p">Despite the slightly increased potency of <b>7</b> in vitro [2× aPTT = 342 nM vs 510 nM for <b>8</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>)], the more favorable hERG channel binding value (25% inhibition at 10 μM vs 50% inhibition at 10 μM for <b>8</b>), and the lower level of human plasma protein binding (49 vs 67% for <b>8</b>), <b>7</b> compared less favorably to <b>8</b> in other respects. As mentioned above, the rat and dog PK parameters of <b>8</b> were generally superior to those of <b>7</b> with the exception of the <i>t</i><sub>1/2</sub> in dogs.</div><div class="NLM_p last">Compound <b>8</b> was studied for hemodynamic and electrophysiological effects after oral administration (20 mg/kg) in conscious dogs. Relative to solvent, <b>8</b> had no statistically significant effect on heart rate, systolic blood pressure, pressure rate product, cardiac output, stroke volume, the duration of the PQ, QRS, QT, QTcB, QTcF, and QTcVdW intervals, QT dispersion, or on ECG morphology. It tended to decrease diastolic blood pressure (peak effect −20% vs baseline at 165 min) and systemic vascular resistance (peak effect −26% vs baseline at 75 min) and increase cardiac contractility (LV d<i>p/</i>d<i>t</i> max, LV d<i>p</i>/d<i>t</i> max/pd) and relaxation (LV d<i>p</i>/d<i>t</i> min).</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Target Selectivity for <b>8</b></h3><div class="NLM_p last">Compound <b>8</b> was tested against a panel of 50 receptors and ion channels (Cerep International, France) and did not inhibit paradigm compound binding to any of the receptors by more than 26% at a concentration of 1 μM. Receptors that demonstrated inhibition >10% at 1 μM (AT<sub>1</sub>, H<sub>1central</sub>, MC<sub>4</sub>, NK<sub>2</sub>, and κ) and all ion channels were reassessed at 10 μM. Even at the higher concentration, <b>8</b> inhibited paradigm compound binding to only one receptor (L-type Ca<sup>2+</sup> channel) more than 29%.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Human Clinical Studies</h3><div class="NLM_p">On the basis of these noteworthy preclinical data, <b>8</b> was advanced into phase 1 safety and biomarker assessment trials in humans. A double-blind, randomized, placebo-controlled study was conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of <b>8</b> (solution formulation) in healthy male volunteers. Eight cohorts of subjects were included. In each cohort, six subjects were randomized to receive a single oral dose of <b>8</b> (4, 12, 36, 100, 200, 300, 400, or 500 mg), and two subjects were randomized to receive placebo. Ascending doses of <b>8</b> were administered to each cohort. Subjects received a single oral dose of <b>8</b> as a solution or matching placebo on the morning of day 1 with 200 mL of water. All subjects had fasted for at least 10 h prior to dose administration. Venous blood samples (5 mL) were collected predose (within 60 min prior to dosing) and at 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 12, 24, and 48 h postdosing for determination of plasma concentrations of <b>8</b>. The pharmacodynamic parameters assessed in this study focused on evaluating the effect of <b>8</b> on coagulation and hemostasis. Evaluated were the following parameters: aPTT, expressed in seconds and as a ratio relative to individual subject baseline (−1 h) values; prothrombin time (PT), expressed in seconds and International Normalized Ratio; ecarin clotting time (ECT), expressed in seconds; and activated clotting time (ACT), expressed in seconds.</div><div class="NLM_p">Compound <b>8</b> was rapidly absorbed into the plasma: the median <i>t</i><sub>max</sub> ranged from 1.25 to 2.50 h (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>; linear and semilogarithmic scales shown). However, subjects generally showed more than one peak in the pharmacokinetic profile. Multiple peaks were also observed in rat studies after oral dosing and are hypothesized to be due to enterohepatic recirculation, supported by results of an additional rat biliary excretion study (data not shown).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mean plasma concentration−time profiles of <b>8</b> in healthy human volunteers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The mean terminal half-life was consistent across the dose range and ranged from 3.85 to 5.57 h; however, due to minimal sampling times in the 12−48 h period, these data should be interpreted with caution. The majority of <b>8</b> was removed from the plasma within 12 h postdosing: Concentrations at 12 h postdose were <17% of the <i>C</i><sub>max</sub>. The mean apparent volume of distribution (V/F) ranged from 530 to 806 L, and the mean apparent clearance (CL/F) varied from 85.3 to 109 L/h across the 100−500 mg dose range.</div><div class="NLM_p">As compared with placebo, mean aPTT values increased in subjects receiving <b>8</b> at doses of 100 mg or higher (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Mean aPTT values peaked between 0.5 and 4 h postdosing (around the same time maximum plasma concentrations were observed) and returned to baseline at around 24 h postdose. The overall effect of <b>8</b> on aPTT increased with higher doses, with the greatest effect seen in the 500 mg dose group. A similar pattern of results was observed for the other ex vivo clotting parameters (PT, ACT, and ECT).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Mean plasma aPTT−time profiles as a function of <b>8</b> in healthy human volunteers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have explored a series of potent nonpeptidic pyrazinone-based thrombin inhibitors featuring a P1 oxyguanidine moiety, which led to <b>8</b> as a promising clinical candidate. This compound exhibited good binding affinity, notable results in a variety of in vitro screening assays, greatly improved PK as compared to thrombin inhibitors with highly basic guanidine/amidine P1 groups, and impressive efficacy in several in vivo thrombosis models, such as ECAT, AV shunt, and DVT. Given the favorable preclinical efficacy and safety profiles for <b>8</b>, it was advanced into human clinical studies. The initial results from the successful completion of phase I clinical safety, tolerability, PK, and pharmacodynamic studies of <b>8</b> were promising.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21176" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21176" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry</h3><div class="NLM_p last">Reagents and solvents were obtained from commercial suppliers and used without further purification. Flash chromatography was performed using Fisher Chemical Silica Gel Sorbent (230−400 mesh, grade 60). <sup>1</sup>H NMR spectra were recorded on a Bruker B-ACS-120 (400 MHz) spectrophotometer at room temperature. Chemical shifts are given in ppm (δ), coupling constants (<i>J</i>) are in hertz (Hz), and signals are designated as follows: (s) singlet, (d) doublet, (t) triplet, (q) quartet, (m) multiplet, (br s) broad singlet, (br t) broad triplet, (br m) broad multiplet, (dd) doublet of doublet, (dt) doublet of triplet, (td) triplet of doublet, (dq) doublet of quartet, (tm) triplet of multiplet, (ddd) doublet of doublet of doublet, (ddt) doublet of doublet of triplet, and (dddd) doublet of doublet of doublet of doublet. LC-MS was performed on a system consisting of an electrospray source on a Finnigan LCQ ion trap mass spectrometer, a SEDEX 75C evaporative light scattering detector, a Shimadzu LC-10ADvp binary gradient pumping system, a Gilson 215 configured as an autosampler, and a Princeton Chromatography HTS HPLC column (5 μm, 50 mm × 3.0 mm). Accurate mass measurements were performed using either of two methods: (1) A Micromass (Manchester, United Kingdom) Autospec E OA-TOF high-resolution magnetic sector mass spectrometer was tuned to a resolution of >5000 using the 5% valley definition. The ions were produced in a fast atom bombardment (FAB) ion source at an accelerating voltage of 8 kV. Linear voltage scans at 33 Da/s were collected to include the protonated sample ion and two polyethylene glycol (PEG) or PEG monomethyl ether ions, which were used as internal reference standards. The molecular mass was calculated using a linear extrapolation method. Reported mass values are averages over 100 s. (2) Positive ion electrospray (ESI) high-resolution mass spectrometry was carried out with a Micromass Q-Tof API US hybrid quadrupole/time-of-flight mass spectrometer. The mass spectrometer was externally calibrated using cesium iodide. PEG 400 was added to the samples as an internal calibrant. The purities of some key target compounds were determined on a Varian HPLC system equipped with two Varian PrepStar delivery pumps (model 218) and a Varian UV−vis detector (model 345). The HPLC method used was as follows: column, PrincetonSPHER-100 Phenyl, 4.6 mm × 150 mm, 5 μm; column temperature, ambient; flow rate, 1.0 mL/min; gradient, 20% acetonitrile (0.01% TFA and 0.2% formic acid) in water (0.01% TFA and 0.2% formic acid) to 80% acetonitrile (0.01% TFA and 0.2% formic acid) in water (0.01% TFA and 0.2% formic acid) in 30 min. All of the final compounds had 95% or greater purity.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-[2-(Benzyloxycarbonylamino)ethoxy]phthalimide (<b>1</b>)</h3><div class="NLM_p last">To a solution of benzyl <i>N</i>-(2-hydroxyethyl)carbamate (5.9 g, 30 mmol), <i>N</i>-hydroxyphthalimide (4.9 g, 30 mmol), and triphenylphosphine (7.9 g, 30 mmol) in tetrahydrofuran (100 mL) was added diethyl azodicarboxylate (5.2 g, 30 mmol). The reaction mixture was stirred at room temperature overnight. Ethyl acetate (200 mL) was added, washed with saturated NaHCO<sub>3</sub> (2 × 100 mL) and brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. After the filtrate was evaporated, the residue was purified by flash column chromatography (methylene chloride/ethyl acetate, 1:0 to 96:4, v/v) to give compound <b>1</b> as a white solid (9.3 g, 91%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.84 (m, 2H), 7.78 (m, 2H), 7.37 (m, 5H), 5.97 (br s, 1H), 5.14 (s, 2H), 4.27 (t, <i>J</i> = 4.9 Hz, 2H), 3.51 (q, <i>J</i> = 5.2 Hz, 2H).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-(Benzyloxycarbonylamino)ethoxyamine (<b>2</b>)</h3><div class="NLM_p last">To a solution of <b>1</b> (1.4 g, 4.0 mmol) in ethanol (20 mL) and tetrahydrofuran (20 mL) was added 40% methylamine (2.0 mL, 25 mmol), and the mixture stirred at room temperature for 1 h. After the solvent was evaporated, the residue was purified by flash column chromatography (hexane/ethyl acetate, 3:1 to 0:1, v/v) to give <b>2</b> as a white solid (800 mg, 95%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.36 (m, 5H), 5.47 (br s, 2H), 5.21 (br s, 1H), 5.10 (s, 2H), 3.72 (t, <i>J</i> = 5.0 Hz, 2H), 3.44 (q, <i>J</i> = 5.0 Hz, 2H).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> [<i>N</i>,<i>N</i>′-Di-(<i>tert-</i>butoxycarbonyl)]-2-(benzyloxycarbonylamino)ethoxyguanidine (<b>3</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (0.78 g, 3.7 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (20 mL) was added [<i>N</i>,<i>N</i>′-di-(<i>tert</i>-butoxycarbonyl)]amidinopyrazole (1.3 g, 4.0 mmol). The mixture was stirred at room temperature overnight, and the solvent was evaporated under high vacuum. The residue was purified by flash column chromatography (methylene chloride/ethyl acetate, 1:0 to 95:5, v/v) to give <b>3</b> as a colorless oil (1.55 g, 93%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.08 (s, 1H), 7.33 (m, 5H), 6.21 (br s, 1H), 5.21 (br s, 1H), 5.11 (s, 2H), 4.12 (t, <i>J</i> = 4.8 Hz, 2H), 3.54 (q, <i>J</i> = 4.9 Hz, 2H), 1.49 (s, 9H), 1.46 (s, 9H).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> [<i>N</i>,<i>N</i>′-Di-(<i>tert</i>-butoxycarbonyl)]-2-aminoethoxyguanidine (<b>4</b>)</h3><div class="NLM_p last">A mixture of <b>4</b> (730 mg, 1.5 mmol), as prepared in the preceding step, 10% palladium on carbon (70 mg) in ethanol (20 mL), and tetrahydrofuran (20 mL) was hydrogenated under hydrogen (balloon) for 30 min. The catalysts were removed by filtration through diatomaceous earth, and the filtrate was concentrated in vacuo. The residue was purified on a 10 g Waters Sep-Pak (methylene chloride/methanol saturated with ammonia, 95:5, v/v) to give the title compound as a colorless oil (290 mg, 61%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.08 (br s, 1H), 4.08 (t, <i>J</i> = 5.2 Hz, 2H), 2.99 (q, <i>J</i> = 5.1 Hz, 2H), 1.50 (s, 9H), 1.48 (s, 9H).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Representative Procedure for the Synthesis of 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-substituted-3-alkylpyrazinones (<b>7</b>−<b>18</b>). Synthesis of <b>7</b></h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Step A: [6-Cyano-3-(2,2-difluoro-2-phenyl-ethylamino)-2-oxo-2<i>H</i>-pyrazin-1-yl]acetic Acid Ethyl Ester</h4><div class="NLM_p last">Compound <b>5</b> (0.20 g, 0.83 mmol) was dissolved in toluene (5 mL), treated with 2,2-difluoro-2-phenylethylamine (0.80 g, 5.1 mmol), and heated to 60 °C for 3 h. The reaction was concentrated to dryness, and the residue was dissolved in dichloromethane, washed with 5% aqueous HCl, saturated NaHCO<sub>3</sub>, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated to dryness, adsorbed onto silica gel, poured onto a 7 cm × 3 cm pad of silica gel, and eluted with ethyl acetate/dichloromethane, 0:1 to 1:9, v/v. The fractions were concentrated in vacuo giving [6-cyano-3-(2,2-difluoro-2-phenyl-ethylamino)-2-oxo-2<i>H</i>-pyrazin-1-yl]acetic acid ethyl ester as a light orange solid (0.29 g, 95%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.53 (m, 2H), 7.46 (m, 3H), 7.38 (s, 1H), 6.95 (br m, 1H), 4.79 (s, 2H), 4.29 (q, 2H, <i>J</i> = 7.1 Hz), 4.16 (td, 2H, <i>J</i> = 6.5 Hz, 14.2 Hz), 1.32 (t, 3H, <i>J</i> = 7.1 Hz).</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Step B: [6-Cyano-3-(2,2-difluoro-2-phenyl-ethylamino)-2-oxo-2<i>H</i>-pyrazin-1-yl]acetic Acid</h4><div class="NLM_p last">The product of step A (0.28 g, 0.77 mmol) was dissolved in 1,4-dioxane (10 mL) and treated with 1 N NaOH (4 mL) at ambient temperature. After it was stirred for 1.5 h, the reaction was concentrated to dryness, dissolved in hot water (10 mL), acidified with 10% aqueous HCl, and cooled to ambient temperature, and the precipitate was filtered. The solids were washed with water, dissolved in tetrahydrofuran, and filtered, and the filtrate was concentrated in vacuo giving [6-cyano-3-(2,2-difluoro-2-phenyl-ethylamino)-2-oxo-2<i>H</i>-pyrazin-1-yl]acetic acid as a gummy red-orange solid (0.27 g, 100% for the hydrate). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.64 (t, 1H, <i>J</i> = 6.6 Hz), 7.62 (s, 1H), 7.53 (m, 5H), 4.72 (s, 2H), 4.14 (td, 2H, <i>J</i> = 6.6 Hz, 15 Hz). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 334.9.</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Step C: 1-{<i>N</i>-[2-(<i>N</i>′,<i>N</i>′′-Bis{<i>tert</i>-butoxycarbonyl}amidinoaminooxy)ethyl]amino}carbonylmethyl-6-cyano-3-[2,2-difluoro-2-phenylethylamino]pyrazinone</h4><div class="NLM_p last">The product of step B (0.27 g, 0.77 mmol) was dissolved in anhydrous <i>N</i>,<i>N</i>-dimethylformamide (10 mL) and treated with <b>4</b>, Castro's reagent (0.42 g, 0.95 mmol), and triethylamine (0.30 mL, 2.2 mmol). After it was stirred at room temperature for 18 h, the reaction was concentrated to an oil, dissolved in dichloromethane, washed with 10% aqueous citric acid, water, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated to dryness, the crude product was purified by flash column chromatography on silica gel with ethyl acetate/hexanes, 1:1 to 2:1, v/v, and the fractions were concentrated in vacuo giving 1-{<i>N</i>-[2-(<i>N</i>′,<i>N</i>′′-bis{<i>tert</i>-butoxycarbonyl}amidinoaminooxy) ethyl]amino}carbonylmethyl-6-cyano-3-[2,2-difluoro-2-phenylethylamino]pyrazinone as a pale yellow solid (0.35 g, 71%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.19 (br s, 1H), 8.78 (br s, 1H), 7.55 (m, 2H), 7.48 (m, 3H), 7.37 (s, 1H), 6.94 (t, 1H, <i>J</i> = 6.3 Hz), 4.88 (s, 2H), 4.15 (m, 4H), 3.66 (m, 2H), 1.54 (s, 9H), 1.51 (s, 9H). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 634.8.</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Step D: 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-cyano-3-[2,2-difluoro-2-phenylethylamino]pyrazinone Dihydrochloride (<b>7</b>)</h4><div class="NLM_p last">The product of step C (0.34 g, 0.54 mmol) was dissolved in dichloromethane (10 mL), treated with trifluoroacetic acid (5 mL), and stirred at ambient temperature for 8 h. The reaction was concentrated to dryness, the crude product was purified by flash column chromatography on silica gel with methanol/dichloromethane saturated with ammonia gas, 85:15, v/v, and the fractions were concentrated in vacuo. The column fractions were treated with 4 N HCl in ethanol, concentrated under high vacuum, and filtered, giving <b>7</b> as a white solid (0.19 g, 82%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.50 (br t, 1H, <i>J</i> = 6.1 Hz), 8.41 (t, 1H, <i>J</i> = 5.5 Hz), 7.57 (s, 1H), 7.52 (m, 5H), 5.13 (br s, 2H), 4.62 (s, 2H), 4.40 (br s, 2H), 4.13 (td, 2H, <i>J</i> = 5.5 Hz, 15 Hz), 3.63 (t, 2H, <i>J</i> = 5.6 Hz), 3.30 (q, 2H, <i>J</i> = 5.6 Hz). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 435.1. Anal. (C<sub>18</sub>H<sub>20</sub>F<sub>2</sub>N<sub>8</sub>O<sub>3</sub>·2HCl·0.1H<sub>2</sub>O·0.17CH<sub>3</sub>N) C, H, N.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone Dihydrochloride (<b>8</b>)</h3><div class="NLM_p last">Yield, 37%; mp 211−214 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.89 (s, 1H), 8.46 (t, <i>J</i> = 5.5 Hz, 1H), 7.69 (br s, 4H), 7.53 (m, 2H), 7.50 (m, 3H), 6.84 (t, <i>J</i> = 6.5 Hz, 1H), 6.64 (s, 1H), 4.62 (s, 2H), 4.06 (dt, <i>J</i> = 6.5, 14.4 Hz, 2H), 3.81 (t, <i>J</i> = 5.4 Hz, 2H), 3.38 (m, 2H), 2.06 (s, 3H). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 424.4. Anal. (C<sub>18</sub>H<sub>23</sub>F<sub>2</sub>N<sub>7</sub>O<sub>3</sub>·2HCl·0.15H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-(4-fluorophenethylamino)pyrazinone Bis-trifluoroacetic Acid Salt (<b>9</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 10.97 (s, 1H), 8.45 (t, <i>J</i> = 5.6 Hz, 1H), 7.74 (br s, 4H), 7.26 (m, 2H), 7.15 (t, <i>J</i> = 8.8 Hz, 2H), 6.68 (s, 1H), 4.61 (s, 2H), 3.81 (t, <i>J</i> = 5.4 Hz, 2H), 3.39 (m, 4H), 2.85 (t, <i>J</i> = 7.3 Hz, 2H), 2.07 (s, 3H). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 406.6. HPLC <i>t</i><sub>R</sub> = 5.06 min, >98% pure.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-(2-[3,4-difluorophenyl]ethylamino)pyrazinone Dihydrochloride (<b>10</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.05 (s, 1H), 8.63 (t, 1H, <i>J</i> = 5.5 Hz), 7.74 (br s, 4H), 7.46 (t, 1H, <i>J</i> = 10 Hz), 7.36 (dt, 1H, <i>J</i> = 10.9 Hz, 8.5 Hz), 7.15 (m, 1H), 6.70 (s, 1H), 4.66 (s, 2H), 3.82 (t, 2H, <i>J</i> = 5.4 Hz), 3.66 (m, 2H), 3.38 (m, 2H), 2.91 (t, 2H, <i>J</i> = 7.4 Hz), 2.13 (s, 3H). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 424.4. HPLC <i>t</i><sub>R</sub> = 5.33 min, >98% pure.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-(2-[2,4-difluorophenyl]ethylamino)pyrazinone Bis-trifluoroacetic Acid Salt (<b>11</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.03 (s, 1H), 8.46 (t, <i>J</i> = 5.6 Hz, 1H), 7.77 (br s, 4H), 7.34 (q, <i>J</i> = 7.8 Hz, 1H), 7.18 (t, <i>J</i> = 9.5 Hz, 1H), 7.03 (t, <i>J</i> = 8.0 Hz, 1H), 6.67 (s, 1H), 4.62 (s, 2H), 3.81 (t, <i>J</i> = 5.4 Hz, 2H), 3.51 (m, 2H), 3.39 (t, <i>J</i> = 5.5 Hz, 2H), 2.89 (t, <i>J</i> = 7.1 Hz, 2H), 2.08 (s, 3H). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 424.4. HPLC <i>t</i><sub>R</sub> = 5.81 min, >98% pure.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-(2-[4-trifluoromethylphenyl]ethylamino)pyrazinone Bis-trifluoroacetic Acid Salt (<b>12</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 10.98 (s, 1H), 8.45 (t, 1H, <i>J</i> = 5.5 Hz), 7.74 (br s, 4H), 7.66 (d, 2H, <i>J</i> = 8.1 Hz), 7.47 (d, 2H, <i>J</i> = 8.0 Hz), 6.68 (s, 1H), 4.62 (s, 2H), 3.81 (t, 2H, <i>J</i> = 5.4 Hz), 3.50 (m, 2H), 3.38 (q, 2H, <i>J</i> = 5.4 Hz), 2.97 (t, 2H, <i>J</i> = 7 Hz), 2.08 (s, 3H). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 456.2. HPLC <i>t</i><sub>R</sub> = 6.32 min, >98% pure.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-(4-methoxyphenethylamino)pyrazinone Bis-trifluoroacetic Acid Salt (<b>13</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 10.88 (s, 1H), 8.42 (t, <i>J</i> = 5.5 Hz, 1H), 7.68 (br s, 4H), 7.15 (d, <i>J</i> = 8.6 Hz, 2H), 6.85 (d, <i>J</i> = 8.7 Hz, 2H), 6.67 (s, 1H), 4.61 (s, 2H), 3.81 (t, <i>J</i> = 5.3 Hz, 2H), 3.72 (s, 3H), 3.50 (m, 2H), 3.38 (m, 2H), 2.79 (t, <i>J</i> = 6.9 Hz, 2H), 2.07 (s, 3H). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 418.3. Anal. (C<sub>19</sub>H<sub>27</sub>N<sub>7</sub>O<sub>4</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·0.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-(3,4-dimethoxyphenylethylamino)pyrazinone Bis-trifluoroacetic Acid Salt (<b>14</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 10.95 (s, 1H), 8.44 (t, <i>J</i> = 5.6 Hz, 1H), 7.72 (br s, 4H), 6.85 (t, <i>J</i> = 8.1 Hz, 2H), 6.73 (d, <i>J</i> = 8.1 Hz, 1H), 6.67 (s, 1H), 4.61 (s, 2H), 3.81 (t, <i>J</i> = 5.3 Hz, 2H), 3.73 (s, 3H), 3.71 (s, 3H), 3.39 (m, 4H), 2.79 (t, <i>J</i> = 7.2 Hz, 2H), 2.07 (s, 3H). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 448.2. HPLC <i>t</i><sub>R</sub> = 4.84 min, >98% pure.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-(4-ethylphenethylamino)pyrazinone Bis-trifluoroacetic Acid Salt (<b>15</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 10.97 (s, 1H), 8.44 (t, <i>J</i> = 5.6 Hz, 1H), 7.73 (br s, 4H), 7.14 (s, 4H), 6.67 (s, 1H), 4.61 (s, 2H), 3.81 (t, <i>J</i> = 5.2 Hz, 2H), 3.39 (m, 4H), 2.82 (t, <i>J</i> = 7.5 Hz, 2H), 2.56 (q, <i>J</i> = 7.6 Hz, 2H), 2.07 (s, 3H), 1.16 (t, <i>J</i> = 7.5 Hz, 3H). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 416.2. Anal. (C<sub>20</sub>H<sub>29</sub>N<sub>7</sub>O<sub>3</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-(2-[5-indanyl]ethylamino)pyrazinone Dihydrochloride (<b>16</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.13 (s, 1H), 8.71 (t, 1H, <i>J</i> = 5.5 Hz), 7.78 (br s, 4H), 7.19 (s, 1H), 7.14 (d, 1H, <i>J</i> = 7.7 Hz), 7.07 (m, 1H), 6.70 (s, 1H), 4.67 (s, 2H), 3.82 (t, 2H, <i>J</i> = 5.3 Hz), 3.65 (m, 2H), 2.84 (m, 6H), 2.13 (s, 3H), 1.99 (pentet, 2H, <i>J</i> = 7.4 Hz). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 428.3. HPLC <i>t</i><sub>R</sub> = 5.20 min, >98% pure.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2-(1-naphthalene)ethyl]aminopyrazinone Dihydrochloride (<b>17</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.1 (s, 1H), 8.71 (t, 1H, <i>J</i> = 5.3 Hz), 8.26 (d, 1H, <i>J</i> = 8.2 Hz), 7.94 (d, 1H, <i>J</i> = 8.1 Hz), 7.83 (d, 1H, <i>J</i> = 8.2 Hz), 7.78 (br s, 4H), 7.56 (m, 3H), 7.46 (t, 1H, <i>J</i> = 7.5 Hz), 6.73 (s, 1H), 4.69 (s, 2H), 3.80 (m, 4H), 3.42 (m, 4H), 2.14 (s, 3H). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 438.2. Anal. (C<sub>22</sub>H<sub>27</sub>N<sub>7</sub>O<sub>3</sub>·2HCl·0.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-(2,2-diphenylethylamino)pyrazinone Bis-trifluoroacetic Acid Salt (<b>18</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.92 (s, 1H), 8.44 (t, <i>J</i> = 5.6 Hz, 1H), 7.71 (br s, 4H), 7.11 (s, 4H), 6.67 (s, 1H), 4.61 (s, 2H), 3.81 (t, <i>J</i> = 5.4 Hz, 2H), 3.50 (m, 2H), 3.38 (m, 2H), 2.81 (t, <i>J</i> = 6.9 Hz, 2H), 2.27 (s, 3H), 2.07 (s, 3H). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 402.1. Anal. (C<sub>24</sub>H<sub>29</sub>N<sub>7</sub>O<sub>3</sub>·2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·1.0H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> [6-Chloro-3-(2,2-difluoro-2-phenyl-ethylamino)-2-oxo-2<i>H</i>-pyrazin-1-yl]acetic Acid (<b>20</b>)</h3><div class="NLM_p">Compound <b>19</b> (0.78 g, 3.0 mmol) was dissolved in toluene (10 mL), treated with 2,2-difluoro-2-phenylethylamine (1.0 g, 6.4 mmol), heated to reflux for 12 h, and then stirred at ambient temperature for 3 days. The reaction was concentrated to dryness in vacuo, the crude product was purified by flash column chromatography on silica gel with hexanes/ethyl acetate, 1:1, v/v as eluant, and the column fractions were concentrated in vacuo giving [3-(2,2-difluoro-2-phenyl-ethylamino)-2-oxo-2<i>H</i>-pyrazin-1-yl]acetic acid ethyl ester as a pale orange solid (0.75 g, 75%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.56 (m, 2H), 7.45 (m, 3H), 6.83 (d, 1H, <i>J</i> = 4.7 Hz), 6.42 (d, 1H, <i>J</i> = 4.7 Hz), 6.36 (m, 1H), 4.57 (s, 2H), 4.26 (q, 2H, <i>J</i> = 7 Hz), 4.13 (td, 2H, <i>J</i> = 6 Hz, 14 Hz), 1.31 (t, 3H, <i>J</i> = 7 Hz).</div><div class="NLM_p">Next, a solution of [3-(2,2-difluoro-2-phenyl-ethylamino)-2-oxo-2<i>H</i>-pyrazin-1-yl]acetic acid ethyl ester (0.75 g, 2.2 mmol) and <i>N</i>-chlorosuccinimide (0.30 g, 2.3 mmol) in 1,2-dichloroethane (40 mL) was heated to reflux for 2.5 h. After it was cooled to room temperature, the reaction was washed with saturated aqueous NaHCO<sub>3</sub> and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the filtrate was concentrated to dryness. The crude product was then adsorbed onto silica gel, poured onto a 3 cm × 6 cm pad of silica gel, eluted with hexanes/ethyl acetate, 3:1 to 2:1, v/v, and the fractions were concentrated in vacuo giving [6-chloro-3-(2,2-difluoro-2-phenyl-ethylamino)-2-oxo-2<i>H</i>-pyrazin-1-yl]acetic acid ethyl ester as a pale orange solid (0.67 g, 81%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.53 (m, 2H), 7.43 (m, 3H), 6.90 (s, 1H), 6.25 (br t, 1H, <i>J</i> = 5.8 Hz), 4.89 (s, 2H), 4.26 (q, 2H, <i>J</i> = 7 Hz), 4.09 (td, 2H, <i>J</i> = 6 Hz, 14 Hz), 1.30 (t, 3H, <i>J</i> = 7.2 Hz). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 352.0.</div><div class="NLM_p last">[6-Chloro-3-(2,2-difluoro-2-phenyl-ethylamino)-2-oxo-2<i>H</i>-pyrazin-1-yl]acetic acid ethyl ester (0.67 g, 1.8 mmol) was then dissolved in 1,4-dioxane (24 mL) and treated with 1 N aqueous NaOH (8.0 mL, 8.0 mmol). After it was stirred at ambient temperature for 18 h, the reaction was concentrated to dryness, dissolved in water, and treated with 10% aqueous HCl to pH 4, and the white precipitate was filtered, washed thrice with water and once with hexane, and dried in vacuo giving <b>20</b> as a white solid (0.56 g, 90%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.50 (m, 5H), 6.95 (s, 1H), 4.79 (s, 2H), 4.06 (td, 2H, <i>J</i> = 6.5 Hz, 15 Hz).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-{<i>N</i>-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-chloro-3-[2,2-difluoro-2-phenylethylamino]pyrazinone Dihydrochloride (<b>21</b>)</h3><div class="NLM_p">Compound <b>20</b> (0.56 g, 1.6 mmol) was dissolved in anhydrous <i>N</i>,<i>N</i>-dimethylformamide (25 mL) and treated with [<i>N</i>,<i>N</i>′-di(<i>tert</i>-butoxycarbonyl)]-2-aminoethoxyguanidine (0.64 g, 2.0 mmol), Castro's reagent (0.89 g, 2.0 mmol), and triethylamine (1.0 mL, 7.2 mmol). After it was stirred at ambient temperature for 3 days, the reaction was concentrated to dryness in vacuo, the residue was dissolved in dichloromethane, washed with 10% aqueous citric acid, water, saturated aqueous NaHCO<sub>3</sub>, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the filtrate was concentrated in vacuo. The crude product was adsorbed onto silica gel, poured onto a 7 cm × 3 cm pad of silica gel, and eluted with hexanes/ethyl acetate, 2:1 to 0:1, v/v, and the fractions were concentrated in vacuo giving 1-{<i>N</i>-[2-(<i>N</i>′,<i>N</i>′′-bis{<i>tert</i>-butoxycarbonyl}amidinoaminooxy)ethyl]amino}carbonylmethyl-6-chloro-3-[2,2-difluoro-2-phenylethylamino]pyrazinone as a light yellow solid (0.91 g, 86%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.15 (s, 1H), 8.55 (br t, 1H, <i>J</i> = 5 Hz), 7.53 (m, 3H [Aryl + NH]), 7.43 (m, 3H), 6.88 (s, 1H), 6.25 (t, 1H, <i>J</i> = 6.4 Hz), 4.96 (s, 2H), 4.11 (m, 4H), 3.63 (dd, 2H, <i>J</i> = 4.9 Hz, 8.5 Hz), 1.51 (s, 9H), 1.49 (s, 9H).</div><div class="NLM_p last">1-{<i>N</i>-[2-(<i>N</i>′,<i>N</i>′′-Bis{<i>tert</i>-butoxycarbonyl}amidinoaminooxy)ethyl]amino}carbonylmethyl-6-chloro-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (0.91 g, 1.4 mmol) was then dissolved in dichloromethane (10 mL), treated with trifluoroacetic acid (5 mL), and stirred at ambient temperature for 24 h. The reaction was concentrated in vacuo, the residue purified by flash column chromatography on silica gel with methanol/dichloromethane saturated with ammonia gas, 1:9 to 15:85, v/v, and the fractions were concentrated in vacuo. The column fractions were treated with 4 N HCl in ethanol, concentrated under high vacuum, and filtered, giving <b>21</b> as a white solid (0.53 g, 85%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.32 (m, 1H), 7.52 (m, 5H), 7.40 (t, 1H, <i>J</i> = 7 Hz), 6.92 (s, 1H), 5.16 (br m, 1H), 4.72 (s, 2H), 4.42 (br m, 1H), 4.06 (td, 2H, <i>J</i> = 6.6 Hz, 15.2 Hz), 3.62 (t, 2H, <i>J</i> = 5.5 Hz), 3.28 (q, 2H, <i>J</i> = 5.5 Hz). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 444.1. Anal. (C<sub>17</sub>H<sub>20</sub>ClF<sub>2</sub>N<sub>7</sub>O<sub>3</sub>·2HCl·0.33H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-{<i>N</i>-[2-(Amidino-<i>N</i>′-methylaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-(2-[4-methylphenyl]ethylamino)pyrazinone Dihydrochloride (<b>22</b>)</h3><div class="NLM_p last">To a mixture of 1-{<i>N</i>-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-(4-methylphenethylamino)pyrazinone<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (0.076 g, 0.19 mmol) and sodium bicarbonate (0.53 g, 6.3 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (10 mL) was added iodomethane (0.040 mL, 0.64 mmol). After it was stirred for 2 days at ambient temperature, the solution was concentrated in vacuo, and the residue was treated with pH 1 brine and made basic with solid KOH. The resulting precipitate was filtered, washed with water, and removed from the filter with methanol. The filtrate was concentrated in vacuo, dissolved in methanol/dichloromethane, 1:1, v/v, and filtered. The filtrate was evaporated, and the residue was treated with 2 mL of 4 N HCl in ethanol, dissolved in methanol/dichloromethane, and refiltered, giving the title compound as a yellow solid (0.08 g, 86%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.62 (t, 1H, <i>J</i> = 5.3 Hz), 7.90 (br s, 3H), 7.18 (d, 2H, <i>J</i> = 7.9 Hz), 7.11 (d, 2H, <i>J</i> = 7.9 Hz), 6.70 (s, 1H), 4.64 (s, 2H), 3.91 (t, 2H, <i>J</i> = 5.2 Hz), 3.39 (q, 2H, <i>J</i> = 5.2 Hz), 3.25 (s, 3H), 2.86 (t, 2H, <i>J</i> = 7.5 Hz), 2.27 (s, 3H), 2.12 (s, 3H). MS <i>m</i>/<i>z</i> [MH<sup>+</sup>] 416.2. HPLC <i>t</i><sub>R</sub> = 6.21 min, >98% pure.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Enzymology</h3><div class="NLM_p">All compounds were assessed for inhibitory activity toward thrombin, as well as the key enzymes fXa and trypsin, by kinetic analysis using <i>p</i>-nitroaniline chromogenic substrates. The assay buffer employed was 50 mM Hepes, pH 7.5, 200 mM NaCl, and fresh 0.05% <i>n</i>-octyl β-<span class="smallcaps smallerCapital">d</span>-glucopyranoside. DMSO was present at a final concentration of 4%. In a 96-well low-binding polystyrene plate, 280 μL of substrate in assay buffer was preincubated at 37 °C for 15 min with 10 μL of test compound in DMSO to obtain final test compound concentrations that bracketed the <i>K</i><sub>i</sub>. Reactions were initiated by addition of 10 μL of protease, and the increase in absorbance due to proteolytic cleavage of substrate was kinetically monitored at 37 °C and 405 nm with a Molecular Devices Spectramax 340 platereader. Initial velocities were determined by analysis of the initial linear portion of the reactions. Plots of <i>v</i><sub>o</sub>/<i>v</i><sub>i</sub> versus inhibitor concentration, where <i>v</i><sub>o</sub> = velocity without inhibitor and <i>v</i><sub>i</sub> = inhibited velocity, were fit to a linear regression line, and the IC<sub>50</sub> value was determined from the reciprocal of the slope. Alternatively, IC<sub>50</sub> values were determined using GraphPad Prism software and a four-parameter logistics equation. <i>K</i><sub>i</sub> was calculated from the IC<sub>50</sub> using the <i>K</i><sub>i</sub> factor specific for the assay as: <i>K</i><sub>i</sub> = IC<sub>50</sub> × <i>K</i><sub>i</sub> factor or <i>K</i><sub>i</sub> = IC<sub>50</sub> × {1/(1 + [S]/<i>K</i><sub>m</sub>)}, where S is the substrate concentration in the assay and <i>K</i><sub>m</sub> is the Michaelis constant for the substrate.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">The thrombin assay incorporated substrate SucAAPR pNA (Bachem L-1720, [S] = 100 μM final, <i>K</i><sub>m</sub> = 320 μM, and <i>K</i><sub>i</sub> factor = 0.76). Human α-thrombin (Enzyme Research Laboratories HT1002a) was diluted in assay buffer for a final assay concentration of 1.1 nM. The fXa assay incorporated substrate S-2765 (Diapharma/Chromogenix S-2765, Z-<span class="smallcaps smallerCapital">d</span>-Arg-Gly-Arg-pNA·2HCl, [S] = 100 μM final, <i>K</i><sub>m</sub> = 260 μM, and <i>K</i><sub>i</sub> factor = 0.72). Human fXa (Enzyme Research Laboratories HFXa 1500) was diluted in assay buffer for a final assay concentration of 0.53 nM.</div><div class="NLM_p last">The trypsin assay also incorporated substrate S-2765 ([S] = 60 μM final, <i>K</i><sub>m</sub> = 61 μM, and <i>K</i><sub>i</sub> factor = 0.50). Human trypsin (Calbiochem 650275) was diluted in assay buffer for 333 pM final concentration. The within-run assay coefficient of variation (CV) was generally <10%; the between-run CV was <20%. The inhibitory capacity of <b>7</b> and <b>8</b> for other proteases was determined by CEREP protease assay service.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Crystallization, Data Collection, and Structure Determination and Refinement</h3><div class="NLM_p">Human α-thrombin was purchased from Enzyme Research Laboratories and crystallized at 4 °C in a complex with sulfated hirudin 53-65 (Bachem Biosciences) as previously described.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Complexes of thrombin with the hirudin fragment and active site-directed inhibitors were formed by adding inhibitor solutions to standing vapor diffusion drops (2 μL) containing large single crystals of μ-thrombin. Crystals were undamaged by this procedure and were mounted for data collection 4−5 h after the addition of inhibitors. Compound <b>8</b> was dissolved in DMSO at a concentration of 200 mM and then diluted to 4 mM in 28% PEG 8000 containing 100 mM phosphate buffer (pH 7.3), 0.15 M NaCl, and 3 mM NaN<sub>3</sub>. An aliquot (1 μL) of this solution was added to a drop (2 μL) containing single thrombin crystals to produce a final inhibitor concentration of 1.3 mM.</div><div class="NLM_p last">The crystals were then transferred to a cryoprotectant solution containing 40% PEG 3350, 10 mM CaCl<sub>2</sub>, and 100 mM Tris-maleate at a pH of 5.5 and flash frozen by immersion in liquid nitrogen. X-ray diffraction data to a resolution of 2.06 Å were collected on a Bruker AXS Proteum 6000 detector. Diffraction data were indexed, integrated, and scaled using the Proteum Processing Program suite from Bruker AXS. The crystal belongs to the <i>C</i>2 space group, with unit cell parameters <i>a</i> = 71.1 Å, <i>b</i> = 72.0 Å, <i>c</i> = 73.41 Å, and β = 101.06. The structure was determined by molecular replacement with CNX<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> using the PDB<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> coordinates <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QBV">1QBV</a> as the search model. All model building was done using the computer program CHAIN;<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> refinement and map calculations were carried out using CNX.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The final structure was refined to an Rfactor of 17.8 and Rfree of 22.8.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Platelet Aggregation</h3><div class="NLM_p last">PRP concentrate (Biological Specialties, Inc.) was diluted with platelet-poor plasma (PPP) to yield a final plate count per well of 300 000 platelets/μL. PPP was obtained by spinning PRP at 3000 rpms for 10 min at 25 °C. H-Gly-Pro-Arg-Pro-NH<sub>2</sub> (GPRP-NH<sub>2</sub>, final concentration of 4 mM) was added to the PRP to minimize the effects of fibrinogen. Aggregation was run in a 96-well assay plate with a total volume of 150 μL (120 μL of PRP, 15 μL of inhibitor, and 15 μL of agonist) in each well.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Animal Studies</h3><div class="NLM_p last">All procedures involving the use of animals were performed in accordance with the Guide for the Care and Use of Laboratory Animals (1996) and the Animal Care and Use Committee, Johnson and Johnson Pharmaceutical Research and Development.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> In Vitro Coagulation Assays</h3><div class="NLM_p last">The plasma concentrations of <b>7</b> and <b>8</b> needed to produce a 2-fold prolongation of aPTT were determined in human plasma. Fresh whole blood from humans, dogs, and rats was centrifuged to obtain plasma, and the thrombin inhibitors were added to yield concentrations from 0.001 to 100 μM. After a short stabilization period, the samples were placed in an automated coagulation analyzer (Instrumentation Laboratory ACL100, Beckman Coulter, Miami, FL) to determine clotting times in seconds.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Rat DVT Model</h3><div class="NLM_p">Male Sprague−Dawley Rats (300−450 g) were anesthetized with a mixture of ketamine and xylazine (1 mL/kg, IM). A midline incision was made in the neck to expose and isolate the left carotid and right jugular. The left carotid artery was cannulated with a 24 ga/0.75 in angiocath catheter for the withdrawal of blood samples. The right jugular vein was cannulated with saline-filled PE50 tubing for administration of the compound or vehicle. The left femoral vein was isolated and cannulated with saline-filled PE50 tubing for administration of thromboplastin. For thrombus formation, a ventral midline incision was made, and the descending vena cava was carefully exposed and separated from the aorta. Just distal to the renal veins, a suture was looped under the vena cava, and a second loop was placed around the vena cava just proximal to the iliac veins. The main iliolumbar and internal spermatic branches of the vena cava were tied off. At this time, a thrombus was formed by injecting 0.2 mL/kg thromboplastin (ThromboMAX with calcium, Sigma Diagnostics T-9902) into the femoral vein over 10 s followed by a 10 s waiting period. Then, the proximal loop just below the renal veins was tied, and after a 15 min waiting period, the distal loop was tied. At this time, the section of vena cava was removed and carefully cut open followed by removal and weighing of the thrombus.</div><div class="NLM_p last">In the intravenous studies, vehicle (solutol 10% and D5W) or <b>8</b> was infused over a 45 min time period at 0.04 mL/min. The total cumulative doses of <b>8</b> studied were 0.1, 0.3, and 1.0 mg/kg, iv. The procedure for thrombus formation detailed above was begun at the 30 min point of the infusion. In the oral dose studies, <b>8</b> at 10, 30, and 50 mg/kg was solubilized in 0.5% methocel in a total volume of 5 mL/kg and administered by an oral dosing tube. The rats were anesthetized 45 min after the oral dose, and the above thrombus formation procedure was begun at 70 min postdosing. In both the intravenous and the oral studies, a blood sample was taken at the termination of the experiment to measure coagulation times and drug plasma concentration.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Rat ECAT Model</h3><div class="NLM_p">Male Sprague−Dawley rats (350−450 g) were anesthetized with pentobarbital 65 mg/mL (1 mL/kg, i.p.). A midline incision was made in the neck to expose and isolate the blood vessels. The right carotid artery was cannulated with a saline-filled PE-50 catheter attached to a statham pressure transducer to measure blood pressure and heart rate. The left carotid artery was isolated, and a pulsed Doppler flow probe (HVPD-20, Crystal Biotech, Hopkinton, MA) was placed distally on the artery to measure blood flow. The left jugular vein was cannulated for administration of the compound or vehicle. To prevent thrombosis, the arterial catheters were coated with Sigmacote and air-dried. Proximal to the flow probe, the carotid artery was laid across the exposed electrode wire in the hook end of a bipolar Dastre electrode (Harvard Apparatus, Holliston, MA). The electrode was fitted onto a micromanipulator and positioned with slight upward tension but so that flow was unaffected.</div><div class="NLM_p last">Once a steady baseline blood flow was achieved, solutol vehicle (10%) or <b>8</b> (0.03, 0.1, 0.3, or 1.0 mg/kg) was administered by slow infusion into the left jugular vein for 20 min at a rate of 0.05 mL/min. Electrical stimulation was begun after 5 min of infusion and continued for 5 min. The flow crystal sensor was turned off for the duration of electrical stimulation. Occlusion times were recorded during the 30 min observation period beginning at the conclusion of electrical stimulation. Differences in time to occlusion between compound-treated and vehicle-treated rats were compared using an unpaired <i>t</i> test. <i>P</i> < 0.05 was considered statistically different.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Dog Arteriovenous Shunt Model</h3><div class="NLM_p last">Adult mongrel dogs of either sex (13.2−14.5 kg) were dosed with vehicle or <b>8</b> or <b>7</b>. Following a 1 h observation period, the dogs were anesthetized with pentobarbital sodium (35 mg/kg, iv) and ventilated with room air via an endotracheal tube (15 strokes/min, 25 mL/kg). The heart rate was monitored using a cardiotachometer triggered from a lead II electrocardiogram generated by limb leads. A Millar pressure-tipped catheter (Millar Instruments, Houston, TX) was placed in the left femoral artery for measurement of blood pressure. A carotid artery was cannulated (PE-200) for blood withdrawal. The right femoral artery and the right femoral vein were cannulated with silicon-treated saline-filled polyethylene tubing (PE-200) and connected with a 6 cm section of silicon-treated tubing (PE-240) to form an extracorporeal arteriovenous shunt. The shunt patency was monitored using a Doppler flow system and flowprobe (2.4−2.8 mm) placed proximal to the locus of the shunt. All parameters were monitored continuously using an LDS PoNeMah Life Science Suite data acquisition system (LDS Test and Measurement, Middleton, WI). On completion of a 15 min postsurgical stabilization period, an occlusive thrombus was formed by the introduction of a thrombogenic surface (0 braided silk thread, 6 cm in length, Ethicon Inc., Somerville, NJ) into the shunt. Seven 15 min shunt periods were employed with the first starting at 2 h postoral dosing and repeated every 30 min out to 5 h postdrug. At the end of each 15 min shunt period, the silk was carefully removed and weighed. The thrombus weight was calculated by subtracting the weight of the silk (9 mg) prior to placement from the total wet weight of the silk on removal from the shunt. Arterial blood was withdrawn prior to the oral dose and at 2−5 h postdrug for determination of aPTT. The template bleeding time was also performed at 2−5 h postdrug by making an incision into the gum (Surgicutt, ITC Corp., Edison, NJ), and the time to clot formation was monitored. Coagulation parameters were determined using plasma in an ACL-100 microsampler coagulation analyzer. Plasma samples were measured for drug plasma concentration.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark R. Player</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#caa7baa6abb3afb88aa3beb9e4a0a4a0e4a9a5a7"><span class="__cf_email__" data-cfemail="6805180409110d1a28011c1b46020602460b0705">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tianbao Lu</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Markotan</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shelley K. Ballentine</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward C. Giardino</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Spurlino</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathryn Brown</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce E. Maryanoff</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce E. Tomczuk</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce P. Damiano</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Umesh Shukla</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David End</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patricia Andrade-Gordon</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roger F. Bone</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm901802n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33444" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33444" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lilienfeld, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godbold, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landrigan, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, G.</span><span> </span><span class="NLM_article-title">Mortality from pulmonary embolism in the United States: 1962 to 1984</span> <span class="citation_source-journal">Chest</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1990&pages=1067-1072&author=D.+E.+Lilienfeldauthor=E.+Chanauthor=J.+Ehlandauthor=J.+H.+Godboldauthor=P.+J.+Landriganauthor=G.+Marsh&title=Mortality+from+pulmonary+embolism+in+the+United+States%3A+1962+to+1984"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLilienfeld%26aufirst%3DD.%2BE.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DEhland%26aufirst%3DJ.%26aulast%3DGodbold%26aufirst%3DJ.%2BH.%26aulast%3DLandrigan%26aufirst%3DP.%2BJ.%26aulast%3DMarsh%26aufirst%3DG.%26atitle%3DMortality%2520from%2520pulmonary%2520embolism%2520in%2520the%2520United%2520States%253A%25201962%2520to%25201984%26jtitle%3DChest%26date%3D1990%26volume%3D98%26spage%3D1067%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lilienfeld, D. E.</span><span> </span><span class="NLM_article-title">Decreasing mortality from pulmonary embolism in the United States, 1979−1996</span> <span class="citation_source-journal">Int. J. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1093%2Fije%2F29.3.465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=10869318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A280%3ADC%252BD3cvnt1Cquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=465-469&author=D.+E.+Lilienfeld&title=Decreasing+mortality+from+pulmonary+embolism+in+the+United+States%2C+1979%E2%88%921996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Decreasing mortality from pulmonary embolism in the United States, 1979-1996</span></div><div class="casAuthors">Lilienfeld D E</div><div class="citationInfo"><span class="NLM_cas:title">International journal of epidemiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">465-9</span>
        ISSN:<span class="NLM_cas:issn">0300-5771</span>.
    </div><div class="casAbstract">BACKGROUND:  Mortality trends and patterns for pulmonary embolism may yield clues to its aetiology.  Previous investigations had identified several mortality contrasts in pulmonary embolism mortality among US residents.  These findings had been made in the context of a trend of increasing rates during 1962-1984.  METHODS:  Annual age-specific and age-adjusted pulmonary embolism mortality rates for US residents during 1979-1996 were compiled from the US National Center for Health Statistics web site.  These data were analysed for mortality contrasts and trends.  RESULTS:  For all racial-gender groups, age-adjusted mortality declined throughout the period.  The greatest rate of decline was found among black men, followed by (in decreasing order) black women, white men, other men, white women, and other women.  In 1996, the previously observed demographic contrasts of blacks experiencing the highest pulmonary embolism mortality, followed by whites and then others, and the male rate being higher than the female one were still present despite this decline.  Age-specific mortality from pulmonary embolism in the US during 1996 also mirrored that reported for the 1970s, with mortality increasing during the life span (the risk of death doubling with each decade of life).  Specifically, the annual age-adjusted pulmonary embolism mortality rate in 1996 for white men was 2.4 per 100 000 persons; white women, 2.3 per 100 000 persons; black men, 6.0 per 100 000 persons; black women, 4.8 per 100 000 persons; non-black non-white men, 1.0 per 100 000 persons; and non-black non-white women, 0.7 per 100 000 persons.  CONCLUSIONS:  Mortality from pulmonary embolism in the US declined significantly during 1979-1996.  Several demographic contrasts, particularly an excess among men, continue to exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCPretjO9SsEbxh97K6Vt6fW6udTcc2eZzynA6lvGfQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3cvnt1Cquw%253D%253D&md5=3cea3cabc55a380421433ad74d5dddf3</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1093%2Fije%2F29.3.465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fije%252F29.3.465%26sid%3Dliteratum%253Aachs%26aulast%3DLilienfeld%26aufirst%3DD.%2BE.%26atitle%3DDecreasing%2520mortality%2520from%2520pulmonary%2520embolism%2520in%2520the%2520United%2520States%252C%25201979%25E2%2588%25921996%26jtitle%3DInt.%2520J.%2520Epidemiol.%26date%3D2000%26volume%3D29%26spage%3D465%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Melnikova, I.</span><span> </span><span class="NLM_article-title">The anticoagulants market</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=353-354&author=I.+Melnikova&title=The+anticoagulants+market"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMelnikova%26aufirst%3DI.%26atitle%3DThe%2520anticoagulants%2520market%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D353%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Halperin, J. L.</span><span> </span><span class="NLM_article-title">Ximelagatran: Oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1016%2Fj.jacc.2004.09.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=15629364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlSr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=1-9&author=J.+L.+Halperin&title=Ximelagatran%3A+Oral+direct+thrombin+inhibition+as+anticoagulant+therapy+in+atrial+fibrillation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Ximelagatran: Oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation</span></div><div class="casAuthors">Halperin, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Atrial fibrillation (AF) causes 50,000 to 100,000 ischemic strokes annually in the U.S., most of which could be prevented by oral anticoagulant treatment of the highest-risk patients.  The greatest barrier to such treatment is the narrow therapeutic index of the vitamin K antagonists ([VKAs]: warfarin and related coumarin derivs.), the only oral anticoagulant agents currently available.  Safe and effective treatment with the VKAs requires careful monitoring, because they interact with many other drugs and foods, and their anticoagulant action is unpredictable.  Besides vitamin K, candidate targets for anticoagulant therapy include thrombin, a key prothrombotic mediator.  Ximelagatran, the oral direct thrombin inhibitor at the most advanced stage of clin. development, is rapidly absorbed and bioconverted to its active moiety, melagatran-a potent, competitive inhibitor of both free and clot-bound thrombin.  Two large clin. trials have demonstrated that fixed-dose oral ximelagatran, 36 mg twice daily, administered without coagulation monitoring, prevents stroke and systemic embolic events in patients with nonvalvular AF as effectively as well-controlled, adjusted-dose warfarin (international normalized ratio 2.0 to 3.0).  The overall risk of bleeding was lower with ximelagatran than warfarin, although differences in rates of major hemorrhage were not statistically significant.  Elevation of serum alanine aminotransferase levels above 3× the upper limit of normal occurred in approx. 6% of ximelagatran-treated patients but typically returned toward pretreatment levels without assocd. symptoms.  In terms of preventing thromboembolism without hemorrhage, ximelagatran may have a more favorable benefit:risk profile than warfarin for patients with AF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohPKNggClnn7Vg90H21EOLACvtfcHk0lgEDA7BEO1VcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlSr&md5=c628cfb9208c956b4d6e8711f258c198</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2004.09.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2004.09.049%26sid%3Dliteratum%253Aachs%26aulast%3DHalperin%26aufirst%3DJ.%2BL.%26atitle%3DXimelagatran%253A%2520Oral%2520direct%2520thrombin%2520inhibition%2520as%2520anticoagulant%2520therapy%2520in%2520atrial%2520fibrillation%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2005%26volume%3D45%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Borrissoff, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spronk, H. M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeneman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ten Cate, H.</span><span> </span><span class="NLM_article-title">Is thrombin a key player in the ‘coagulation-antherogenesis’ maze?</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2009&pages=392-403&author=J.+I.+Borrissoffauthor=H.+M.+H.+Spronkauthor=S.+Heenemanauthor=H.+ten+Cate&title=Is+thrombin+a+key+player+in+the+%E2%80%98coagulation-antherogenesis%E2%80%99+maze%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorrissoff%26aufirst%3DJ.%2BI.%26aulast%3DSpronk%26aufirst%3DH.%2BM.%2BH.%26aulast%3DHeeneman%26aufirst%3DS.%26aulast%3Dten%2BCate%26aufirst%3DH.%26atitle%3DIs%2520thrombin%2520a%2520key%2520player%2520in%2520the%2520%25E2%2580%2598coagulation-antherogenesis%25E2%2580%2599%2520maze%253F%26jtitle%3DCardiovasc.%2520Res.%26date%3D2009%26volume%3D82%26spage%3D392%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tanaka, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Key, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, J. H.</span><span> </span><span class="NLM_article-title">Blood coagulation: Hemostasis and thrombin regulation</span> <span class="citation_source-journal">Anesth. Analg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1433</span><span class="NLM_x">–</span> <span class="NLM_lpage">1446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1213%2Fane.0b013e31819bcc9c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=19372317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvV2gt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2009&pages=1433-1446&author=K.+A.+Tanakaauthor=N.+S.+Keyauthor=J.+H.+Levy&title=Blood+coagulation%3A+Hemostasis+and+thrombin+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Blood Coagulation: Hemostasis and Thrombin Regulation</span></div><div class="casAuthors">Tanaka, Kenichi A.; Key, Nigel S.; Levy, Jerrold H.</div><div class="citationInfo"><span class="NLM_cas:title">Anesthesia & Analgesia (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1433-1446</span>CODEN:
                <span class="NLM_cas:coden">AACRAT</span>;
        ISSN:<span class="NLM_cas:issn">0003-2999</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Perioperative bleeding is a major challenge particularly because of increasing clin. use of potent antithrombotic drugs.  Understanding current concepts of coagulation is important in detg. the preoperative bleeding risk of patients, and in managing hemostatic therapy perioperatively.  The serine protease thrombin plays pivotal roles in the activation of addnl. serine protease zymogens (inactive enzymic precursors), cofactors, and cell-surface receptors.  Thrombin generation is closely regulated to locally achieve rapid hemostasis after injury without causing uncontrolled systemic thrombosis.  During surgery, there are major disturbances in coagulation and inflammatory systems because of hemorrhage/hemodilution, blood transfusion, and surgical stresses.  Postoperative bleeding often requires allogeneic blood transfusions, which support thrombin generation and hemostasis.  However, procoagulant activity and inflammation are increased postoperatively; thus, antithrombotic therapy may be required to prevent perioperative thrombotic complications.  There have been significant advances in the management of perioperative hemostasis and thrombosis because of the introduction of novel hemostatic and antithrombotic drugs.  However, a limitation of current treatment is that conventional clotting tests do not reflect the entire physiol. processes of coagulation making optimal pharmacol. therapy difficult.  Understanding the in vivo regulatory mechanisms and pharmacol. modulation of thrombin generation may help control bleeding without potentially increasing prothrombotic risks.  In this review, we focus on the regulatory mechanisms of hemostasis and thrombin generation using multiple, simplified models of coagulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbBIhgaNmkebVg90H21EOLACvtfcHk0ljHHduaOX-_Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvV2gt70%253D&md5=507878d0e9a3ceefc145f7d249eb9607</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1213%2Fane.0b013e31819bcc9c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1213%252Fane.0b013e31819bcc9c%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DK.%2BA.%26aulast%3DKey%26aufirst%3DN.%2BS.%26aulast%3DLevy%26aufirst%3DJ.%2BH.%26atitle%3DBlood%2520coagulation%253A%2520Hemostasis%2520and%2520thrombin%2520regulation%26jtitle%3DAnesth.%2520Analg.%26date%3D2009%26volume%3D108%26spage%3D1433%26epage%3D1446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Santilli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davì, G.</span><span> </span><span class="NLM_article-title">Thrombin as a common downstream target blocking both platelet and monocyte activation</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=19190800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVyrtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2009&pages=220-221&author=F.+Santilliauthor=G.+Dav%C3%AC&title=Thrombin+as+a+common+downstream+target+blocking+both+platelet+and+monocyte+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombin as a common downstream target blocking both platelet and monocyte activation</span></div><div class="casAuthors">Santilli, Francesca; Davi, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">220-221</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">A review.  Thrombin is a potent agonist for both platelet and monocyte activation through the protease-activated receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2DYvcHMeKIrVg90H21EOLACvtfcHk0ljHHduaOX-_Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVyrtLw%253D&md5=e71ed0ae416fc730171134997e906105</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantilli%26aufirst%3DF.%26aulast%3DDav%25C3%25AC%26aufirst%3DG.%26atitle%3DThrombin%2520as%2520a%2520common%2520downstream%2520target%2520blocking%2520both%2520platelet%2520and%2520monocyte%2520activation%26jtitle%3DThromb.%2520Haemostasis%26date%3D2009%26volume%3D101%26spage%3D220%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sambrano, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soughlin, S. R.</span><span> </span><span class="NLM_article-title">Role of thrombin signaling in platelets in haemostasis and thrombosis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">413</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2001&pages=74-78&author=G.+R.+Sambranoauthor=E.+J.+Weissauthor=Y.+W.+Zhengauthor=W.+Huangauthor=S.+R.+Soughlin&title=Role+of+thrombin+signaling+in+platelets+in+haemostasis+and+thrombosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSambrano%26aufirst%3DG.%2BR.%26aulast%3DWeiss%26aufirst%3DE.%2BJ.%26aulast%3DZheng%26aufirst%3DY.%2BW.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DSoughlin%26aufirst%3DS.%2BR.%26atitle%3DRole%2520of%2520thrombin%2520signaling%2520in%2520platelets%2520in%2520haemostasis%2520and%2520thrombosis%26jtitle%3DNature%26date%3D2001%26volume%3D413%26spage%3D74%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Crowther, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitz, J. I.</span><span> </span><span class="NLM_article-title">Ximelagatran: The first oral direct thrombin inhibitor</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=403-413&author=M.+A.+Crowtherauthor=J.+I.+Weitz&title=Ximelagatran%3A+The+first+oral+direct+thrombin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrowther%26aufirst%3DM.%2BA.%26aulast%3DWeitz%26aufirst%3DJ.%2BI.%26atitle%3DXimelagatran%253A%2520The%2520first%2520oral%2520direct%2520thrombin%2520inhibitor%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D13%26spage%3D403%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Patterson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stouffer, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madamanchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runge, M. S.</span><span> </span><span class="NLM_article-title">New tricks for old dogs: Nonthrombotic effects of thrombin in vessel wall biology</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2001&pages=987-997&author=C.+Pattersonauthor=G.+A.+Stoufferauthor=N.+Madamanchiauthor=M.+S.+Runge&title=New+tricks+for+old+dogs%3A+Nonthrombotic+effects+of+thrombin+in+vessel+wall+biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DC.%26aulast%3DStouffer%26aufirst%3DG.%2BA.%26aulast%3DMadamanchi%26aufirst%3DN.%26aulast%3DRunge%26aufirst%3DM.%2BS.%26atitle%3DNew%2520tricks%2520for%2520old%2520dogs%253A%2520Nonthrombotic%2520effects%2520of%2520thrombin%2520in%2520vessel%2520wall%2520biology%26jtitle%3DCirc.%2520Res.%26date%3D2001%26volume%3D88%26spage%3D987%26epage%3D997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Fleitz, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volante, R. P.</span><span> </span><span class="NLM_article-title">Kilogram scale synthesis of the pyrazinone acetic acid core of an orally efficacious thrombin inhibitor</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3171</span><span class="NLM_x">–</span> <span class="NLM_lpage">3180</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1080%2F00397910008086927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsVGrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2000&pages=3171-3180&author=F.+J.+Fleitzauthor=T.+A.+Lyleauthor=N.+Zhengauthor=J.+D.+Armstrongauthor=R.+P.+Volante&title=Kilogram+scale+synthesis+of+the+pyrazinone+acetic+acid+core+of+an+orally+efficacious+thrombin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Kilogram scale synthesis of the pyrazinone acetic acid core of an orally efficacious thrombin inhibitor</span></div><div class="casAuthors">Fleitz, Fred J.; Lyle, Terry A.; Zheng, Nan; Armstrong, Joseph D., III; Volante, R. P.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3171-3180</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A multi-kilogram scale synthesis of the orally efficacious thrombin inhibitor I was achieved via construction of the pyrazinone core from an unsym. oxalic diamide.  Key features include judicious choice of reagents to minimize side products, a key Ru catalyzed oxidn., and development of reaction conditions amenable to large-scale synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQOmYrqWbxobVg90H21EOLACvtfcHk0ljHHduaOX-_Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVGrs7k%253D&md5=8c0c517fdd34f5c19f8242918e9056d9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1080%2F00397910008086927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910008086927%26sid%3Dliteratum%253Aachs%26aulast%3DFleitz%26aufirst%3DF.%2BJ.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DArmstrong%26aufirst%3DJ.%2BD.%26aulast%3DVolante%26aufirst%3DR.%2BP.%26atitle%3DKilogram%2520scale%2520synthesis%2520of%2520the%2520pyrazinone%2520acetic%2520acid%2520core%2520of%2520an%2520orally%2520efficacious%2520thrombin%2520inhibitor%26jtitle%3DSynth.%2520Commun.%26date%3D2000%26volume%3D30%26spage%3D3171%26epage%3D3180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chung, J. Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cvetovick, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsay, F.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dormer, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMichele, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathre, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilenski, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenslow, R.</span><span> </span><span class="NLM_article-title">Synthesis of 3-aminopyrazinone mediated by 2-pyridylthioimidate−ZnCl<sub>2</sub> complexes. Development of an efficient route to a thrombin inhibitor</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">8838</span><span class="NLM_x">–</span> <span class="NLM_lpage">8846</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo034835e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=8838-8846&author=J.+Y.+L.+Chungauthor=R.+J.+Cvetovickauthor=F.-R.+Tsayauthor=P.+G.+Dormerauthor=L.+DiMicheleauthor=D.+J.+Mathreauthor=J.+R.+Chilenskiauthor=B.+Maoauthor=R.+Wenslow&title=Synthesis+of+3-aminopyrazinone+mediated+by+2-pyridylthioimidate%E2%88%92ZnCl2+complexes.+Development+of+an+efficient+route+to+a+thrombin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjo034835e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo034835e%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DJ.%2BY.%2BL.%26aulast%3DCvetovick%26aufirst%3DR.%2BJ.%26aulast%3DTsay%26aufirst%3DF.-R.%26aulast%3DDormer%26aufirst%3DP.%2BG.%26aulast%3DDiMichele%26aufirst%3DL.%26aulast%3DMathre%26aufirst%3DD.%2BJ.%26aulast%3DChilenski%26aufirst%3DJ.%2BR.%26aulast%3DMao%26aufirst%3DB.%26aulast%3DWenslow%26aufirst%3DR.%26atitle%3DSynthesis%2520of%25203-aminopyrazinone%2520mediated%2520by%25202-pyridylthioimidate%25E2%2588%2592ZnCl2%2520complexes.%2520Development%2520of%2520an%2520efficient%2520route%2520to%2520a%2520thrombin%2520inhibitor%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D8838%26epage%3D8846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Burgey, C. S.; Robinson, K. A.; Williams, P. D.; Coburn, C. A.; Lyle, T. A.; Sanderson, P. E.</span> PCT Int. Appl. WO 0075134,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Burgey%2C+C.+S.%3B+Robinson%2C+K.+A.%3B+Williams%2C+P.+D.%3B+Coburn%2C+C.+A.%3B+Lyle%2C+T.+A.%3B+Sanderson%2C+P.+E.+PCT+Int.+Appl.+WO+0075134%2C+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurgey%26aufirst%3DC.%2BS.%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last"><b>CAUTION!</b> Solid bromopyrazinone is known to be thermally unstable with an exothermic transition at 50 °C, is potentially shock sensitive, and gradually decomposes at room temperature.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CAUTION%21+Solid+bromopyrazinone+is+known+to+be+thermally+unstable+with+an+exothermic+transition+at+50+%C2%B0C%2C+is+potentially+shock+sensitive%2C+and+gradually+decomposes+at+room+temperature."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Costanzo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecker, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schott, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabut, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulinsky, A.</span><span> </span><span class="NLM_article-title">Potent thrombin inhibitors that probe the S1’ subsite: Tripeptide transition state analogues based on a heterocycle-activated carbonyl group</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">3039</span><span class="NLM_x">–</span> <span class="NLM_lpage">3043</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9603274" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=3039-3043&author=M.+J.+Costanzoauthor=B.+E.+Maryanoffauthor=L.+R.+Heckerauthor=M.+R.+Schottauthor=S.+C.+Yabutauthor=H.-C.+Zhangauthor=P.+Andrade-Gordonauthor=J.+A.+Kaufmannauthor=J.+M.+Lewisauthor=R.+Krishnanauthor=A.+Tulinsky&title=Potent+thrombin+inhibitors+that+probe+the+S1%E2%80%99+subsite%3A+Tripeptide+transition+state+analogues+based+on+a+heterocycle-activated+carbonyl+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm9603274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9603274%26sid%3Dliteratum%253Aachs%26aulast%3DCostanzo%26aufirst%3DM.%2BJ.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DHecker%26aufirst%3DL.%2BR.%26aulast%3DSchott%26aufirst%3DM.%2BR.%26aulast%3DYabut%26aufirst%3DS.%2BC.%26aulast%3DZhang%26aufirst%3DH.-C.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DKaufmann%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DJ.%2BM.%26aulast%3DKrishnan%26aufirst%3DR.%26aulast%3DTulinsky%26aufirst%3DA.%26atitle%3DPotent%2520thrombin%2520inhibitors%2520that%2520probe%2520the%2520S1%25E2%2580%2599%2520subsite%253A%2520Tripeptide%2520transition%2520state%2520analogues%2520based%2520on%2520a%2520heterocycle-activated%2520carbonyl%2520group%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D3039%26epage%3D3043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Costanzo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almond, H. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecker, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schott, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabut, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corcoran, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardino, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Garavilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haertlein, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span> </span><span class="NLM_article-title">In-depth study of tripeptide-based α-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1′ subsite and its implications to structure-based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1984</span><span class="NLM_x">–</span> <span class="NLM_lpage">2008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0303857" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1984-2008&author=M.+J.+Costanzoauthor=H.+R.+Almondauthor=L.+R.+Heckerauthor=M.+R.+Schottauthor=S.+C.+Yabutauthor=H.-C.+Zhangauthor=P.+Andrade-Gordonauthor=T.+W.+Corcoranauthor=E.+C.+Giardinoauthor=J.+A.+Kaufmannauthor=J.+M.+Lewisauthor=L.+de+Garavillaauthor=B.+J.+Haertleinauthor=B.+E.+Maryanoff&title=In-depth+study+of+tripeptide-based+%CE%B1-ketoheterocycles+as+inhibitors+of+thrombin.+Effective+utilization+of+the+S1%E2%80%B2+subsite+and+its+implications+to+structure-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm0303857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0303857%26sid%3Dliteratum%253Aachs%26aulast%3DCostanzo%26aufirst%3DM.%2BJ.%26aulast%3DAlmond%26aufirst%3DH.%2BR.%26aulast%3DHecker%26aufirst%3DL.%2BR.%26aulast%3DSchott%26aufirst%3DM.%2BR.%26aulast%3DYabut%26aufirst%3DS.%2BC.%26aulast%3DZhang%26aufirst%3DH.-C.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DCorcoran%26aufirst%3DT.%2BW.%26aulast%3DGiardino%26aufirst%3DE.%2BC.%26aulast%3DKaufmann%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DJ.%2BM.%26aulast%3Dde%2BGaravilla%26aufirst%3DL.%26aulast%3DHaertlein%26aufirst%3DB.%2BJ.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26atitle%3DIn-depth%2520study%2520of%2520tripeptide-based%2520%25CE%25B1-ketoheterocycles%2520as%2520inhibitors%2520of%2520thrombin.%2520Effective%2520utilization%2520of%2520the%2520S1%25E2%2580%25B2%2520subsite%2520and%2520its%2520implications%2520to%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1984%26epage%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Brown, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andisik, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccarelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damewood, J. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ealey, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosmider, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krell, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steelman, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacek, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veale, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuthill, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolanin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolson, S. A.</span><span> </span><span class="NLM_article-title">Design of orally active, non-peptidic inhibitors of human leukocyte elastase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1261</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00035a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1259-1261&author=F.+J.+Brownauthor=D.+W.+Andisikauthor=P.+R.+Bernsteinauthor=C.+B.+Bryantauthor=C.+Ceccarelliauthor=J.+R.+Damewoodauthor=P.+D.+Edwardsauthor=R.+A.+Ealeyauthor=S.+Feeneyauthor=R.+C.+Greenauthor=B.+Gomesauthor=B.+J.+Kosmiderauthor=R.+D.+Krellauthor=A.+Shawauthor=G.+B.+Steelmanauthor=R.+M.+Thomasauthor=E.+P.+Vacekauthor=C.+A.+Vealeauthor=P.+A.+Tuthillauthor=P.+Warnerauthor=J.+C.+Williamsauthor=D.+J.+Wolaninauthor=S.+A.+Woolson&title=Design+of+orally+active%2C+non-peptidic+inhibitors+of+human+leukocyte+elastase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm00035a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00035a004%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DF.%2BJ.%26aulast%3DAndisik%26aufirst%3DD.%2BW.%26aulast%3DBernstein%26aufirst%3DP.%2BR.%26aulast%3DBryant%26aufirst%3DC.%2BB.%26aulast%3DCeccarelli%26aufirst%3DC.%26aulast%3DDamewood%26aufirst%3DJ.%2BR.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DEaley%26aufirst%3DR.%2BA.%26aulast%3DFeeney%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DR.%2BC.%26aulast%3DGomes%26aufirst%3DB.%26aulast%3DKosmider%26aufirst%3DB.%2BJ.%26aulast%3DKrell%26aufirst%3DR.%2BD.%26aulast%3DShaw%26aufirst%3DA.%26aulast%3DSteelman%26aufirst%3DG.%2BB.%26aulast%3DThomas%26aufirst%3DR.%2BM.%26aulast%3DVacek%26aufirst%3DE.%2BP.%26aulast%3DVeale%26aufirst%3DC.%2BA.%26aulast%3DTuthill%26aufirst%3DP.%2BA.%26aulast%3DWarner%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DJ.%2BC.%26aulast%3DWolanin%26aufirst%3DD.%2BJ.%26aulast%3DWoolson%26aufirst%3DS.%2BA.%26atitle%3DDesign%2520of%2520orally%2520active%252C%2520non-peptidic%2520inhibitors%2520of%2520human%2520leukocyte%2520elastase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1259%26epage%3D1261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Sanderson, P. E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutrona, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyer, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonough, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranieri, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vastag, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridone or 3-aminopyrazinone acetamide peptidomimetic templates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4466</span><span class="NLM_x">–</span> <span class="NLM_lpage">4474</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980368v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4466-4474&author=P.+E.+J.+Sandersonauthor=T.+A.+Lyleauthor=K.+J.+Cutronaauthor=D.+L.+Dyerauthor=B.+D.+Dorseyauthor=C.+M.+McDonoughauthor=A.+M.+Naylor-Olsenauthor=I.-W.+Chenauthor=Z.+Chenauthor=J.+J.+Cookauthor=C.+M.+Cooperauthor=S.+J.+Gardellauthor=T.+R.+Hareauthor=J.+A.+Kruegerauthor=S.+D.+Lewisauthor=J.+H.+Linauthor=B.+J.+Lucasauthor=E.+A.+Lyleauthor=J.+J.+Lynchauthor=M.+T.+Stranieriauthor=K.+Vastagauthor=Y.+Yanauthor=J.+A.+Shaferauthor=J.+P.+Vacca&title=Efficacious%2C+orally+bioavailable+thrombin+inhibitors+based+on+3-aminopyridone+or+3-aminopyrazinone+acetamide+peptidomimetic+templates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm980368v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980368v%26sid%3Dliteratum%253Aachs%26aulast%3DSanderson%26aufirst%3DP.%2BE.%2BJ.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DCutrona%26aufirst%3DK.%2BJ.%26aulast%3DDyer%26aufirst%3DD.%2BL.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMcDonough%26aufirst%3DC.%2BM.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DI.-W.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DCooper%26aufirst%3DC.%2BM.%26aulast%3DGardell%26aufirst%3DS.%2BJ.%26aulast%3DHare%26aufirst%3DT.%2BR.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DLyle%26aufirst%3DE.%2BA.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DStranieri%26aufirst%3DM.%2BT.%26aulast%3DVastag%26aufirst%3DK.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DShafer%26aufirst%3DJ.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DEfficacious%252C%2520orally%2520bioavailable%2520thrombin%2520inhibitors%2520based%2520on%25203-aminopyridone%2520or%25203-aminopyrazinone%2520acetamide%2520peptidomimetic%2520templates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4466%26epage%3D4474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Isaacs, R. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solinsky, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutrona, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span> </span><span class="NLM_article-title">Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 1: Weakly basic azoles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2000&pages=338-342&author=R.+C.+A.+Isaacsauthor=M.+G.+Solinskyauthor=K.+J.+Cutronaauthor=C.+L.+Newtonauthor=A.+M.+Naylor-Olsenauthor=J.+A.+Kruegerauthor=S.+D.+Lewisauthor=B.+J.+Lucas&title=Structure-based+design+of+novel+groups+for+use+in+the+P1+position+of+thrombin+inhibitor+scaffolds.+Part+1%3A+Weakly+basic+azoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsaacs%26aufirst%3DR.%2BC.%2BA.%26aulast%3DSolinsky%26aufirst%3DM.%2BG.%26aulast%3DCutrona%26aufirst%3DK.%2BJ.%26aulast%3DNewton%26aufirst%3DC.%2BL.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%2BM.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520groups%2520for%2520use%2520in%2520the%2520P1%2520position%2520of%2520thrombin%2520inhibitor%2520scaffolds.%2520Part%25201%253A%2520Weakly%2520basic%2520azoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D16%26spage%3D338%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Tomczuk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedde, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crysler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisennagel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bone, R.</span><span> </span><span class="NLM_article-title">Oxyguanidines: Application to non-peptide phenyl-based thrombin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1495</span><span class="NLM_x">–</span> <span class="NLM_lpage">1498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1495-1498&author=B.+Tomczukauthor=T.+Luauthor=R.+M.+Sollauthor=C.+Feddeauthor=A.+Wangauthor=L.+Murphyauthor=C.+Cryslerauthor=M.+Dasguptaauthor=S.+Eisennagelauthor=J.+Spurlinoauthor=R.+Bone&title=Oxyguanidines%3A+Application+to+non-peptide+phenyl-based+thrombin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTomczuk%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DFedde%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DCrysler%26aufirst%3DC.%26aulast%3DDasgupta%26aufirst%3DM.%26aulast%3DEisennagel%26aufirst%3DS.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DBone%26aufirst%3DR.%26atitle%3DOxyguanidines%253A%2520Application%2520to%2520non-peptide%2520phenyl-based%2520thrombin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1495%26epage%3D1498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Burgey, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantermet, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, R. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranieri, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicore, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1 N-benzylamines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1353</span><span class="NLM_x">–</span> <span class="NLM_lpage">1357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1353-1357&author=C.+S.+Burgeyauthor=K.+A.+Robinsonauthor=T.+A.+Lyleauthor=P.+G.+Nantermetauthor=H.+G.+Selnickauthor=R.+C.+A.+Isaacsauthor=S.+D.+Lewisauthor=B.+J.+Lucasauthor=J.+A.+Kuegerauthor=R.+Singhauthor=C.+Miller-Steinauthor=R.+B.+Whiteauthor=B.+Wongauthor=E.+A.+Lyleauthor=M.+T.+Stranieriauthor=J.+J.+Cookauthor=D.+R.+McMastersauthor=J.+M.+Pellicoreauthor=S.+Palauthor=A.+A.+Wallaceauthor=F.+C.+Claytonauthor=D.+Bohnauthor=D.+C.+Welshauthor=J.+J.+Lynchauthor=Y.+Yanauthor=Z.+Chenauthor=L.+Kuoauthor=S.+J.+Gardellauthor=J.+A.+Shaferauthor=J.+P.+Vacca&title=Pharmacokinetic+optimization+of+3-amino-6-chloropyrazinone+acetamide+thrombin+inhibitors.+Implementation+of+P3+pyridine+N-oxides+to+deliver+an+orally+bioavailable+series+containing+P1+N-benzylamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurgey%26aufirst%3DC.%2BS.%26aulast%3DRobinson%26aufirst%3DK.%2BA.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DIsaacs%26aufirst%3DR.%2BC.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DKueger%26aufirst%3DJ.%2BA.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DMiller-Stein%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DR.%2BB.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DLyle%26aufirst%3DE.%2BA.%26aulast%3DStranieri%26aufirst%3DM.%2BT.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DPellicore%26aufirst%3DJ.%2BM.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DWallace%26aufirst%3DA.%2BA.%26aulast%3DClayton%26aufirst%3DF.%2BC.%26aulast%3DBohn%26aufirst%3DD.%26aulast%3DWelsh%26aufirst%3DD.%2BC.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DGardell%26aufirst%3DS.%2BJ.%26aulast%3DShafer%26aufirst%3DJ.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DPharmacokinetic%2520optimization%2520of%25203-amino-6-chloropyrazinone%2520acetamide%2520thrombin%2520inhibitors.%2520Implementation%2520of%2520P3%2520pyridine%2520N-oxides%2520to%2520deliver%2520an%2520orally%2520bioavailable%2520series%2520containing%2520P1%2520N-benzylamines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1353%26epage%3D1357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Riffel, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hengchang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M.-W.</span><span> </span><span class="NLM_article-title">Simultaneous determination of a novel thrombin inhibitor and its two metabolites in human plasma by liquid chromatography/tandem mass spectrometry</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1016%2FS0731-7085%2800%2900353-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=10933555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFChu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=607-616&author=K.+A.+Riffelauthor=S.+Hengchangauthor=X.+Guauthor=K.+Yanauthor=M.-W.+Lo&title=Simultaneous+determination+of+a+novel+thrombin+inhibitor+and+its+two+metabolites+in+human+plasma+by+liquid+chromatography%2Ftandem+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous determination of a novel thrombin inhibitor and its two metabolites in human plasma by liquid chromatography/tandem mass spectrometry</span></div><div class="casAuthors">Riffel, K. A.; Song, H.; Gu, X.; Yan, K.; Lo, M.-W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">607-616</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">I, 3-(2-phenethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylene-carboxamidomethylpyridinyl)-pyrazinone dihydrochloride monohydrate, is a potent, orally active thrombin inhibitor.  The compd. also has two metabolites which have been shown to have thrombin inhibitory activity: benzylic alc. M3 metabolite (II) and hydroxymethylpyrazinone M7 metabolite (III).  A liq. chromatog./tandem mass spectrometry (LC/MS/MS) method for the simultaneous detn. of I and its two metabolites in human plasma has successfully been developed.  The method consists of treating 0.5 mL plasma with 2 N NaOH and extg. I, II, III and internal std. (IV) with Et acetate:methyl-t-Bu ether (1:3,vol./vol.).  The analytes were then back-extd. into 2% formic acid.  The analytes were chromatographed by high performance liq. chromatog. (HPLC) and detected by MS/MS.  Pos. ionization was used on a heated nebulizer probe monitoring precursor product ion combinations in multiple reaction monitoring mode.  The linear range is 0.5-1000 nM for I and III and 0.75-1000 nM for II.  Recoveries were 88, 74, 78 and 102.1% for I, II and III and the internal std., resp. in human plasma.  Intraday variation using this method was ≤7.9% for I, ≤9.0% for II and ≤9.5% for III across the std. curve range.  This method exhibits good linearity and reproducibility for the three analytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTGUNPHSd2sLVg90H21EOLACvtfcHk0lheCfVjwgxKwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFChu78%253D&md5=ebe5a481d37f35e1ca84351db93f13c6</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2FS0731-7085%2800%2900353-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0731-7085%252800%252900353-8%26sid%3Dliteratum%253Aachs%26aulast%3DRiffel%26aufirst%3DK.%2BA.%26aulast%3DHengchang%26aufirst%3DS.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DK.%26aulast%3DLo%26aufirst%3DM.-W.%26atitle%3DSimultaneous%2520determination%2520of%2520a%2520novel%2520thrombin%2520inhibitor%2520and%2520its%2520two%2520metabolites%2520in%2520human%2520plasma%2520by%2520liquid%2520chromatography%252Ftandem%2520mass%2520spectrometry%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2000%26volume%3D23%26spage%3D607%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Burgey, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, P. E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranieri, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitko, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonough, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Detwiler, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020311f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=461-473&author=C.+S.+Burgeyauthor=K.+A.+Robinsonauthor=T.+A.+Lyleauthor=P.+E.+J.+Sandersonauthor=S.+D.+Lewisauthor=B.+J.+Lucasauthor=J.+A.+Kruegerauthor=R.+Singhauthor=C.+Miller-Steinauthor=R.+B.+Whiteauthor=B.+Wongauthor=E.+A.+Lyleauthor=P.+D.+Williamsauthor=C.+A.+Coburnauthor=B.+D.+Dorseyauthor=J.+C.+Barrowauthor=M.+T.+Stranieriauthor=M.+A.+Holahanauthor=G.+R.+Sitkoauthor=J.+J.+Cookauthor=D.+R.+McMastersauthor=C.+M.+McDonoughauthor=W.+M.+Sandersauthor=A.+A.+Wallaceauthor=F.+C.+Claytonauthor=D.+Bohnauthor=Y.+M.+Leonardauthor=T.+J.+Detwilerauthor=J.+J.+Lynchauthor=Y.+Yanauthor=Z.+Chenauthor=L.+Kuoauthor=S.+J.+Gardellauthor=J.+A.+Shaferauthor=J.+P.+Vacca&title=Metabolism-directed+optimization+of+3-aminopyrazinone+acetamide+thrombin+inhibitors.+Development+of+an+orally+bioavailable+series+containing+P1+and+P3+pyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjm020311f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020311f%26sid%3Dliteratum%253Aachs%26aulast%3DBurgey%26aufirst%3DC.%2BS.%26aulast%3DRobinson%26aufirst%3DK.%2BA.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DSanderson%26aufirst%3DP.%2BE.%2BJ.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DMiller-Stein%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DR.%2BB.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DLyle%26aufirst%3DE.%2BA.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DStranieri%26aufirst%3DM.%2BT.%26aulast%3DHolahan%26aufirst%3DM.%2BA.%26aulast%3DSitko%26aufirst%3DG.%2BR.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DMcDonough%26aufirst%3DC.%2BM.%26aulast%3DSanders%26aufirst%3DW.%2BM.%26aulast%3DWallace%26aufirst%3DA.%2BA.%26aulast%3DClayton%26aufirst%3DF.%2BC.%26aulast%3DBohn%26aufirst%3DD.%26aulast%3DLeonard%26aufirst%3DY.%2BM.%26aulast%3DDetwiler%26aufirst%3DT.%2BJ.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DGardell%26aufirst%3DS.%2BJ.%26aulast%3DShafer%26aufirst%3DJ.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMetabolism-directed%2520optimization%2520of%25203-aminopyrazinone%2520acetamide%2520thrombin%2520inhibitors.%2520Development%2520of%2520an%2520orally%2520bioavailable%2520series%2520containing%2520P1%2520and%2520P3%2520pyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D461%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Young, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicore, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantermet, P. G.</span><span> </span><span class="NLM_article-title">Discovery and evaluation of potent P1 aryl hetercycle-based thrombin inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2995</span><span class="NLM_x">–</span> <span class="NLM_lpage">3008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030303e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2995-3008&author=M.+B.+Youngauthor=J.+C.+Barrowauthor=K.+L.+Glassauthor=G.+F.+Lundellauthor=C.+L.+Newtonauthor=J.+M.+Pellicoreauthor=K.+E.+Rittleauthor=H.+G.+Selnickauthor=K.+J.+Staufferauthor=J.+P.+Vaccaauthor=P.+D.+Williamsauthor=D.+Bohnauthor=F.+C.+Claytonauthor=J.+J.+Cookauthor=J.+A.+Kruegerauthor=L.+C.+Kuoauthor=S.+D.+Lewisauthor=B.+J.+Lucasauthor=D.+R.+McMastersauthor=C.+Miller-Steinauthor=B.+L.+Pietrakauthor=A.+A.+Wallaceauthor=R.+B.+Whiteauthor=B.+Wongauthor=Y.+Yanauthor=P.+G.+Nantermet&title=Discovery+and+evaluation+of+potent+P1+aryl+hetercycle-based+thrombin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm030303e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030303e%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DM.%2BB.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DGlass%26aufirst%3DK.%2BL.%26aulast%3DLundell%26aufirst%3DG.%2BF.%26aulast%3DNewton%26aufirst%3DC.%2BL.%26aulast%3DPellicore%26aufirst%3DJ.%2BM.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DStauffer%26aufirst%3DK.%2BJ.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DBohn%26aufirst%3DD.%26aulast%3DClayton%26aufirst%3DF.%2BC.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DMiller-Stein%26aufirst%3DC.%26aulast%3DPietrak%26aufirst%3DB.%2BL.%26aulast%3DWallace%26aufirst%3DA.%2BA.%26aulast%3DWhite%26aufirst%3DR.%2BB.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520potent%2520P1%2520aryl%2520hetercycle-based%2520thrombin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2995%26epage%3D3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markotan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomczuk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crysler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisennagel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gremminger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardino, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bone, R.</span><span> </span><span class="NLM_article-title">Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3727</span><span class="NLM_x">–</span> <span class="NLM_lpage">3731</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3727-3731&author=T.+Luauthor=T.+Markotanauthor=F.+Coppoauthor=B.+Tomczukauthor=C.+Cryslerauthor=S.+Eisennagelauthor=J.+Spurlinoauthor=L.+Gremmingerauthor=R.+M.+Sollauthor=E.+C.+Giardinoauthor=R.+Bone&title=Oxyguanidines.+Part+2%3A+Discovery+of+a+novel+orally+active+thrombin+inhibitor+through+structure-based+drug+design+and+parallel+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DT.%26aulast%3DMarkotan%26aufirst%3DT.%26aulast%3DCoppo%26aufirst%3DF.%26aulast%3DTomczuk%26aufirst%3DB.%26aulast%3DCrysler%26aufirst%3DC.%26aulast%3DEisennagel%26aufirst%3DS.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DGremminger%26aufirst%3DL.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DGiardino%26aufirst%3DE.%2BC.%26aulast%3DBone%26aufirst%3DR.%26atitle%3DOxyguanidines.%2520Part%25202%253A%2520Discovery%2520of%2520a%2520novel%2520orally%2520active%2520thrombin%2520inhibitor%2520through%2520structure-based%2520drug%2520design%2520and%2520parallel%2520synthesis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3727%26epage%3D3731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Walkowiak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmanowski, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strzykala, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bychowiec, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Songin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, K.-H.</span><span> </span><span class="NLM_article-title">Inhibition of endogenous pancreatic enzyme secretion by oral pancreatic enzyme treatment</span> <span class="citation_source-journal">Eur. J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=65-69&author=J.+Walkowiakauthor=H.+Witmanowskiauthor=K.+Strzykalaauthor=B.+Bychowiecauthor=T.+Songinauthor=K.+Borskiauthor=K.-H.+Herzig&title=Inhibition+of+endogenous+pancreatic+enzyme+secretion+by+oral+pancreatic+enzyme+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalkowiak%26aufirst%3DJ.%26aulast%3DWitmanowski%26aufirst%3DH.%26aulast%3DStrzykala%26aufirst%3DK.%26aulast%3DBychowiec%26aufirst%3DB.%26aulast%3DSongin%26aufirst%3DT.%26aulast%3DBorski%26aufirst%3DK.%26aulast%3DHerzig%26aufirst%3DK.-H.%26atitle%3DInhibition%2520of%2520endogenous%2520pancreatic%2520enzyme%2520secretion%2520by%2520oral%2520pancreatic%2520enzyme%2520treatment%26jtitle%3DEur.%2520J.%2520Clin.%2520Invest.%26date%3D2003%26volume%3D33%26spage%3D65%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Obourn, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frame, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. C.</span><span> </span><span class="NLM_article-title">Evidence that A8947 enhances pancreas growth via a trypsin inhibitor mechanism</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1006%2Ftaap.1997.8231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=9299603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADyaK2sXmt1WgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=1997&pages=116-126&author=J.+D.+Obournauthor=S.+R.+Frameauthor=T.+Shiuauthor=T.+E.+Solomonauthor=J.+C.+Cook&title=Evidence+that+A8947+enhances+pancreas+growth+via+a+trypsin+inhibitor+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence that A8947 enhances pancreas growth via a trypsin inhibitor mechanism</span></div><div class="casAuthors">Obourn, John D.; Frame, Steven R.; Chiu, Taisan; Solomon, Travis E.; Cook, Jon C.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">116-126</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">The objectives of this study were to investigate the mechanism(s) for the A8947 induction of pancreatic acinar cell hypertrophy and proliferation and to evaluate whether these pancreatic changes are reversible.  A8947 was fed to male Crl:CD BR rats for up to 28 days (0, 300, 10,000, 30,000 ppm) or 56 days (0, 30,000 ppm).  Rats were terminated on Test Days 7, 14, and 28 to assess the time course and dose response for the A8947-induced pancreatic changes, while rats terminated on Test Day 56 were used to assess the reversibility of the pancreas effects at 30,000 ppm A8947.  A8947 produced significant increases in pancreatic wt. and acinar cell proliferation and diffuse acinar cell hypertrophy in 7 days at 10,000 and 30,000 ppm dose levels.  By Day 14, abs. pancreas wts. in the 10,000 and 30,000 ppm groups were maximally increased and remained at these levels throughout the study.  In contrast, acinar cell proliferation in the 30,000 ppm group was still elevated at Test Day 14, but attenuated relative to the 7-day response, and returned to control levels by Test Day 28.  No effects were obsd. at 300 ppm after a 28-day exposure period, while complete reversibility of A8947-induced pancreatic effects was demonstrated at 30,000 ppm following a 1-mo recovery period (Test Day 56).  Cholecystokinin (CCK) levels were increased by A8947 and closely followed the time course for pancreatic changes.  MK-329, a specific CCKA receptor antagonist, completely ablated the ability of 30,000 ppm A8947 to increase pancreas wt. following 7 days of exposure.  A8947 did not bind the CCKA receptor in a receptor competition assay, negating any potential agonist mechanism.  A8947 did, however, inhibit trypsin in vitro, suggesting a mechanism of action similar to that of raw soy protein, in which trypsin inhibition in vivo results in increased CCK levels followed by pancreatic acinar cell hypertrophy and proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow6ER5r-41ybVg90H21EOLACvtfcHk0liKH2mh4-SARg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmt1WgsLc%253D&md5=02d5f46ff084c90b554519f647c4e52f</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1006%2Ftaap.1997.8231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Ftaap.1997.8231%26sid%3Dliteratum%253Aachs%26aulast%3DObourn%26aufirst%3DJ.%2BD.%26aulast%3DFrame%26aufirst%3DS.%2BR.%26aulast%3DShiu%26aufirst%3DT.%26aulast%3DSolomon%26aufirst%3DT.%2BE.%26aulast%3DCook%26aufirst%3DJ.%2BC.%26atitle%3DEvidence%2520that%2520A8947%2520enhances%2520pancreas%2520growth%2520via%2520a%2520trypsin%2520inhibitor%2520mechanism%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D1997%26volume%3D146%26spage%3D116%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulichak, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, J. A.</span><span> </span><span class="NLM_article-title">Crystal structure of human α-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 Å resolution</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=1995&pages=198-203&author=Z.+Chenauthor=Y.+Liauthor=A.+M.+Mulichakauthor=S.+D.+Lewisauthor=J.+A.+Shafer&title=Crystal+structure+of+human+%CE%B1-thrombin+complexed+with+hirugen+and+p-amidinophenylpyruvate+at+1.6+%C3%85+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMulichak%26aufirst%3DA.%2BM.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DShafer%26aufirst%3DJ.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520human%2520%25CE%25B1-thrombin%2520complexed%2520with%2520hirugen%2520and%2520p-amidinophenylpyruvate%2520at%25201.6%2520%25C3%2585%2520resolution%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1995%26volume%3D322%26spage%3D198%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Sanderson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonough, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span> </span><span class="NLM_article-title">Azaindoles: Moderately basic P1 groups for enhancing the selectivity of thrombin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">–</span> <span class="NLM_lpage">798</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=795-798&author=P.+E.+Sandersonauthor=M.+G.+Stantonauthor=B.+D.+Dorseyauthor=T.+A.+Lyleauthor=C.+McDonoughauthor=W.+M.+Sandersauthor=K.+L.+Savageauthor=A.+M.+Naylor-Olsenauthor=J.+A.+Kruegerauthor=S.+D.+Lewisauthor=B.+J.+Lucasauthor=J.+J.+Lynchauthor=Y.+Yan&title=Azaindoles%3A+Moderately+basic+P1+groups+for+enhancing+the+selectivity+of+thrombin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanderson%26aufirst%3DP.%2BE.%26aulast%3DStanton%26aufirst%3DM.%2BG.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DMcDonough%26aufirst%3DC.%26aulast%3DSanders%26aufirst%3DW.%2BM.%26aulast%3DSavage%26aufirst%3DK.%2BL.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%2BM.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DYan%26aufirst%3DY.%26atitle%3DAzaindoles%253A%2520Moderately%2520basic%2520P1%2520groups%2520for%2520enhancing%2520the%2520selectivity%2520of%2520thrombin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D795%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Isaacs, R. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solinsky, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutrona, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span> </span><span class="NLM_article-title">Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 1: Weakly basic azoles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=338-342&author=R.+C.+A.+Isaacsauthor=M.+G.+Solinskyauthor=K.+J.+Cutronaauthor=C.+L.+Newtonauthor=A.+M.+Naylor-Olsenauthor=J.+A.+Kruegerauthor=S.+D.+Lewisauthor=B.+J.+Lucas&title=Structure-based+design+of+novel+groups+for+use+in+the+P1+position+of+thrombin+inhibitor+scaffolds.+Part+1%3A+Weakly+basic+azoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsaacs%26aufirst%3DR.%2BC.%2BA.%26aulast%3DSolinsky%26aufirst%3DM.%2BG.%26aulast%3DCutrona%26aufirst%3DK.%2BJ.%26aulast%3DNewton%26aufirst%3DC.%2BL.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%2BM.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520groups%2520for%2520use%2520in%2520the%2520P1%2520position%2520of%2520thrombin%2520inhibitor%2520scaffolds.%2520Part%25201%253A%2520Weakly%2520basic%2520azoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D338%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Isaacs, R. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solinsky, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutrona, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, E. A.</span><span> </span><span class="NLM_article-title">Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2062</span><span class="NLM_x">–</span> <span class="NLM_lpage">2066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2062-2066&author=R.+C.+A.+Isaacsauthor=M.+G.+Solinskyauthor=K.+J.+Cutronaauthor=C.+L.+Newtonauthor=A.+M.+Naylor-Olsenauthor=D.+R.+McMastersauthor=J.+A.+Kruegerauthor=S.+D.+Lewisauthor=B.+J.+Lucasauthor=L.+C.+Kuoauthor=Y.+Yanauthor=J.+J.+Lynchauthor=E.+A.+Lyle&title=Structure-based+design+of+novel+groups+for+use+in+the+P1+position+of+thrombin+inhibitor+scaffolds.+Part+2%3A+N-acetamidoimidazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsaacs%26aufirst%3DR.%2BC.%2BA.%26aulast%3DSolinsky%26aufirst%3DM.%2BG.%26aulast%3DCutrona%26aufirst%3DK.%2BJ.%26aulast%3DNewton%26aufirst%3DC.%2BL.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%2BM.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DLyle%26aufirst%3DE.%2BA.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520groups%2520for%2520use%2520in%2520the%2520P1%2520position%2520of%2520thrombin%2520inhibitor%2520scaffolds.%2520Part%25202%253A%2520N-acetamidoimidazoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2062%26epage%3D2066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Reiner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siev, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araldi, G.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamedova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K-S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradbury, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semple, J. E.</span><span> </span><span class="NLM_article-title">Non-covalent thrombin inhibitors featuring P3-heterocycles with P1-monocyclic arginine surrogates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1203</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1203-1208&author=J.+E.+Reinerauthor=D.+V.+Sievauthor=G.-L.+Araldiauthor=J.+J.+Cuiauthor=J.+Z.+Hoauthor=K.+M.+Reddyauthor=L.+Mamedovaauthor=P.+H.+Vuauthor=K-S.+S.+Leeauthor=N.+K.+Minamiauthor=T.+S.+Gibsonauthor=S.+M.+Andersonauthor=A.+E.+Bradburyauthor=T.+G.+Nolanauthor=J.+E.+Semple&title=Non-covalent+thrombin+inhibitors+featuring+P3-heterocycles+with+P1-monocyclic+arginine+surrogates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReiner%26aufirst%3DJ.%2BE.%26aulast%3DSiev%26aufirst%3DD.%2BV.%26aulast%3DAraldi%26aufirst%3DG.-L.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DHo%26aufirst%3DJ.%2BZ.%26aulast%3DReddy%26aufirst%3DK.%2BM.%26aulast%3DMamedova%26aufirst%3DL.%26aulast%3DVu%26aufirst%3DP.%2BH.%26aulast%3DLee%26aufirst%3DK-S.%2BS.%26aulast%3DMinami%26aufirst%3DN.%2BK.%26aulast%3DGibson%26aufirst%3DT.%2BS.%26aulast%3DAnderson%26aufirst%3DS.%2BM.%26aulast%3DBradbury%26aufirst%3DA.%2BE.%26aulast%3DNolan%26aufirst%3DT.%2BG.%26aulast%3DSemple%26aufirst%3DJ.%2BE.%26atitle%3DNon-covalent%2520thrombin%2520inhibitors%2520featuring%2520P3-heterocycles%2520with%2520P1-monocyclic%2520arginine%2520surrogates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1203%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schumacher, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heran, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbacher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Megill, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giancarli, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durham, S. K.</span><span> </span><span class="NLM_article-title">Thrombin inhibition compared with other antithrombotic drugs in rats</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1016%2F0049-3848%2892%2990031-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=1475778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADyaK3sXhsFOksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1992&pages=157-66&author=W.+A.+Schumacherauthor=C.+H.+Heranauthor=T.+E.+Steinbacherauthor=J.+R.+Megillauthor=J.+E.+Birdauthor=M.+R.+Giancarliauthor=S.+K.+Durham&title=Thrombin+inhibition+compared+with+other+antithrombotic+drugs+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombin inhibition compared with other antithrombotic drugs in rats</span></div><div class="casAuthors">Schumacher, W. A.; Heran, C. H.; Steinbacher, T. E.; Megill, J. R.; Bird, J. E.; Giancarli, M. R.; Durham, S. K.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-66</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    </div><div class="casAbstract">An aspirin-sensitive model of arterial thrombosis suitable for rapid evaluation of antithrombotic drugs was developed and characterized in anesthetized rats.  Carotid artery thrombi were formed in response to elec. stimulation and were occlusive in 84% of vehicle-treated rats.  Light and electron microscopy revealed these thrombi to be platelet-rich and fibrin-rich masses adherent to the injured vessel wall.  I.v. administration of aspirin (10 mg/kg), heparin (300 U/kg), a thromboxane (Tx) A2-receptor antagonist (SQ 29,548, 0.2 mg/kg + 0.2 mg/kg/h), or the thrombin inhibitor D-Ph alanyl-L-prolyl-L-arginyl chloromethyl ketone (PPACK, 52 μg/kg/min) decreased av. thrombus wt. by 35, 50, 57 and 94%, resp.  Each of these drugs also reduced the frequency of occlusion to <25%.  In contrast, thrombus wt. and vessel occlusion were not decreased by a serotonin antagonist (ketanserin, 3.0 mg/kg, i.v.), or after 14 days or oral dosing with either the calcium antagonist diltiazem (60 mg/kg) or SQ 33,351 (30 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBqEwKBuvDd7Vg90H21EOLACvtfcHk0liga47Bd7VcZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhsFOksw%253D%253D&md5=adcff7547a31c16242948019144164f0</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1016%2F0049-3848%2892%2990031-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0049-3848%252892%252990031-5%26sid%3Dliteratum%253Aachs%26aulast%3DSchumacher%26aufirst%3DW.%2BA.%26aulast%3DHeran%26aufirst%3DC.%2BH.%26aulast%3DSteinbacher%26aufirst%3DT.%2BE.%26aulast%3DMegill%26aufirst%3DJ.%2BR.%26aulast%3DBird%26aufirst%3DJ.%2BE.%26aulast%3DGiancarli%26aufirst%3DM.%2BR.%26aulast%3DDurham%26aufirst%3DS.%2BK.%26atitle%3DThrombin%2520inhibition%2520compared%2520with%2520other%2520antithrombotic%2520drugs%2520in%2520rats%26jtitle%3DThromb.%2520Res.%26date%3D1992%26volume%3D68%26spage%3D157%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Berry, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecoffre, C.</span><span> </span><span class="NLM_article-title">Antithrombotic actions of argatroban in rat models of venous, ‘mixed’ and arterial thrombosis, and its effects on the tail transaction bleeding time</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">1209</span><span class="NLM_x">–</span> <span class="NLM_lpage">1214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1111%2Fj.1476-5381.1994.tb17126.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=7889274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADyaK2MXisFajtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1994&pages=1209-1214&author=C.+N.+Berryauthor=D.+Girardauthor=S.+Lochotauthor=C.+Lecoffre&title=Antithrombotic+actions+of+argatroban+in+rat+models+of+venous%2C+%E2%80%98mixed%E2%80%99+and+arterial+thrombosis%2C+and+its+effects+on+the+tail+transaction+bleeding+time"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Antithrombotic actions of argatroban in rat models of venous, 'mixed' [arteriovenous] and arterial thrombosis, and its effects on the tail transection bleeding time</span></div><div class="casAuthors">Berry, Christopher N.; Girard, Denise; Lochot, Sylvette; Lecoffre, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1209-14</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The antithrombotic action of argatroban, a synthetic thrombin inhibitor, was studied in the title 3 models of thrombosis in the rat, and in the tail transection bleeding time test.  Heparin was studied as a ref. anticoagulant.  In the model of venous thrombosis induced by thromboplastin followed by stasis of the abdominal vena cava, argatroban had an ED50 of 12 μg/kg, when administered as an i.v. bolus 5 min prior to the thromboplastin injection: the ED50 of heparin was 42 μg/kg.  When the two compds. were administered by continuous i.v. infusion, argatroban (ED50 = 1.5 μg/kg/min) had the same potency as heparin (ED50 = 1.2 μg/kg/min).  Argatroban was active in the arteriovenous shunt model, with an ED50 of 0.6 mg/kg when the compd. was given as a bolus.  The ED50 of heparin was 0.04 mg/kg under the same conditions.  The 2 compds. had ED50 values of 6 μg/kg/min (argatroban) and 3 μg/kg/min (heparin), when administered by continuous i.v. infusion.  When tested against occlusive arterial thrombus formation by elec. stimulation of the left carotid artery, both compds., given as either an i.v. bolus or a continuous infusion, led to dose-dependent increases in the duration of postlesion vessel patency.  The antithrombotic effects of argatroban were accompanied by only moderate changes in the coagulation parameters (thrombin time and activated partial thromboplatin time, APTT), whereas, even at a subthreshold dose of heparin, both the thrombin time and the APTT were >150 s.  Infusions of both compds. caused dose-dependent increases in the tail transection bleeding time, with the dose of argatroban that doubles the bleeding time (11 μg/kg) being 5 times greater than that of heparin (ED100 = 2.2 μg/kg/min).  These data show that, when administered as an i.v. infusion, argatroban is a potent antithrombotic agent in rat models of venous, 'mixed' and arterial thrombosis; this effect can be obtained with a lower degree of systemic anticoagulation than with heparin in the arterial model, and argatroban has a lower hemorrhagic potential than heparin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2c3pmCWsHqLVg90H21EOLACvtfcHk0liga47Bd7VcZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXisFajtr4%253D&md5=a3055f4130afcb326ccacfba40480f0b</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1994.tb17126.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1994.tb17126.x%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DC.%2BN.%26aulast%3DGirard%26aufirst%3DD.%26aulast%3DLochot%26aufirst%3DS.%26aulast%3DLecoffre%26aufirst%3DC.%26atitle%3DAntithrombotic%2520actions%2520of%2520argatroban%2520in%2520rat%2520models%2520of%2520venous%252C%2520%25E2%2580%2598mixed%25E2%2580%2599%2520and%2520arterial%2520thrombosis%252C%2520and%2520its%2520effects%2520on%2520the%2520tail%2520transaction%2520bleeding%2520time%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D113%26spage%3D1209%26epage%3D1214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crain, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meade, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, A. M.</span><span> </span><span class="NLM_article-title">Nonpeptide factor Xa inhibitors II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=10991981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1ygu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=212-218&author=P.+C.+Wongauthor=E.+J.+Crainauthor=R.+M.+Knabbauthor=R.+P.+Meadeauthor=M.+L.+Quanauthor=C.+A.+Watsonauthor=R.+R.+Wexlerauthor=M.+R.+Wrightauthor=A.+M.+Slee&title=Nonpeptide+factor+Xa+inhibitors+II.+Antithrombotic+evaluation+in+a+rabbit+model+of+electrically+induced+carotid+artery+thrombosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide factor Xa inhibitors. II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis</span></div><div class="casAuthors">Wong, Pancras C.; Crain, Earl J.; Knabb, Robert M.; Meade, Raymond P.; Quan, Mimi L.; Watson, Carol A.; Wexler, Ruth R.; Wright, Matthew R.; Slee, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">212-218</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">SK549 (mol. wt. 546 Da) is a synthetic, selective inhibitor of human coagulation factor Xa (fXa) (Ki = 0.52 nM).  This study compared the antithrombotic effects of SK549 and a series of benzamidine isoxazoline fXa inhibitors with aspirin, DuP 714 (a direct thrombin inhibitor), recombinant tick anticoagulant peptide, or heparin in a rabbit model of elec. induced carotid arterial thrombosis.  Compds. were infused i.v. continuously from 60 min before elec. stimulation to the end of the expt.  Values of ED50 (dose that increases the carotid blood flow to 50% of the control) were 0.12 μmol/kg/h for SK549, 0.56 μmol/kg/h for aspirin, 0.14 μmol/kg/h for DuP 714, 0.06 μmol/kg/h for recombinant tick anticoagulant peptide, and >100 U/kg/h for heparin.  The EC50 (plasma concn. that increased blood flow to 50% of the control) for SK549 was 97 nM.  Unlike aspirin and heparin, SK549 was efficacious and, at 1.5 μmol/kg/h i.v. (n = 9), maintained carotid blood flow at 87±6% of control level for greater than 90 min.  Unlike heparin, SK549 inhibited ex vivo fXa activity but not ex vivo thrombin activity.  There was a highly significant correlation between Ki (fXa) and ED50 of a series of fXa inhibitors (r = 0.85, P <.001).  Therefore, these results suggest that SK549 is a novel, potent, and effective antithrombotic agent in a rabbit model of arterial thrombosis.  It is likely that SK549 exerts its antithrombotic effect through selective inhibition of fXa.  Furthermore, SK549 may be clin. useful for the prevention of arterial thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7m_8Krs2pdrVg90H21EOLACvtfcHk0lhyts9wQBj6Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1ygu74%253D&md5=52ed9fac0aeb3b953fd1a5825d03b5af</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DCrain%26aufirst%3DE.%2BJ.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DMeade%26aufirst%3DR.%2BP.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DWright%26aufirst%3DM.%2BR.%26aulast%3DSlee%26aufirst%3DA.%2BM.%26atitle%3DNonpeptide%2520factor%2520Xa%2520inhibitors%2520II.%2520Antithrombotic%2520evaluation%2520in%2520a%2520rabbit%2520model%2520of%2520electrically%2520induced%2520carotid%2520artery%2520thrombosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D295%26spage%3D212%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Giardino, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span> </span><span class="NLM_article-title">Antithrombotic properties of RWJ-50353, a potent and novel thrombin inhibitor</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1016%2FS0049-3848%2899%2900219-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=10706936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsFOjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2000&pages=83-93&author=E.+C.+Giardinoauthor=M.+J.+Costanzoauthor=J.+A.+Kauffmanauthor=Q.-S.+Liauthor=B.+E.+Maryanoffauthor=P.+Andrade-Gordon&title=Antithrombotic+properties+of+RWJ-50353%2C+a+potent+and+novel+thrombin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Antithrombotic Properties of RWJ-50353, a Potent and Novel Thrombin Inhibitor</span></div><div class="casAuthors">Giardino, E. C.; Costanzo, M. J.; Kauffman, J. A.; Li, Q. S.; Maryanoff, B. E.; Andrade-Gordon, P.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-93</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The antithrombotic, anticoagulant, and kinetic properties of RWJ-50353, a novel, reversible, active-site-directed thrombin inhibitor, were evaluated.  RWJ-50353 inhibited the catalytic activity of human α-thrombin with a Ki of 0.19±0.02 nM.  It showed a 16-fold selectivity relative to inhibition of trypsin and at least 330-fold selectivity relative to inhibition of other biol. important serine proteases.  In a gel-filtered platelet prepn., RWJ-50353 inhibited α-thrombin-induced aggregation with an IC50 of 32±6 nM.  In a canine arteriovenous shunt antithrombotic model, RWJ-50353 demonstrated a significant dose-related (0.1-1.0 mg/kg, i.v.) redn. in thrombus formation with 50% inhibition (ID50) obtained at 0.46±0.1 mg/kg.  In a rabbit deep vein thrombosis model, RWJ-50353 dose-dependently (0.1-1.0 mg/kg, i.v.) reduced thrombus formation with an ID50 of 0.25±0.03 mg/kg.  The antithrombotic activity in both of these models was assocd. with only mild prolongations in bleeding time and coagulation parameters.  These results demonstrate that RWJ-50353 is a potent, selective thrombin inhibitor that is an effective antithrombotic agent after i.v. administration in models of arterial and venous thrombosis and may be useful in the management of various thrombotic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDy7TwvOiotrVg90H21EOLACvtfcHk0lhyts9wQBj6Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsFOjt7s%253D&md5=1b8b77d6a55b157f4f59e9d5f10f4377</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0049-3848%2899%2900219-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0049-3848%252899%252900219-4%26sid%3Dliteratum%253Aachs%26aulast%3DGiardino%26aufirst%3DE.%2BC.%26aulast%3DCostanzo%26aufirst%3DM.%2BJ.%26aulast%3DKauffman%26aufirst%3DJ.%2BA.%26aulast%3DLi%26aufirst%3DQ.-S.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26atitle%3DAntithrombotic%2520properties%2520of%2520RWJ-50353%252C%2520a%2520potent%2520and%2520novel%2520thrombin%2520inhibitor%26jtitle%3DThromb.%2520Res.%26date%3D2000%26volume%3D98%26spage%3D83%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Barrett, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crocker, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damphousse, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heminway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazewatsky, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazaika, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, T. R.</span><span> </span><span class="NLM_article-title">Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with <sup>99m</sup>Tc</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc970001p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADyaK2sXhsFGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=155-160&author=J.+A.+Barrettauthor=A.+C.+Crockerauthor=D.+J.+Damphousseauthor=S.+J.+Heminwayauthor=S.+Liuauthor=D.+S.+Edwardsauthor=J.+L.+Lazewatskyauthor=M.+Kaganauthor=T.+J.+Mazaikaauthor=T.+R.+Carroll&title=Biological+evaluation+of+thrombus+imaging+agents+utilizing+water+soluble+phosphines+and+tricine+as+coligands+when+used+to+label+a+hydrazinonicotinamide-modified+cyclic+glycoprotein+IIb%2FIIIa+receptor+antagonist+with+99mTc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Biological Evaluation of Thrombus Imaging Agents Utilizing Water Soluble Phosphines and Tricine as Coligands When Used To Label a Hydrazinonicotinamide-Modified Cyclic Glycoprotein IIb/IIIa Receptor Antagonist with 99mTc</span></div><div class="casAuthors">Barrett, John A.; Crocker, Andrew C.; Damphousse, David J.; Heminway, Stuart J.; Liu, Shuang; Edwards, D. Scott; Lazewatsky, Joel L.; Kagan, Mikhail; Mazaika, Theresa J.; Carroll, Timothy R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-160</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hydrazinonicotinamide-functionalized cyclic glycoprotein IIb/IIIa (GPIIb/IIIa) receptor antagonist [cyclo(D-Val-NMeArg-Gly-Asp-Mamb(5-(6-(6-hydrazinonicotinamido)hexanamide))) (HYNICtide)] was labeled with 99mTc using tricine and a water sol. phosphine [trisodium triphenylphosphine-3,3',3''-trisulfonate (TPPTS); disodium triphenylphosphine-3,3'-disulfonate (TPPDS); or sodium triphenylphosphine-3-monosulfonate (TPPMS)] as coligands.  Three complexes, [99mTc(HYNICtide)(L)(tricine)] (1, L = TPPTS; 2, L = TPPDS; 3, L = TPPMS), were evaluated in the canine arteriovenous shunt (AV shunt) model and canine deep vein thrombosis imaging (DVT) model.  All three agents were adequately incorporated into the arterial and venous portions of the growing thrombus (7.8-9.9 and 0.2-3.7% ID/g, resp.) in the canine AV shunt model.  In the canine DVT model all three complexes had thrombus uptake that far exceeded the neg. control, [99mTc]albumin.  The findings indicate similar incorporation into a venous thrombus (% ID/g = 2.86 ± 0.4, 3.4 ± 0.9, and 3.38 ± 1.1 for complexes 1, 2, and 3, resp.) and similar blood clearance with a t1/2 of approx. 90 min.  Gamma camera scintigraphy allowed visualization of deep vein thrombosis in as little as 15 min with the thrombus/muscle ratios being 3.8 ± 0.8, 2.8 ± 0.4, and 3.0 ± 0.8 for complexes 1, 2, and 3, resp.  The visualization of the thrombus improved over time, and the thrombus/muscle ratios were 9.7 ± 1.9, 13.8 ± 3.6, and 9.4 ± 2 for complexes 1, 2, and 3, resp., at 120 min postinjection.  The administration of complexes 1-3 did not alter platelet function, hemodynamics, or the coagulation cascade.  Furthermore, complexes 1-3 did not significantly differ in their uptake into the growing thrombus, blood clearance, and target to background ratios.  Therefore, all three complexes have the capability to detect rapidly growing venous and arterial thrombi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY4h9ZUWNT2LVg90H21EOLACvtfcHk0lhyts9wQBj6Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsFGjtLs%253D&md5=5e4e19de4c5f9afabb3bebe791f65a5c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fbc970001p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc970001p%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DJ.%2BA.%26aulast%3DCrocker%26aufirst%3DA.%2BC.%26aulast%3DDamphousse%26aufirst%3DD.%2BJ.%26aulast%3DHeminway%26aufirst%3DS.%2BJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DD.%2BS.%26aulast%3DLazewatsky%26aufirst%3DJ.%2BL.%26aulast%3DKagan%26aufirst%3DM.%26aulast%3DMazaika%26aufirst%3DT.%2BJ.%26aulast%3DCarroll%26aufirst%3DT.%2BR.%26atitle%3DBiological%2520evaluation%2520of%2520thrombus%2520imaging%2520agents%2520utilizing%2520water%2520soluble%2520phosphines%2520and%2520tricine%2520as%2520coligands%2520when%2520used%2520to%2520label%2520a%2520hydrazinonicotinamide-modified%2520cyclic%2520glycoprotein%2520IIb%252FIIIa%2520receptor%2520antagonist%2520with%252099mTc%26jtitle%3DBioconjugate%2520Chem.%26date%3D1997%26volume%3D8%26spage%3D155%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Lorrain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechaire, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visconte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sainte-Marie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunven, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Connor, S. E.</span><span> </span><span class="NLM_article-title">Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1124%2Fjpet.102.044610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=12538808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVCgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2003&pages=567-574&author=J.+Lorrainauthor=L.+Milletauthor=I.+Lechaireauthor=S.+Lochotauthor=P.+Ferrariauthor=C.+Visconteauthor=M.+Sainte-Marieauthor=C.+Lunvenauthor=C.+N.+Berryauthor=P.+Schaefferauthor=J.-M.+Herbertauthor=S.+E.+O%27Connor&title=Antithrombotic+properties+of+SSR182289A%2C+a+new%2C+orally+active+thrombin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor</span></div><div class="casAuthors">Lorrain, J.; Millet, L.; Lechaire, I.; Lochot, S.; Ferrari, P.; Visconte, C.; Sainte-Marie, M.; Lunven, C.; Berry, C. N.; Schaeffer, P.; Herbert, J.-M.; O'Connor, S. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">567-574</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">N-[3-[[[(1S)-4-(5-Amino-2-pyridinyl)-1-[[4-difluoromethylene)-1-piperidinyl]carbonyl]butyl]amino]sulfonyl][1,1'-biphenyl]-2-yl]acetamide hydrochloride (SSR182289A) is a novel, potent, and selective thrombin inhibitor.  We have examd. the antithrombotic properties of SSR182289A administered by i.v. and p.o. routes in several different animal thrombosis models in comparison with ref. antithrombotic agents.  Oral administration of SSR182289A produced dose-related antithrombotic effects in the following models; rat venous thrombosis (ED50 0.9 mg/kg p.o.), rat silk thread arterio-venous (AV) shunt (ED50 3.8 mg/kg p.o.), rat thromboplastin-induced AV shunt (ED50 3.1 mg/kg p.o.), rat carotid artery thrombosis (ED200 5.9 mg/kg p.o.), and rabbit venous thrombosis (ED50 7.5 mg/kg p.o.).  Administered as an i.v. bolus, SSR182289A showed antithrombotic activity in the above models with ED50/ED200 values in the range of 0.2 to 1.9 mg/kg i.v. SSR182289A increased rat tail transection bleeding time at doses ≥10 mg/kg p.o.  In the rat thromboplastin-induced AV shunt model, SSR182289A 10 mg/kg p.o. produced marked antithrombotic effects at 30, 60, 120, and 240 min after administration.  Hence, SSR182289A demonstrates potent oral antithrombotic properties in animal venous, AV-shunt, and arterial thrombosis models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphIVi0E6pTNbVg90H21EOLACvtfcHk0lhj0N9mOmrFTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVCgtg%253D%253D&md5=40ee6cad6478dab6dd63b242b0a8357a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.044610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.044610%26sid%3Dliteratum%253Aachs%26aulast%3DLorrain%26aufirst%3DJ.%26aulast%3DMillet%26aufirst%3DL.%26aulast%3DLechaire%26aufirst%3DI.%26aulast%3DLochot%26aufirst%3DS.%26aulast%3DFerrari%26aufirst%3DP.%26aulast%3DVisconte%26aufirst%3DC.%26aulast%3DSainte-Marie%26aufirst%3DM.%26aulast%3DLunven%26aufirst%3DC.%26aulast%3DBerry%26aufirst%3DC.%2BN.%26aulast%3DSchaeffer%26aufirst%3DP.%26aulast%3DHerbert%26aufirst%3DJ.-M.%26aulast%3DO%2527Connor%26aufirst%3DS.%2BE.%26atitle%3DAntithrombotic%2520properties%2520of%2520SSR182289A%252C%2520a%2520new%252C%2520orally%2520active%2520thrombin%2520inhibitor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D304%26spage%3D567%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lu, T.; Tomczuk, B. T.; Markotan, T. P.</span> U.S. Patent 6,204,263 B1,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lu%2C+T.%3B+Tomczuk%2C+B.+T.%3B+Markotan%2C+T.+P.+U.S.+Patent+6%2C204%2C263+B1%2C+2001."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DT.%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K<sub>i</sub>) and the concentration of inhibitor which causes 50% inhibition (IC<sub>50</sub>) of an enzymatic reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28IC50%29+of+an+enzymatic+reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lhj0N9mOmrFTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528IC50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Webber, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewandowski, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schadt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettner, C. A.</span><span> </span><span class="NLM_article-title">Kinetic and crystallographic studies of thrombin with Ac-(D)Phe-Pro-boroArg-OH and its lysine, amidine, homolysine and ornithine analogs</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">3750</span><span class="NLM_x">–</span> <span class="NLM_lpage">3757</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=3750-3757&author=P.+C.+Webberauthor=S.-L.+Leeauthor=F.+A.+Lewandowskiauthor=M.+C.+Schadtauthor=C.-H.+Changauthor=C.+A.+Kettner&title=Kinetic+and+crystallographic+studies+of+thrombin+with+Ac-%28D%29Phe-Pro-boroArg-OH+and+its+lysine%2C+amidine%2C+homolysine+and+ornithine+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWebber%26aufirst%3DP.%2BC.%26aulast%3DLee%26aufirst%3DS.-L.%26aulast%3DLewandowski%26aufirst%3DF.%2BA.%26aulast%3DSchadt%26aufirst%3DM.%2BC.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DKettner%26aufirst%3DC.%2BA.%26atitle%3DKinetic%2520and%2520crystallographic%2520studies%2520of%2520thrombin%2520with%2520Ac-%2528D%2529Phe-Pro-boroArg-OH%2520and%2520its%2520lysine%252C%2520amidine%252C%2520homolysine%2520and%2520ornithine%2520analogs%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D34%26spage%3D3750%26epage%3D3757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Skrzypczak-Jankun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carperos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravichandran, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulinsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maraganore, J. M.</span><span> </span><span class="NLM_article-title">Structure of the hirugen and hirulog 1 complexes of α-thrombin</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">1379</span><span class="NLM_x">–</span> <span class="NLM_lpage">1393</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1991&pages=1379-1393&author=E.+Skrzypczak-Jankunauthor=V.+Carperosauthor=K.+G.+Ravichandranauthor=A.+Tulinskyauthor=M.+Westbrookauthor=J.+M.+Maraganore&title=Structure+of+the+hirugen+and+hirulog+1+complexes+of+%CE%B1-thrombin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkrzypczak-Jankun%26aufirst%3DE.%26aulast%3DCarperos%26aufirst%3DV.%26aulast%3DRavichandran%26aufirst%3DK.%2BG.%26aulast%3DTulinsky%26aufirst%3DA.%26aulast%3DWestbrook%26aufirst%3DM.%26aulast%3DMaraganore%26aufirst%3DJ.%2BM.%26atitle%3DStructure%2520of%2520the%2520hirugen%2520and%2520hirulog%25201%2520complexes%2520of%2520%25CE%25B1-thrombin%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1991%26volume%3D221%26spage%3D1379%26epage%3D1393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Brunger, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karplus, M.</span><span> </span><span class="NLM_article-title">Crystallographic R-factor refinement by molecular dynamics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">235</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1987&pages=458-460&author=A.+T.+Brungerauthor=J.+Kuriyanauthor=M.+Karplus&title=Crystallographic+R-factor+refinement+by+molecular+dynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunger%26aufirst%3DA.%2BT.%26aulast%3DKuriyan%26aufirst%3DJ.%26aulast%3DKarplus%26aufirst%3DM.%26atitle%3DCrystallographic%2520R-factor%2520refinement%2520by%2520molecular%2520dynamics%26jtitle%3DScience%26date%3D1987%26volume%3D235%26spage%3D458%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Bernstein, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koetzle, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, E. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brice, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennard, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimanouchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasumi, M.</span><span> </span><span class="NLM_article-title">The protein databank: A computer based archival file for macro-molecular structures</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1977&pages=535-542&author=F.+C.+Bernsteinauthor=T.+F.+Koetzleauthor=E.+F.+Meyerauthor=M.+D.+Briceauthor=J.+R.+Rodgersauthor=O.+Kennardauthor=T.+Shimanouchiauthor=M.+Tasumi&title=The+protein+databank%3A+A+computer+based+archival+file+for+macro-molecular+structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBernstein%26aufirst%3DF.%2BC.%26aulast%3DKoetzle%26aufirst%3DT.%2BF.%26aulast%3DMeyer%26aufirst%3DE.%2BF.%26aulast%3DBrice%26aufirst%3DM.%2BD.%26aulast%3DRodgers%26aufirst%3DJ.%2BR.%26aulast%3DKennard%26aufirst%3DO.%26aulast%3DShimanouchi%26aufirst%3DT.%26aulast%3DTasumi%26aufirst%3DM.%26atitle%3DThe%2520protein%2520databank%253A%2520A%2520computer%2520based%2520archival%2520file%2520for%2520macro-molecular%2520structures%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1977%26volume%3D112%26spage%3D535%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Sack, J. S.</span><span> </span><span class="NLM_article-title">CHAIN—A crystallographic modeling program</span> <span class="citation_source-journal">J. Mol. Graphics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">249</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1016%2FS0263-7855%2898%2980040-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=249&publication_year=1988&pages=224-225&author=J.+S.+Sack&title=CHAIN%E2%80%94A+crystallographic+modeling+program"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0263-7855%2898%2980040-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0263-7855%252898%252980040-4%26sid%3Dliteratum%253Aachs%26aulast%3DSack%26aufirst%3DJ.%2BS.%26atitle%3DCHAIN%25E2%2580%2594A%2520crystallographic%2520modeling%2520program%26jtitle%3DJ.%2520Mol.%2520Graphics%26date%3D1988%26volume%3D249%26spage%3D224%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b','cit9c'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25a','cit25b','cit25c'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31a','cit31b'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 23 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Peter M. Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Small-Molecule Active-Site Inhibitors of the S1A Family Proteases as Procoagulant and Anticoagulant Drugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (9)
                                     , 3799-3822. <a href="https://doi.org/10.1021/acs.jmedchem.7b00772" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00772%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BSmall-Molecule%252BActive-Site%252BInhibitors%252Bof%252Bthe%252BS1A%252BFamily%252BProteases%252Bas%252BProcoagulant%252Band%252BAnticoagulant%252BDrugs%26aulast%3DFischer%26aufirst%3DPeter%2BM.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D25052017%26date%3D09112017%26date%3D26102017%26volume%3D61%26issue%3D9%26spage%3D3799%26epage%3D3822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Wo</span>, <span class="hlFld-ContribAuthor ">Dekun  Kong</span>, <span class="hlFld-ContribAuthor ">Nelson L.  Brock</span>, <span class="hlFld-ContribAuthor ">Fei  Xu</span>, <span class="hlFld-ContribAuthor ">Xiufen  Zhou</span>, <span class="hlFld-ContribAuthor ">Zixin  Deng</span>, and <span class="hlFld-ContribAuthor ">Shuangjun  Lin</span>  . </span><span class="cited-content_cbyCitation_article-title">Transformation of Streptonigrin to Streptonigrone: Flavin Reductase-Mediated Flavin-Catalyzed Concomitant Oxidative Decarboxylation of Picolinic Acid Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2016,</strong> <em>6 </em>
                                    (5)
                                     , 2831-2835. <a href="https://doi.org/10.1021/acscatal.6b00154" title="DOI URL">https://doi.org/10.1021/acscatal.6b00154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.6b00154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.6b00154%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DTransformation%252Bof%252BStreptonigrin%252Bto%252BStreptonigrone%25253A%252BFlavin%252BReductase-Mediated%252BFlavin-Catalyzed%252BConcomitant%252BOxidative%252BDecarboxylation%252Bof%252BPicolinic%252BAcid%252BDerivatives%26aulast%3DWo%26aufirst%3DJing%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D16012016%26date%3D25032016%26date%3D17042016%26date%3D06052016%26date%3D29032016%26volume%3D6%26issue%3D5%26spage%3D2831%26epage%3D2835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jhonny  Azuaje</span>, <span class="hlFld-ContribAuthor ">Abdelaziz  El Maatougui</span>, <span class="hlFld-ContribAuthor ">José M.  Pérez-Rubio</span>, <span class="hlFld-ContribAuthor ">Alberto  Coelho</span>, <span class="hlFld-ContribAuthor ">Franco  Fernández</span>, and <span class="hlFld-ContribAuthor ">Eddy  Sotelo</span>  . </span><span class="cited-content_cbyCitation_article-title">Multicomponent Assembly of Diverse Pyrazin-2(1H)-one Chemotypes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (9)
                                     , 4402-4409. <a href="https://doi.org/10.1021/jo4003163" title="DOI URL">https://doi.org/10.1021/jo4003163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo4003163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo4003163%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMulticomponent%252BAssembly%252Bof%252BDiverse%252BPyrazin-2%2525281H%252529-one%252BChemotypes%26aulast%3DAzuaje%26aufirst%3DJhonny%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D25022013%26date%3D12042013%26date%3D03052013%26date%3D03042013%26volume%3D78%26issue%3D9%26spage%3D4402%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (8)
                                     , 2529-2591. <a href="https://doi.org/10.1021/jm1013693" title="DOI URL">https://doi.org/10.1021/jm1013693</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm1013693%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynopsis%252Bof%252BSome%252BRecent%252BTactical%252BApplication%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D20102010%26date%3D17032011%26date%3D28042011%26volume%3D54%26issue%3D8%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohanram  Sivaraja</span>, <span class="hlFld-ContribAuthor ">Daniel M.  Clemens</span>, <span class="hlFld-ContribAuthor ">Sivan  Sizikov</span>, <span class="hlFld-ContribAuthor ">Subhadra  Dash</span>, <span class="hlFld-ContribAuthor ">Chengpei  Xu</span>, <span class="hlFld-ContribAuthor ">Matthew  Rienzo</span>, <span class="hlFld-ContribAuthor ">Bo  Yang</span>, <span class="hlFld-ContribAuthor ">Molly  Ryan</span>, <span class="hlFld-ContribAuthor ">Madhuri  Chattopadhyay</span>, <span class="hlFld-ContribAuthor ">Lev  Igoudin</span>, <span class="hlFld-ContribAuthor ">Stephanie S.  Chang</span>, <span class="hlFld-ContribAuthor ">Samuel  Keutzer</span>, <span class="hlFld-ContribAuthor ">Piotr  Zalicki</span>, <span class="hlFld-ContribAuthor ">M. Angels  Estiarte</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Shiau</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Short</span>, <span class="hlFld-ContribAuthor ">David C.  Williams</span>, <span class="hlFld-ContribAuthor ">Anirban  Datta</span>, <span class="hlFld-ContribAuthor ">Nicola  Pozzi</span>, <span class="hlFld-ContribAuthor ">Enrico  Di Cera</span>, <span class="hlFld-ContribAuthor ">C. Michael  Gibson</span>, <span class="hlFld-ContribAuthor ">Keith A.A.  Fox</span>, <span class="hlFld-ContribAuthor ">David B.  Kita</span>. </span><span class="cited-content_cbyCitation_article-title">VE-1902—A direct thrombin inhibitor with reversible covalent mechanism of action shows efficacy with reduced bleeding in rodent models of thrombosis. </span><span class="cited-content_cbyCitation_journal-name">Thrombosis Research</span><span> <strong>2020,</strong> <em>190 </em>, 112-121. <a href="https://doi.org/10.1016/j.thromres.2020.04.020" title="DOI URL">https://doi.org/10.1016/j.thromres.2020.04.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.thromres.2020.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.thromres.2020.04.020%26sid%3Dliteratum%253Aachs%26jtitle%3DThrombosis%2520Research%26atitle%3DVE-1902%2525E2%252580%252594A%252Bdirect%252Bthrombin%252Binhibitor%252Bwith%252Breversible%252Bcovalent%252Bmechanism%252Bof%252Baction%252Bshows%252Befficacy%252Bwith%252Breduced%252Bbleeding%252Bin%252Brodent%252Bmodels%252Bof%252Bthrombosis%26aulast%3DSivaraja%26aufirst%3DMohanram%26date%3D2020%26volume%3D190%26spage%3D112%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleksandr V.  Geraschenko</span>, <span class="hlFld-ContribAuthor ">Vitalii V.  Solomin</span>, <span class="hlFld-ContribAuthor ">Bohdan V.  Vashchenko</span>, <span class="hlFld-ContribAuthor ">Pavlo  Khodakivskyi</span>, <span class="hlFld-ContribAuthor ">Andrey A.  Tolmachev</span>, <span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and chemical transformations of diazolyl α,α-difluoroacetates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2020,</strong> <em>229 </em>, 109407. <a href="https://doi.org/10.1016/j.jfluchem.2019.109407" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2019.109407</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2019.109407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2019.109407%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DSynthesis%252Band%252Bchemical%252Btransformations%252Bof%252Bdiazolyl%252B%2525CE%2525B1%25252C%2525CE%2525B1-difluoroacetates%26aulast%3DGeraschenko%26aufirst%3DOleksandr%2BV.%26date%3D2020%26volume%3D229%26spage%3D109407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yulu  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhimin  Xiong</span>, <span class="hlFld-ContribAuthor ">Jiayan  Qiu</span>, <span class="hlFld-ContribAuthor ">Lichun  Kong</span>, <span class="hlFld-ContribAuthor ">Gangguo  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Visible light photocatalytic acyldifluoroalkylation of unactivated alkenes for the direct synthesis of
              gem
              -difluorinated ketones. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2019,</strong> <em>6 </em>
                                    (7)
                                     , 1022-1026. <a href="https://doi.org/10.1039/C9QO00136K" title="DOI URL">https://doi.org/10.1039/C9QO00136K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9QO00136K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9QO00136K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DVisible%252Blight%252Bphotocatalytic%252Bacyldifluoroalkylation%252Bof%252Bunactivated%252Balkenes%252Bfor%252Bthe%252Bdirect%252Bsynthesis%252Bof%252Bgem%252B-difluorinated%252Bketones%26aulast%3DZhou%26aufirst%3DYulu%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D7%26spage%3D1022%26epage%3D1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhouling  Xie</span>, <span class="hlFld-ContribAuthor ">Yongbing  Tian</span>, <span class="hlFld-ContribAuthor ">Xiao  Lv</span>, <span class="hlFld-ContribAuthor ">Xuan  Xiao</span>, <span class="hlFld-ContribAuthor ">Meimiao  Zhan</span>, <span class="hlFld-ContribAuthor ">Kai  Cheng</span>, <span class="hlFld-ContribAuthor ">Shiyu  Li</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>. </span><span class="cited-content_cbyCitation_article-title">The selectivity and bioavailability improvement of novel oral anticoagulants: An overview. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>146 </em>, 299-317. <a href="https://doi.org/10.1016/j.ejmech.2018.01.067" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.01.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.01.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.01.067%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bselectivity%252Band%252Bbioavailability%252Bimprovement%252Bof%252Bnovel%252Boral%252Banticoagulants%25253A%252BAn%252Boverview%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2018%26volume%3D146%26spage%3D299%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.L.  Quan</span>, <span class="hlFld-ContribAuthor ">P.W.  Glunz</span>, <span class="hlFld-ContribAuthor ">J.M.  Smallheer</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Anticoagulants. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 600-627. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12433-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12433-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12433-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12433-3%26sid%3Dliteratum%253Aachs%26atitle%3DAdvances%252Bin%252BAnticoagulants%26aulast%3DQuan%26aufirst%3DM.L.%26date%3D2017%26spage%3D600%26epage%3D627%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Abrahamsson</span>, <span class="hlFld-ContribAuthor ">P.  Andersson</span>, <span class="hlFld-ContribAuthor ">J.  Bergman</span>, <span class="hlFld-ContribAuthor ">U.  Bredberg</span>, <span class="hlFld-ContribAuthor ">J.  Brånalt</span>, <span class="hlFld-ContribAuthor ">A.-C.  Egnell</span>, <span class="hlFld-ContribAuthor ">U.  Eriksson</span>, <span class="hlFld-ContribAuthor ">D.  Gustafsson</span>, <span class="hlFld-ContribAuthor ">K.-J.  Hoffman</span>, <span class="hlFld-ContribAuthor ">S.  Nielsen</span>, <span class="hlFld-ContribAuthor ">I.  Nilsson</span>, <span class="hlFld-ContribAuthor ">S.  Pehrsson</span>, <span class="hlFld-ContribAuthor ">M. O.  Polla</span>, <span class="hlFld-ContribAuthor ">T.  Skjaeret</span>, <span class="hlFld-ContribAuthor ">M.  Strimfors</span>, <span class="hlFld-ContribAuthor ">C.  Wern</span>, <span class="hlFld-ContribAuthor ">M.  Ölwegård-Halvarsson</span>, <span class="hlFld-ContribAuthor ">Y.  Örtengren</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of AZD8165 – a clinical candidate from a novel series of neutral thrombin inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (2)
                                     , 272-281. <a href="https://doi.org/10.1039/C5MD00479A" title="DOI URL">https://doi.org/10.1039/C5MD00479A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00479A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00479A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252BAZD8165%252B%2525E2%252580%252593%252Ba%252Bclinical%252Bcandidate%252Bfrom%252Ba%252Bnovel%252Bseries%252Bof%252Bneutral%252Bthrombin%252Binhibitors%26aulast%3DAbrahamsson%26aufirst%3DK.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D2%26spage%3D272%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pooja  Purohit</span>, <span class="hlFld-ContribAuthor ">Anand Kumar  Pandey</span>, <span class="hlFld-ContribAuthor ">Brijesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Prem M. S.  Chauhan</span>. </span><span class="cited-content_cbyCitation_article-title">Diversity oriented synthesis of β-carbolinone and indolo-pyrazinone analogues based on an Ugi four component reaction and subsequent cyclisation of the resulting indole intermediate. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (25)
                                     , 21165-21186. <a href="https://doi.org/10.1039/C5RA27090A" title="DOI URL">https://doi.org/10.1039/C5RA27090A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA27090A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA27090A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDiversity%252Boriented%252Bsynthesis%252Bof%252B%2525CE%2525B2-carbolinone%252Band%252Bindolo-pyrazinone%252Banalogues%252Bbased%252Bon%252Ban%252BUgi%252Bfour%252Bcomponent%252Breaction%252Band%252Bsubsequent%252Bcyclisation%252Bof%252Bthe%252Bresulting%252Bindole%252Bintermediate%26aulast%3DPurohit%26aufirst%3DPooja%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D25%26spage%3D21165%26epage%3D21186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karel  Mena-Ulecia</span>, <span class="hlFld-ContribAuthor ">William  Tiznado</span>, <span class="hlFld-ContribAuthor ">Julio  Caballero</span>, . </span><span class="cited-content_cbyCitation_article-title">Study of the Differential Activity of Thrombin Inhibitors Using Docking, QSAR, Molecular Dynamics, and MM-GBSA. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (11)
                                     , e0142774. <a href="https://doi.org/10.1371/journal.pone.0142774" title="DOI URL">https://doi.org/10.1371/journal.pone.0142774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0142774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0142774%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DStudy%252Bof%252Bthe%252BDifferential%252BActivity%252Bof%252BThrombin%252BInhibitors%252BUsing%252BDocking%25252C%252BQSAR%25252C%252BMolecular%252BDynamics%25252C%252Band%252BMM-GBSA%26aulast%3DMena-Ulecia%26aufirst%3DKarel%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D11%26spage%3De0142774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Wei  He</span>, <span class="hlFld-ContribAuthor ">Wei-Chen  Dai</span>, <span class="hlFld-ContribAuthor ">Nian-Guang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Orally Active Thrombin Inhibitors for the Treatment of Thrombotic Disorder Diseases. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (6)
                                     , 11046-11062. <a href="https://doi.org/10.3390/molecules200611046" title="DOI URL">https://doi.org/10.3390/molecules200611046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules200611046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules200611046%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDevelopment%252Bof%252BOrally%252BActive%252BThrombin%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BThrombotic%252BDisorder%252BDiseases%26aulast%3DHe%26aufirst%3DLi-Wei%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D6%26spage%3D11046%26epage%3D11062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mei-Ling  Yang</span>, <span class="hlFld-ContribAuthor ">Yu-Min  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and investigation of water-soluble anticoagulant warfarin/ferulic acid grafted rare earth oxide nanoparticle materials. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (23)
                                     , 17824-17833. <a href="https://doi.org/10.1039/C4RA14633F" title="DOI URL">https://doi.org/10.1039/C4RA14633F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA14633F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA14633F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Binvestigation%252Bof%252Bwater-soluble%252Banticoagulant%252Bwarfarin%25252Fferulic%252Bacid%252Bgrafted%252Brare%252Bearth%252Boxide%252Bnanoparticle%252Bmaterials%26aulast%3DYang%26aufirst%3DMei-Ling%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D23%26spage%3D17824%26epage%3D17833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Hao  Shi</span>, <span class="hlFld-ContribAuthor ">Nian-Guang  Li</span>, <span class="hlFld-ContribAuthor ">Yu-Ping  Tang</span>, <span class="hlFld-ContribAuthor ">Jin-Ao  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Prolinamide derivatives as thrombin inhibitors for the treatment of thrombin-mediated diseases: a patent evaluation of US2013296245. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (10)
                                     , 1139-1148. <a href="https://doi.org/10.1517/13543776.2014.959493" title="DOI URL">https://doi.org/10.1517/13543776.2014.959493</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.959493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.959493%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DProlinamide%252Bderivatives%252Bas%252Bthrombin%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bthrombin-mediated%252Bdiseases%25253A%252Ba%252Bpatent%252Bevaluation%252Bof%252BUS2013296245%26aulast%3DShi%26aufirst%3DZhi-Hao%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D10%26spage%3D1139%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingjie  Zhao</span>, <span class="hlFld-ContribAuthor ">Chunkai  Wang</span>, <span class="hlFld-ContribAuthor ">Edward L.  Ezell</span>, <span class="hlFld-ContribAuthor ">Yuxiang  Dong</span>, <span class="hlFld-ContribAuthor ">Jonathan L.  Vennerstrom</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrasubstituted pyrazinones derived from the reaction of praziquantel with N-bromosuccinimide. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (32)
                                     , 4463-4465. <a href="https://doi.org/10.1016/j.tetlet.2014.06.083" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.06.083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.06.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.06.083%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DTetrasubstituted%252Bpyrazinones%252Bderived%252Bfrom%252Bthe%252Breaction%252Bof%252Bpraziquantel%252Bwith%252BN-bromosuccinimide%26aulast%3DZhao%26aufirst%3DQingjie%26date%3D2014%26volume%3D55%26issue%3D32%26spage%3D4463%26epage%3D4465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan R.  Del Valle</span>, <span class="hlFld-ContribAuthor ">Eric  Therrien</span>, <span class="hlFld-ContribAuthor ">Stephen  Hanessian</span>. </span><span class="cited-content_cbyCitation_article-title">Aeruginosins as Thrombin Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 333-364. <a href="https://doi.org/10.1002/9783527676545.ch10" title="DOI URL">https://doi.org/10.1002/9783527676545.ch10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527676545.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527676545.ch10%26sid%3Dliteratum%253Aachs%26atitle%3DAeruginosins%252Bas%252BThrombin%252BInhibitors%26aulast%3DDel%2BValle%26aufirst%3DJuan%2BR.%26date%3D2014%26date%3D2014%26spage%3D333%26epage%3D364%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DNatural%252BProducts%252Bin%252BMedicinal%252BChemistry%26aulast%3DHanessian%26aufirst%3DStephen%26date%3D2014%26volume%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Influence of Bioisosteres in Drug Design: Tactical Applications to Address Developability Problems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 283-381. <a href="https://doi.org/10.1007/7355_2013_29" title="DOI URL">https://doi.org/10.1007/7355_2013_29</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2013_29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2013_29%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BInfluence%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%25253A%252BTactical%252BApplications%252Bto%252BAddress%252BDevelopability%252BProblems%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2013%26date%3D2014%26spage%3D283%26epage%3D381%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DTactics%252Bin%252BContemporary%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karel  Piron</span>, <span class="hlFld-ContribAuthor ">Sara  Kenis</span>, <span class="hlFld-ContribAuthor ">Guido  Verniest</span>, <span class="hlFld-ContribAuthor ">Riccardo  Surmont</span>, <span class="hlFld-ContribAuthor ">Jan Willem  Thuring</span>, <span class="hlFld-ContribAuthor ">Peter  ten Holte</span>, <span class="hlFld-ContribAuthor ">Frederik  Deroose</span>, <span class="hlFld-ContribAuthor ">Norbert  De Kimpe</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of gem-difluorinated 1,6-naphthyridine-5,7-diones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2012,</strong> <em>68 </em>
                                    (34)
                                     , 6941-6947. <a href="https://doi.org/10.1016/j.tet.2012.05.122" title="DOI URL">https://doi.org/10.1016/j.tet.2012.05.122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2012.05.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2012.05.122%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bgem-difluorinated%252B1%25252C6-naphthyridine-5%25252C7-diones%26aulast%3DPiron%26aufirst%3DKarel%26date%3D2012%26volume%3D68%26issue%3D34%26spage%3D6941%26epage%3D6947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberto G. S.  Berlinck</span>, <span class="hlFld-ContribAuthor ">Amaro E.  Trindade-Silva</span>, <span class="hlFld-ContribAuthor ">Mario F. C.  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">The chemistry and biology of organic guanidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Reports</span><span> <strong>2012,</strong> <em>29 </em>
                                    (12)
                                     , 1382. <a href="https://doi.org/10.1039/c2np20071f" title="DOI URL">https://doi.org/10.1039/c2np20071f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2np20071f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2np20071f%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Reports%26atitle%3DThe%252Bchemistry%252Band%252Bbiology%252Bof%252Borganic%252Bguanidine%252Bderivatives%26aulast%3DBerlinck%26aufirst%3DRoberto%2BG.%2BS.%26date%3D2012%26volume%3D29%26issue%3D12%26spage%3D1382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Straub</span>, <span class="hlFld-ContribAuthor ">Susanne  Roehrig</span>, <span class="hlFld-ContribAuthor ">Alexander  Hillisch</span>. </span><span class="cited-content_cbyCitation_article-title">Orale, direkte Thrombin- und Faktor-Xa-Hemmer: Kommt die Ablösung für Warfarin, Blutegel und Schweinedärme?. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2011,</strong> <em>123 </em>
                                    (20)
                                     , 4670-4686. <a href="https://doi.org/10.1002/ange.201004575" title="DOI URL">https://doi.org/10.1002/ange.201004575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201004575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201004575%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DOrale%25252C%252Bdirekte%252BThrombin-%252Bund%252BFaktor-Xa-Hemmer%25253A%252BKommt%252Bdie%252BAbl%2525C3%2525B6sung%252Bf%2525C3%2525BCr%252BWarfarin%25252C%252BBlutegel%252Bund%252BSchweined%2525C3%2525A4rme%25253F%26aulast%3DStraub%26aufirst%3DAlexander%26date%3D2011%26date%3D2011%26volume%3D123%26issue%3D20%26spage%3D4670%26epage%3D4686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Straub</span>, <span class="hlFld-ContribAuthor ">Susanne  Roehrig</span>, <span class="hlFld-ContribAuthor ">Alexander  Hillisch</span>. </span><span class="cited-content_cbyCitation_article-title">Oral, Direct Thrombin and Factor Xa Inhibitors: The Replacement for Warfarin, Leeches, and Pig Intestines?. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2011,</strong> <em>50 </em>
                                    (20)
                                     , 4574-4590. <a href="https://doi.org/10.1002/anie.201004575" title="DOI URL">https://doi.org/10.1002/anie.201004575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201004575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201004575%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DOral%25252C%252BDirect%252BThrombin%252Band%252BFactor%2525E2%252580%252585Xa%252BInhibitors%25253A%252BThe%252BReplacement%252Bfor%252BWarfarin%25252C%252BLeeches%25252C%252Band%252BPig%252BIntestines%25253F%26aulast%3DStraub%26aufirst%3DAlexander%26date%3D2011%26date%3D2011%26volume%3D50%26issue%3D20%26spage%3D4574%26epage%3D4590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Maurice  Médebielle</span>, <span class="hlFld-ContribAuthor ">Marie-Hélène  Bellance</span>, <span class="hlFld-ContribAuthor ">William R.  Dolbier</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Aldol-Reduction Process using Difluoromethyl Aryl Ketones and Aryl Aldehydes in the Presence of Potassium tert-Butoxide: One-Pot Efficient Stereoselective Synthesis of Symmetrical and Unsymmetrical anti-2,2-Difluoropropane-1,3-diols. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2010,</strong> <em>352 </em>
                                    (16)
                                     , 2787-2790. <a href="https://doi.org/10.1002/adsc.201000548" title="DOI URL">https://doi.org/10.1002/adsc.201000548</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201000548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201000548%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DDirect%252BAldol-Reduction%252BProcess%252Busing%252BDifluoromethyl%252BAryl%252BKetones%252Band%252BAryl%252BAldehydes%252Bin%252Bthe%252BPresence%252Bof%252BPotassium%252Btert-Butoxide%25253A%252BOne-Pot%252BEfficient%252BStereoselective%252BSynthesis%252Bof%252BSymmetrical%252Band%252BUnsymmetrical%252Banti-2%25252C2-Difluoropropane-1%25252C3-diols%26aulast%3DXu%26aufirst%3DWei%26date%3D2010%26date%3D2010%26volume%3D352%26issue%3D16%26spage%3D2787%26epage%3D2790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-Hydroxyphthalimide, PPh<sub>3</sub>, DEAD, room temperature, 10 h. (b) MeNH<sub>2</sub>, EtOH/THF, room temperature, 1 h. (c) [<i>N</i>,<i>N</i>′-Di(<i>tert</i>-butoxycarbonyl)]amidinopyrazole, room temperature, 10 h. (d) 10% Pd/C, H<sub>2</sub>(g), EtOH/THF, room temperature, 30 min.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PhMe, 60 °C, 3 h. (b) (i) Dioxane/1 N NaOH(aq), room temperature, 1.5 h; (ii) 10% HCl(aq). (c) Castro's reagent, TEA, DMF, room temperature, 18 h. (d) DCM, TFA, room temperature, 8 h.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PhMe, reflux, 12 h and then room temperature, 5 days. (b) NCS, DCE, reflux, 2.5 h. (c) (i) dioxane/1 N NaOH(aq), room temperature, 18 h; (ii) 10% HCl(aq). (d) Castro's reagent, TEA, DMF, room temperature, 3 days. (e) DCM, TFA, room temperature, 24 h.</p></p></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Hydrogen-bonding interactions of <b>8</b> with thrombin (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LDX">3LDX</a>). The atoms are colored by atom type. Primary interactions are shown as dotted lines, and secondary shell interactions are shown as thin solid lines. (b) Accessible surface representation of thrombin is shown with the surface colored by atom type with <b>8</b> shown as a stick representation. (c) Accessible surface representation of thrombin with the inhibitor (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T4U">1T4U</a>) shown as a stick figure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Time to carotid artery occlusion as a function of dose for <b>7</b> and <b>8</b> in the rat ECAT model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. aPTT as a function of dose for <b>7</b> and <b>8</b> in the rat ECAT model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Antithrombotic effect of <b>7</b> and <b>8</b> after an oral dose of 3 mg/kg in the canine arteriovenous shunt model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mean plasma concentration−time profiles of <b>8</b> in healthy human volunteers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/medium/jm-2009-01802n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Mean plasma aPTT−time profiles as a function of <b>8</b> in healthy human volunteers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901802n/production/images/large/jm-2009-01802n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901802n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lilienfeld, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godbold, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landrigan, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, G.</span><span> </span><span class="NLM_article-title">Mortality from pulmonary embolism in the United States: 1962 to 1984</span> <span class="citation_source-journal">Chest</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1990&pages=1067-1072&author=D.+E.+Lilienfeldauthor=E.+Chanauthor=J.+Ehlandauthor=J.+H.+Godboldauthor=P.+J.+Landriganauthor=G.+Marsh&title=Mortality+from+pulmonary+embolism+in+the+United+States%3A+1962+to+1984"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLilienfeld%26aufirst%3DD.%2BE.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DEhland%26aufirst%3DJ.%26aulast%3DGodbold%26aufirst%3DJ.%2BH.%26aulast%3DLandrigan%26aufirst%3DP.%2BJ.%26aulast%3DMarsh%26aufirst%3DG.%26atitle%3DMortality%2520from%2520pulmonary%2520embolism%2520in%2520the%2520United%2520States%253A%25201962%2520to%25201984%26jtitle%3DChest%26date%3D1990%26volume%3D98%26spage%3D1067%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lilienfeld, D. E.</span><span> </span><span class="NLM_article-title">Decreasing mortality from pulmonary embolism in the United States, 1979−1996</span> <span class="citation_source-journal">Int. J. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1093%2Fije%2F29.3.465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=10869318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A280%3ADC%252BD3cvnt1Cquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=465-469&author=D.+E.+Lilienfeld&title=Decreasing+mortality+from+pulmonary+embolism+in+the+United+States%2C+1979%E2%88%921996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Decreasing mortality from pulmonary embolism in the United States, 1979-1996</span></div><div class="casAuthors">Lilienfeld D E</div><div class="citationInfo"><span class="NLM_cas:title">International journal of epidemiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">465-9</span>
        ISSN:<span class="NLM_cas:issn">0300-5771</span>.
    </div><div class="casAbstract">BACKGROUND:  Mortality trends and patterns for pulmonary embolism may yield clues to its aetiology.  Previous investigations had identified several mortality contrasts in pulmonary embolism mortality among US residents.  These findings had been made in the context of a trend of increasing rates during 1962-1984.  METHODS:  Annual age-specific and age-adjusted pulmonary embolism mortality rates for US residents during 1979-1996 were compiled from the US National Center for Health Statistics web site.  These data were analysed for mortality contrasts and trends.  RESULTS:  For all racial-gender groups, age-adjusted mortality declined throughout the period.  The greatest rate of decline was found among black men, followed by (in decreasing order) black women, white men, other men, white women, and other women.  In 1996, the previously observed demographic contrasts of blacks experiencing the highest pulmonary embolism mortality, followed by whites and then others, and the male rate being higher than the female one were still present despite this decline.  Age-specific mortality from pulmonary embolism in the US during 1996 also mirrored that reported for the 1970s, with mortality increasing during the life span (the risk of death doubling with each decade of life).  Specifically, the annual age-adjusted pulmonary embolism mortality rate in 1996 for white men was 2.4 per 100 000 persons; white women, 2.3 per 100 000 persons; black men, 6.0 per 100 000 persons; black women, 4.8 per 100 000 persons; non-black non-white men, 1.0 per 100 000 persons; and non-black non-white women, 0.7 per 100 000 persons.  CONCLUSIONS:  Mortality from pulmonary embolism in the US declined significantly during 1979-1996.  Several demographic contrasts, particularly an excess among men, continue to exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCPretjO9SsEbxh97K6Vt6fW6udTcc2ead7W8QMSrdAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3cvnt1Cquw%253D%253D&md5=3cea3cabc55a380421433ad74d5dddf3</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1093%2Fije%2F29.3.465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fije%252F29.3.465%26sid%3Dliteratum%253Aachs%26aulast%3DLilienfeld%26aufirst%3DD.%2BE.%26atitle%3DDecreasing%2520mortality%2520from%2520pulmonary%2520embolism%2520in%2520the%2520United%2520States%252C%25201979%25E2%2588%25921996%26jtitle%3DInt.%2520J.%2520Epidemiol.%26date%3D2000%26volume%3D29%26spage%3D465%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Melnikova, I.</span><span> </span><span class="NLM_article-title">The anticoagulants market</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=353-354&author=I.+Melnikova&title=The+anticoagulants+market"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMelnikova%26aufirst%3DI.%26atitle%3DThe%2520anticoagulants%2520market%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D353%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Halperin, J. L.</span><span> </span><span class="NLM_article-title">Ximelagatran: Oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1016%2Fj.jacc.2004.09.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=15629364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlSr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=1-9&author=J.+L.+Halperin&title=Ximelagatran%3A+Oral+direct+thrombin+inhibition+as+anticoagulant+therapy+in+atrial+fibrillation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Ximelagatran: Oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation</span></div><div class="casAuthors">Halperin, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Atrial fibrillation (AF) causes 50,000 to 100,000 ischemic strokes annually in the U.S., most of which could be prevented by oral anticoagulant treatment of the highest-risk patients.  The greatest barrier to such treatment is the narrow therapeutic index of the vitamin K antagonists ([VKAs]: warfarin and related coumarin derivs.), the only oral anticoagulant agents currently available.  Safe and effective treatment with the VKAs requires careful monitoring, because they interact with many other drugs and foods, and their anticoagulant action is unpredictable.  Besides vitamin K, candidate targets for anticoagulant therapy include thrombin, a key prothrombotic mediator.  Ximelagatran, the oral direct thrombin inhibitor at the most advanced stage of clin. development, is rapidly absorbed and bioconverted to its active moiety, melagatran-a potent, competitive inhibitor of both free and clot-bound thrombin.  Two large clin. trials have demonstrated that fixed-dose oral ximelagatran, 36 mg twice daily, administered without coagulation monitoring, prevents stroke and systemic embolic events in patients with nonvalvular AF as effectively as well-controlled, adjusted-dose warfarin (international normalized ratio 2.0 to 3.0).  The overall risk of bleeding was lower with ximelagatran than warfarin, although differences in rates of major hemorrhage were not statistically significant.  Elevation of serum alanine aminotransferase levels above 3× the upper limit of normal occurred in approx. 6% of ximelagatran-treated patients but typically returned toward pretreatment levels without assocd. symptoms.  In terms of preventing thromboembolism without hemorrhage, ximelagatran may have a more favorable benefit:risk profile than warfarin for patients with AF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohPKNggClnn7Vg90H21EOLACvtfcHk0ljchUtZNlH4BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlSr&md5=c628cfb9208c956b4d6e8711f258c198</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2004.09.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2004.09.049%26sid%3Dliteratum%253Aachs%26aulast%3DHalperin%26aufirst%3DJ.%2BL.%26atitle%3DXimelagatran%253A%2520Oral%2520direct%2520thrombin%2520inhibition%2520as%2520anticoagulant%2520therapy%2520in%2520atrial%2520fibrillation%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2005%26volume%3D45%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Borrissoff, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spronk, H. M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeneman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ten Cate, H.</span><span> </span><span class="NLM_article-title">Is thrombin a key player in the ‘coagulation-antherogenesis’ maze?</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2009&pages=392-403&author=J.+I.+Borrissoffauthor=H.+M.+H.+Spronkauthor=S.+Heenemanauthor=H.+ten+Cate&title=Is+thrombin+a+key+player+in+the+%E2%80%98coagulation-antherogenesis%E2%80%99+maze%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorrissoff%26aufirst%3DJ.%2BI.%26aulast%3DSpronk%26aufirst%3DH.%2BM.%2BH.%26aulast%3DHeeneman%26aufirst%3DS.%26aulast%3Dten%2BCate%26aufirst%3DH.%26atitle%3DIs%2520thrombin%2520a%2520key%2520player%2520in%2520the%2520%25E2%2580%2598coagulation-antherogenesis%25E2%2580%2599%2520maze%253F%26jtitle%3DCardiovasc.%2520Res.%26date%3D2009%26volume%3D82%26spage%3D392%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tanaka, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Key, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, J. H.</span><span> </span><span class="NLM_article-title">Blood coagulation: Hemostasis and thrombin regulation</span> <span class="citation_source-journal">Anesth. Analg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1433</span><span class="NLM_x">–</span> <span class="NLM_lpage">1446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1213%2Fane.0b013e31819bcc9c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=19372317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvV2gt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2009&pages=1433-1446&author=K.+A.+Tanakaauthor=N.+S.+Keyauthor=J.+H.+Levy&title=Blood+coagulation%3A+Hemostasis+and+thrombin+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Blood Coagulation: Hemostasis and Thrombin Regulation</span></div><div class="casAuthors">Tanaka, Kenichi A.; Key, Nigel S.; Levy, Jerrold H.</div><div class="citationInfo"><span class="NLM_cas:title">Anesthesia & Analgesia (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1433-1446</span>CODEN:
                <span class="NLM_cas:coden">AACRAT</span>;
        ISSN:<span class="NLM_cas:issn">0003-2999</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Perioperative bleeding is a major challenge particularly because of increasing clin. use of potent antithrombotic drugs.  Understanding current concepts of coagulation is important in detg. the preoperative bleeding risk of patients, and in managing hemostatic therapy perioperatively.  The serine protease thrombin plays pivotal roles in the activation of addnl. serine protease zymogens (inactive enzymic precursors), cofactors, and cell-surface receptors.  Thrombin generation is closely regulated to locally achieve rapid hemostasis after injury without causing uncontrolled systemic thrombosis.  During surgery, there are major disturbances in coagulation and inflammatory systems because of hemorrhage/hemodilution, blood transfusion, and surgical stresses.  Postoperative bleeding often requires allogeneic blood transfusions, which support thrombin generation and hemostasis.  However, procoagulant activity and inflammation are increased postoperatively; thus, antithrombotic therapy may be required to prevent perioperative thrombotic complications.  There have been significant advances in the management of perioperative hemostasis and thrombosis because of the introduction of novel hemostatic and antithrombotic drugs.  However, a limitation of current treatment is that conventional clotting tests do not reflect the entire physiol. processes of coagulation making optimal pharmacol. therapy difficult.  Understanding the in vivo regulatory mechanisms and pharmacol. modulation of thrombin generation may help control bleeding without potentially increasing prothrombotic risks.  In this review, we focus on the regulatory mechanisms of hemostasis and thrombin generation using multiple, simplified models of coagulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbBIhgaNmkebVg90H21EOLACvtfcHk0ljMck6T7Ezr1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvV2gt70%253D&md5=507878d0e9a3ceefc145f7d249eb9607</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1213%2Fane.0b013e31819bcc9c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1213%252Fane.0b013e31819bcc9c%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DK.%2BA.%26aulast%3DKey%26aufirst%3DN.%2BS.%26aulast%3DLevy%26aufirst%3DJ.%2BH.%26atitle%3DBlood%2520coagulation%253A%2520Hemostasis%2520and%2520thrombin%2520regulation%26jtitle%3DAnesth.%2520Analg.%26date%3D2009%26volume%3D108%26spage%3D1433%26epage%3D1446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Santilli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davì, G.</span><span> </span><span class="NLM_article-title">Thrombin as a common downstream target blocking both platelet and monocyte activation</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=19190800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVyrtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2009&pages=220-221&author=F.+Santilliauthor=G.+Dav%C3%AC&title=Thrombin+as+a+common+downstream+target+blocking+both+platelet+and+monocyte+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombin as a common downstream target blocking both platelet and monocyte activation</span></div><div class="casAuthors">Santilli, Francesca; Davi, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">220-221</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">A review.  Thrombin is a potent agonist for both platelet and monocyte activation through the protease-activated receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2DYvcHMeKIrVg90H21EOLACvtfcHk0ljMck6T7Ezr1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVyrtLw%253D&md5=e71ed0ae416fc730171134997e906105</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantilli%26aufirst%3DF.%26aulast%3DDav%25C3%25AC%26aufirst%3DG.%26atitle%3DThrombin%2520as%2520a%2520common%2520downstream%2520target%2520blocking%2520both%2520platelet%2520and%2520monocyte%2520activation%26jtitle%3DThromb.%2520Haemostasis%26date%3D2009%26volume%3D101%26spage%3D220%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sambrano, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soughlin, S. R.</span><span> </span><span class="NLM_article-title">Role of thrombin signaling in platelets in haemostasis and thrombosis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">413</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2001&pages=74-78&author=G.+R.+Sambranoauthor=E.+J.+Weissauthor=Y.+W.+Zhengauthor=W.+Huangauthor=S.+R.+Soughlin&title=Role+of+thrombin+signaling+in+platelets+in+haemostasis+and+thrombosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSambrano%26aufirst%3DG.%2BR.%26aulast%3DWeiss%26aufirst%3DE.%2BJ.%26aulast%3DZheng%26aufirst%3DY.%2BW.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DSoughlin%26aufirst%3DS.%2BR.%26atitle%3DRole%2520of%2520thrombin%2520signaling%2520in%2520platelets%2520in%2520haemostasis%2520and%2520thrombosis%26jtitle%3DNature%26date%3D2001%26volume%3D413%26spage%3D74%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Crowther, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitz, J. I.</span><span> </span><span class="NLM_article-title">Ximelagatran: The first oral direct thrombin inhibitor</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=403-413&author=M.+A.+Crowtherauthor=J.+I.+Weitz&title=Ximelagatran%3A+The+first+oral+direct+thrombin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrowther%26aufirst%3DM.%2BA.%26aulast%3DWeitz%26aufirst%3DJ.%2BI.%26atitle%3DXimelagatran%253A%2520The%2520first%2520oral%2520direct%2520thrombin%2520inhibitor%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D13%26spage%3D403%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Patterson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stouffer, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madamanchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runge, M. S.</span><span> </span><span class="NLM_article-title">New tricks for old dogs: Nonthrombotic effects of thrombin in vessel wall biology</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2001&pages=987-997&author=C.+Pattersonauthor=G.+A.+Stoufferauthor=N.+Madamanchiauthor=M.+S.+Runge&title=New+tricks+for+old+dogs%3A+Nonthrombotic+effects+of+thrombin+in+vessel+wall+biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DC.%26aulast%3DStouffer%26aufirst%3DG.%2BA.%26aulast%3DMadamanchi%26aufirst%3DN.%26aulast%3DRunge%26aufirst%3DM.%2BS.%26atitle%3DNew%2520tricks%2520for%2520old%2520dogs%253A%2520Nonthrombotic%2520effects%2520of%2520thrombin%2520in%2520vessel%2520wall%2520biology%26jtitle%3DCirc.%2520Res.%26date%3D2001%26volume%3D88%26spage%3D987%26epage%3D997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Fleitz, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volante, R. P.</span><span> </span><span class="NLM_article-title">Kilogram scale synthesis of the pyrazinone acetic acid core of an orally efficacious thrombin inhibitor</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3171</span><span class="NLM_x">–</span> <span class="NLM_lpage">3180</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1080%2F00397910008086927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsVGrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2000&pages=3171-3180&author=F.+J.+Fleitzauthor=T.+A.+Lyleauthor=N.+Zhengauthor=J.+D.+Armstrongauthor=R.+P.+Volante&title=Kilogram+scale+synthesis+of+the+pyrazinone+acetic+acid+core+of+an+orally+efficacious+thrombin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Kilogram scale synthesis of the pyrazinone acetic acid core of an orally efficacious thrombin inhibitor</span></div><div class="casAuthors">Fleitz, Fred J.; Lyle, Terry A.; Zheng, Nan; Armstrong, Joseph D., III; Volante, R. P.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3171-3180</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A multi-kilogram scale synthesis of the orally efficacious thrombin inhibitor I was achieved via construction of the pyrazinone core from an unsym. oxalic diamide.  Key features include judicious choice of reagents to minimize side products, a key Ru catalyzed oxidn., and development of reaction conditions amenable to large-scale synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQOmYrqWbxobVg90H21EOLACvtfcHk0liwgX7qNFcdfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVGrs7k%253D&md5=8c0c517fdd34f5c19f8242918e9056d9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1080%2F00397910008086927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910008086927%26sid%3Dliteratum%253Aachs%26aulast%3DFleitz%26aufirst%3DF.%2BJ.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DArmstrong%26aufirst%3DJ.%2BD.%26aulast%3DVolante%26aufirst%3DR.%2BP.%26atitle%3DKilogram%2520scale%2520synthesis%2520of%2520the%2520pyrazinone%2520acetic%2520acid%2520core%2520of%2520an%2520orally%2520efficacious%2520thrombin%2520inhibitor%26jtitle%3DSynth.%2520Commun.%26date%3D2000%26volume%3D30%26spage%3D3171%26epage%3D3180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chung, J. Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cvetovick, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsay, F.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dormer, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMichele, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathre, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilenski, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenslow, R.</span><span> </span><span class="NLM_article-title">Synthesis of 3-aminopyrazinone mediated by 2-pyridylthioimidate−ZnCl<sub>2</sub> complexes. Development of an efficient route to a thrombin inhibitor</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">8838</span><span class="NLM_x">–</span> <span class="NLM_lpage">8846</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo034835e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=8838-8846&author=J.+Y.+L.+Chungauthor=R.+J.+Cvetovickauthor=F.-R.+Tsayauthor=P.+G.+Dormerauthor=L.+DiMicheleauthor=D.+J.+Mathreauthor=J.+R.+Chilenskiauthor=B.+Maoauthor=R.+Wenslow&title=Synthesis+of+3-aminopyrazinone+mediated+by+2-pyridylthioimidate%E2%88%92ZnCl2+complexes.+Development+of+an+efficient+route+to+a+thrombin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjo034835e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo034835e%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DJ.%2BY.%2BL.%26aulast%3DCvetovick%26aufirst%3DR.%2BJ.%26aulast%3DTsay%26aufirst%3DF.-R.%26aulast%3DDormer%26aufirst%3DP.%2BG.%26aulast%3DDiMichele%26aufirst%3DL.%26aulast%3DMathre%26aufirst%3DD.%2BJ.%26aulast%3DChilenski%26aufirst%3DJ.%2BR.%26aulast%3DMao%26aufirst%3DB.%26aulast%3DWenslow%26aufirst%3DR.%26atitle%3DSynthesis%2520of%25203-aminopyrazinone%2520mediated%2520by%25202-pyridylthioimidate%25E2%2588%2592ZnCl2%2520complexes.%2520Development%2520of%2520an%2520efficient%2520route%2520to%2520a%2520thrombin%2520inhibitor%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D8838%26epage%3D8846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Burgey, C. S.; Robinson, K. A.; Williams, P. D.; Coburn, C. A.; Lyle, T. A.; Sanderson, P. E.</span> PCT Int. Appl. WO 0075134,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Burgey%2C+C.+S.%3B+Robinson%2C+K.+A.%3B+Williams%2C+P.+D.%3B+Coburn%2C+C.+A.%3B+Lyle%2C+T.+A.%3B+Sanderson%2C+P.+E.+PCT+Int.+Appl.+WO+0075134%2C+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurgey%26aufirst%3DC.%2BS.%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last"><b>CAUTION!</b> Solid bromopyrazinone is known to be thermally unstable with an exothermic transition at 50 °C, is potentially shock sensitive, and gradually decomposes at room temperature.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CAUTION%21+Solid+bromopyrazinone+is+known+to+be+thermally+unstable+with+an+exothermic+transition+at+50+%C2%B0C%2C+is+potentially+shock+sensitive%2C+and+gradually+decomposes+at+room+temperature."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Costanzo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecker, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schott, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabut, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulinsky, A.</span><span> </span><span class="NLM_article-title">Potent thrombin inhibitors that probe the S1’ subsite: Tripeptide transition state analogues based on a heterocycle-activated carbonyl group</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">3039</span><span class="NLM_x">–</span> <span class="NLM_lpage">3043</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9603274" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=3039-3043&author=M.+J.+Costanzoauthor=B.+E.+Maryanoffauthor=L.+R.+Heckerauthor=M.+R.+Schottauthor=S.+C.+Yabutauthor=H.-C.+Zhangauthor=P.+Andrade-Gordonauthor=J.+A.+Kaufmannauthor=J.+M.+Lewisauthor=R.+Krishnanauthor=A.+Tulinsky&title=Potent+thrombin+inhibitors+that+probe+the+S1%E2%80%99+subsite%3A+Tripeptide+transition+state+analogues+based+on+a+heterocycle-activated+carbonyl+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm9603274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9603274%26sid%3Dliteratum%253Aachs%26aulast%3DCostanzo%26aufirst%3DM.%2BJ.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DHecker%26aufirst%3DL.%2BR.%26aulast%3DSchott%26aufirst%3DM.%2BR.%26aulast%3DYabut%26aufirst%3DS.%2BC.%26aulast%3DZhang%26aufirst%3DH.-C.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DKaufmann%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DJ.%2BM.%26aulast%3DKrishnan%26aufirst%3DR.%26aulast%3DTulinsky%26aufirst%3DA.%26atitle%3DPotent%2520thrombin%2520inhibitors%2520that%2520probe%2520the%2520S1%25E2%2580%2599%2520subsite%253A%2520Tripeptide%2520transition%2520state%2520analogues%2520based%2520on%2520a%2520heterocycle-activated%2520carbonyl%2520group%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D3039%26epage%3D3043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Costanzo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almond, H. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecker, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schott, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabut, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corcoran, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardino, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Garavilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haertlein, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span> </span><span class="NLM_article-title">In-depth study of tripeptide-based α-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1′ subsite and its implications to structure-based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1984</span><span class="NLM_x">–</span> <span class="NLM_lpage">2008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0303857" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1984-2008&author=M.+J.+Costanzoauthor=H.+R.+Almondauthor=L.+R.+Heckerauthor=M.+R.+Schottauthor=S.+C.+Yabutauthor=H.-C.+Zhangauthor=P.+Andrade-Gordonauthor=T.+W.+Corcoranauthor=E.+C.+Giardinoauthor=J.+A.+Kaufmannauthor=J.+M.+Lewisauthor=L.+de+Garavillaauthor=B.+J.+Haertleinauthor=B.+E.+Maryanoff&title=In-depth+study+of+tripeptide-based+%CE%B1-ketoheterocycles+as+inhibitors+of+thrombin.+Effective+utilization+of+the+S1%E2%80%B2+subsite+and+its+implications+to+structure-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm0303857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0303857%26sid%3Dliteratum%253Aachs%26aulast%3DCostanzo%26aufirst%3DM.%2BJ.%26aulast%3DAlmond%26aufirst%3DH.%2BR.%26aulast%3DHecker%26aufirst%3DL.%2BR.%26aulast%3DSchott%26aufirst%3DM.%2BR.%26aulast%3DYabut%26aufirst%3DS.%2BC.%26aulast%3DZhang%26aufirst%3DH.-C.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DCorcoran%26aufirst%3DT.%2BW.%26aulast%3DGiardino%26aufirst%3DE.%2BC.%26aulast%3DKaufmann%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DJ.%2BM.%26aulast%3Dde%2BGaravilla%26aufirst%3DL.%26aulast%3DHaertlein%26aufirst%3DB.%2BJ.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26atitle%3DIn-depth%2520study%2520of%2520tripeptide-based%2520%25CE%25B1-ketoheterocycles%2520as%2520inhibitors%2520of%2520thrombin.%2520Effective%2520utilization%2520of%2520the%2520S1%25E2%2580%25B2%2520subsite%2520and%2520its%2520implications%2520to%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1984%26epage%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Brown, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andisik, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccarelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damewood, J. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ealey, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosmider, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krell, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steelman, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacek, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veale, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuthill, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolanin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolson, S. A.</span><span> </span><span class="NLM_article-title">Design of orally active, non-peptidic inhibitors of human leukocyte elastase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1261</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00035a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1259-1261&author=F.+J.+Brownauthor=D.+W.+Andisikauthor=P.+R.+Bernsteinauthor=C.+B.+Bryantauthor=C.+Ceccarelliauthor=J.+R.+Damewoodauthor=P.+D.+Edwardsauthor=R.+A.+Ealeyauthor=S.+Feeneyauthor=R.+C.+Greenauthor=B.+Gomesauthor=B.+J.+Kosmiderauthor=R.+D.+Krellauthor=A.+Shawauthor=G.+B.+Steelmanauthor=R.+M.+Thomasauthor=E.+P.+Vacekauthor=C.+A.+Vealeauthor=P.+A.+Tuthillauthor=P.+Warnerauthor=J.+C.+Williamsauthor=D.+J.+Wolaninauthor=S.+A.+Woolson&title=Design+of+orally+active%2C+non-peptidic+inhibitors+of+human+leukocyte+elastase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm00035a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00035a004%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DF.%2BJ.%26aulast%3DAndisik%26aufirst%3DD.%2BW.%26aulast%3DBernstein%26aufirst%3DP.%2BR.%26aulast%3DBryant%26aufirst%3DC.%2BB.%26aulast%3DCeccarelli%26aufirst%3DC.%26aulast%3DDamewood%26aufirst%3DJ.%2BR.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DEaley%26aufirst%3DR.%2BA.%26aulast%3DFeeney%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DR.%2BC.%26aulast%3DGomes%26aufirst%3DB.%26aulast%3DKosmider%26aufirst%3DB.%2BJ.%26aulast%3DKrell%26aufirst%3DR.%2BD.%26aulast%3DShaw%26aufirst%3DA.%26aulast%3DSteelman%26aufirst%3DG.%2BB.%26aulast%3DThomas%26aufirst%3DR.%2BM.%26aulast%3DVacek%26aufirst%3DE.%2BP.%26aulast%3DVeale%26aufirst%3DC.%2BA.%26aulast%3DTuthill%26aufirst%3DP.%2BA.%26aulast%3DWarner%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DJ.%2BC.%26aulast%3DWolanin%26aufirst%3DD.%2BJ.%26aulast%3DWoolson%26aufirst%3DS.%2BA.%26atitle%3DDesign%2520of%2520orally%2520active%252C%2520non-peptidic%2520inhibitors%2520of%2520human%2520leukocyte%2520elastase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1259%26epage%3D1261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Sanderson, P. E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutrona, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyer, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonough, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranieri, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vastag, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridone or 3-aminopyrazinone acetamide peptidomimetic templates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4466</span><span class="NLM_x">–</span> <span class="NLM_lpage">4474</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980368v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4466-4474&author=P.+E.+J.+Sandersonauthor=T.+A.+Lyleauthor=K.+J.+Cutronaauthor=D.+L.+Dyerauthor=B.+D.+Dorseyauthor=C.+M.+McDonoughauthor=A.+M.+Naylor-Olsenauthor=I.-W.+Chenauthor=Z.+Chenauthor=J.+J.+Cookauthor=C.+M.+Cooperauthor=S.+J.+Gardellauthor=T.+R.+Hareauthor=J.+A.+Kruegerauthor=S.+D.+Lewisauthor=J.+H.+Linauthor=B.+J.+Lucasauthor=E.+A.+Lyleauthor=J.+J.+Lynchauthor=M.+T.+Stranieriauthor=K.+Vastagauthor=Y.+Yanauthor=J.+A.+Shaferauthor=J.+P.+Vacca&title=Efficacious%2C+orally+bioavailable+thrombin+inhibitors+based+on+3-aminopyridone+or+3-aminopyrazinone+acetamide+peptidomimetic+templates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm980368v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980368v%26sid%3Dliteratum%253Aachs%26aulast%3DSanderson%26aufirst%3DP.%2BE.%2BJ.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DCutrona%26aufirst%3DK.%2BJ.%26aulast%3DDyer%26aufirst%3DD.%2BL.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMcDonough%26aufirst%3DC.%2BM.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DI.-W.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DCooper%26aufirst%3DC.%2BM.%26aulast%3DGardell%26aufirst%3DS.%2BJ.%26aulast%3DHare%26aufirst%3DT.%2BR.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DLyle%26aufirst%3DE.%2BA.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DStranieri%26aufirst%3DM.%2BT.%26aulast%3DVastag%26aufirst%3DK.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DShafer%26aufirst%3DJ.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DEfficacious%252C%2520orally%2520bioavailable%2520thrombin%2520inhibitors%2520based%2520on%25203-aminopyridone%2520or%25203-aminopyrazinone%2520acetamide%2520peptidomimetic%2520templates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4466%26epage%3D4474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Isaacs, R. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solinsky, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutrona, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span> </span><span class="NLM_article-title">Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 1: Weakly basic azoles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2000&pages=338-342&author=R.+C.+A.+Isaacsauthor=M.+G.+Solinskyauthor=K.+J.+Cutronaauthor=C.+L.+Newtonauthor=A.+M.+Naylor-Olsenauthor=J.+A.+Kruegerauthor=S.+D.+Lewisauthor=B.+J.+Lucas&title=Structure-based+design+of+novel+groups+for+use+in+the+P1+position+of+thrombin+inhibitor+scaffolds.+Part+1%3A+Weakly+basic+azoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsaacs%26aufirst%3DR.%2BC.%2BA.%26aulast%3DSolinsky%26aufirst%3DM.%2BG.%26aulast%3DCutrona%26aufirst%3DK.%2BJ.%26aulast%3DNewton%26aufirst%3DC.%2BL.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%2BM.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520groups%2520for%2520use%2520in%2520the%2520P1%2520position%2520of%2520thrombin%2520inhibitor%2520scaffolds.%2520Part%25201%253A%2520Weakly%2520basic%2520azoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D16%26spage%3D338%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Tomczuk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedde, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crysler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisennagel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bone, R.</span><span> </span><span class="NLM_article-title">Oxyguanidines: Application to non-peptide phenyl-based thrombin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1495</span><span class="NLM_x">–</span> <span class="NLM_lpage">1498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1495-1498&author=B.+Tomczukauthor=T.+Luauthor=R.+M.+Sollauthor=C.+Feddeauthor=A.+Wangauthor=L.+Murphyauthor=C.+Cryslerauthor=M.+Dasguptaauthor=S.+Eisennagelauthor=J.+Spurlinoauthor=R.+Bone&title=Oxyguanidines%3A+Application+to+non-peptide+phenyl-based+thrombin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTomczuk%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DFedde%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DCrysler%26aufirst%3DC.%26aulast%3DDasgupta%26aufirst%3DM.%26aulast%3DEisennagel%26aufirst%3DS.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DBone%26aufirst%3DR.%26atitle%3DOxyguanidines%253A%2520Application%2520to%2520non-peptide%2520phenyl-based%2520thrombin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1495%26epage%3D1498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Burgey, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantermet, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, R. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranieri, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicore, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1 N-benzylamines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1353</span><span class="NLM_x">–</span> <span class="NLM_lpage">1357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1353-1357&author=C.+S.+Burgeyauthor=K.+A.+Robinsonauthor=T.+A.+Lyleauthor=P.+G.+Nantermetauthor=H.+G.+Selnickauthor=R.+C.+A.+Isaacsauthor=S.+D.+Lewisauthor=B.+J.+Lucasauthor=J.+A.+Kuegerauthor=R.+Singhauthor=C.+Miller-Steinauthor=R.+B.+Whiteauthor=B.+Wongauthor=E.+A.+Lyleauthor=M.+T.+Stranieriauthor=J.+J.+Cookauthor=D.+R.+McMastersauthor=J.+M.+Pellicoreauthor=S.+Palauthor=A.+A.+Wallaceauthor=F.+C.+Claytonauthor=D.+Bohnauthor=D.+C.+Welshauthor=J.+J.+Lynchauthor=Y.+Yanauthor=Z.+Chenauthor=L.+Kuoauthor=S.+J.+Gardellauthor=J.+A.+Shaferauthor=J.+P.+Vacca&title=Pharmacokinetic+optimization+of+3-amino-6-chloropyrazinone+acetamide+thrombin+inhibitors.+Implementation+of+P3+pyridine+N-oxides+to+deliver+an+orally+bioavailable+series+containing+P1+N-benzylamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurgey%26aufirst%3DC.%2BS.%26aulast%3DRobinson%26aufirst%3DK.%2BA.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DIsaacs%26aufirst%3DR.%2BC.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DKueger%26aufirst%3DJ.%2BA.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DMiller-Stein%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DR.%2BB.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DLyle%26aufirst%3DE.%2BA.%26aulast%3DStranieri%26aufirst%3DM.%2BT.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DPellicore%26aufirst%3DJ.%2BM.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DWallace%26aufirst%3DA.%2BA.%26aulast%3DClayton%26aufirst%3DF.%2BC.%26aulast%3DBohn%26aufirst%3DD.%26aulast%3DWelsh%26aufirst%3DD.%2BC.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DGardell%26aufirst%3DS.%2BJ.%26aulast%3DShafer%26aufirst%3DJ.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DPharmacokinetic%2520optimization%2520of%25203-amino-6-chloropyrazinone%2520acetamide%2520thrombin%2520inhibitors.%2520Implementation%2520of%2520P3%2520pyridine%2520N-oxides%2520to%2520deliver%2520an%2520orally%2520bioavailable%2520series%2520containing%2520P1%2520N-benzylamines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1353%26epage%3D1357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Riffel, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hengchang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M.-W.</span><span> </span><span class="NLM_article-title">Simultaneous determination of a novel thrombin inhibitor and its two metabolites in human plasma by liquid chromatography/tandem mass spectrometry</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1016%2FS0731-7085%2800%2900353-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=10933555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFChu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=607-616&author=K.+A.+Riffelauthor=S.+Hengchangauthor=X.+Guauthor=K.+Yanauthor=M.-W.+Lo&title=Simultaneous+determination+of+a+novel+thrombin+inhibitor+and+its+two+metabolites+in+human+plasma+by+liquid+chromatography%2Ftandem+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous determination of a novel thrombin inhibitor and its two metabolites in human plasma by liquid chromatography/tandem mass spectrometry</span></div><div class="casAuthors">Riffel, K. A.; Song, H.; Gu, X.; Yan, K.; Lo, M.-W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">607-616</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">I, 3-(2-phenethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylene-carboxamidomethylpyridinyl)-pyrazinone dihydrochloride monohydrate, is a potent, orally active thrombin inhibitor.  The compd. also has two metabolites which have been shown to have thrombin inhibitory activity: benzylic alc. M3 metabolite (II) and hydroxymethylpyrazinone M7 metabolite (III).  A liq. chromatog./tandem mass spectrometry (LC/MS/MS) method for the simultaneous detn. of I and its two metabolites in human plasma has successfully been developed.  The method consists of treating 0.5 mL plasma with 2 N NaOH and extg. I, II, III and internal std. (IV) with Et acetate:methyl-t-Bu ether (1:3,vol./vol.).  The analytes were then back-extd. into 2% formic acid.  The analytes were chromatographed by high performance liq. chromatog. (HPLC) and detected by MS/MS.  Pos. ionization was used on a heated nebulizer probe monitoring precursor product ion combinations in multiple reaction monitoring mode.  The linear range is 0.5-1000 nM for I and III and 0.75-1000 nM for II.  Recoveries were 88, 74, 78 and 102.1% for I, II and III and the internal std., resp. in human plasma.  Intraday variation using this method was ≤7.9% for I, ≤9.0% for II and ≤9.5% for III across the std. curve range.  This method exhibits good linearity and reproducibility for the three analytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTGUNPHSd2sLVg90H21EOLACvtfcHk0liFHygooqo5sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFChu78%253D&md5=ebe5a481d37f35e1ca84351db93f13c6</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2FS0731-7085%2800%2900353-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0731-7085%252800%252900353-8%26sid%3Dliteratum%253Aachs%26aulast%3DRiffel%26aufirst%3DK.%2BA.%26aulast%3DHengchang%26aufirst%3DS.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DK.%26aulast%3DLo%26aufirst%3DM.-W.%26atitle%3DSimultaneous%2520determination%2520of%2520a%2520novel%2520thrombin%2520inhibitor%2520and%2520its%2520two%2520metabolites%2520in%2520human%2520plasma%2520by%2520liquid%2520chromatography%252Ftandem%2520mass%2520spectrometry%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2000%26volume%3D23%26spage%3D607%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Burgey, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, P. E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranieri, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitko, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonough, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Detwiler, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020311f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=461-473&author=C.+S.+Burgeyauthor=K.+A.+Robinsonauthor=T.+A.+Lyleauthor=P.+E.+J.+Sandersonauthor=S.+D.+Lewisauthor=B.+J.+Lucasauthor=J.+A.+Kruegerauthor=R.+Singhauthor=C.+Miller-Steinauthor=R.+B.+Whiteauthor=B.+Wongauthor=E.+A.+Lyleauthor=P.+D.+Williamsauthor=C.+A.+Coburnauthor=B.+D.+Dorseyauthor=J.+C.+Barrowauthor=M.+T.+Stranieriauthor=M.+A.+Holahanauthor=G.+R.+Sitkoauthor=J.+J.+Cookauthor=D.+R.+McMastersauthor=C.+M.+McDonoughauthor=W.+M.+Sandersauthor=A.+A.+Wallaceauthor=F.+C.+Claytonauthor=D.+Bohnauthor=Y.+M.+Leonardauthor=T.+J.+Detwilerauthor=J.+J.+Lynchauthor=Y.+Yanauthor=Z.+Chenauthor=L.+Kuoauthor=S.+J.+Gardellauthor=J.+A.+Shaferauthor=J.+P.+Vacca&title=Metabolism-directed+optimization+of+3-aminopyrazinone+acetamide+thrombin+inhibitors.+Development+of+an+orally+bioavailable+series+containing+P1+and+P3+pyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjm020311f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020311f%26sid%3Dliteratum%253Aachs%26aulast%3DBurgey%26aufirst%3DC.%2BS.%26aulast%3DRobinson%26aufirst%3DK.%2BA.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DSanderson%26aufirst%3DP.%2BE.%2BJ.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DMiller-Stein%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DR.%2BB.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DLyle%26aufirst%3DE.%2BA.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DStranieri%26aufirst%3DM.%2BT.%26aulast%3DHolahan%26aufirst%3DM.%2BA.%26aulast%3DSitko%26aufirst%3DG.%2BR.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DMcDonough%26aufirst%3DC.%2BM.%26aulast%3DSanders%26aufirst%3DW.%2BM.%26aulast%3DWallace%26aufirst%3DA.%2BA.%26aulast%3DClayton%26aufirst%3DF.%2BC.%26aulast%3DBohn%26aufirst%3DD.%26aulast%3DLeonard%26aufirst%3DY.%2BM.%26aulast%3DDetwiler%26aufirst%3DT.%2BJ.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DGardell%26aufirst%3DS.%2BJ.%26aulast%3DShafer%26aufirst%3DJ.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMetabolism-directed%2520optimization%2520of%25203-aminopyrazinone%2520acetamide%2520thrombin%2520inhibitors.%2520Development%2520of%2520an%2520orally%2520bioavailable%2520series%2520containing%2520P1%2520and%2520P3%2520pyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D461%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Young, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicore, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantermet, P. G.</span><span> </span><span class="NLM_article-title">Discovery and evaluation of potent P1 aryl hetercycle-based thrombin inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2995</span><span class="NLM_x">–</span> <span class="NLM_lpage">3008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030303e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2995-3008&author=M.+B.+Youngauthor=J.+C.+Barrowauthor=K.+L.+Glassauthor=G.+F.+Lundellauthor=C.+L.+Newtonauthor=J.+M.+Pellicoreauthor=K.+E.+Rittleauthor=H.+G.+Selnickauthor=K.+J.+Staufferauthor=J.+P.+Vaccaauthor=P.+D.+Williamsauthor=D.+Bohnauthor=F.+C.+Claytonauthor=J.+J.+Cookauthor=J.+A.+Kruegerauthor=L.+C.+Kuoauthor=S.+D.+Lewisauthor=B.+J.+Lucasauthor=D.+R.+McMastersauthor=C.+Miller-Steinauthor=B.+L.+Pietrakauthor=A.+A.+Wallaceauthor=R.+B.+Whiteauthor=B.+Wongauthor=Y.+Yanauthor=P.+G.+Nantermet&title=Discovery+and+evaluation+of+potent+P1+aryl+hetercycle-based+thrombin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm030303e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030303e%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DM.%2BB.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DGlass%26aufirst%3DK.%2BL.%26aulast%3DLundell%26aufirst%3DG.%2BF.%26aulast%3DNewton%26aufirst%3DC.%2BL.%26aulast%3DPellicore%26aufirst%3DJ.%2BM.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DStauffer%26aufirst%3DK.%2BJ.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DBohn%26aufirst%3DD.%26aulast%3DClayton%26aufirst%3DF.%2BC.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DMiller-Stein%26aufirst%3DC.%26aulast%3DPietrak%26aufirst%3DB.%2BL.%26aulast%3DWallace%26aufirst%3DA.%2BA.%26aulast%3DWhite%26aufirst%3DR.%2BB.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520potent%2520P1%2520aryl%2520hetercycle-based%2520thrombin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2995%26epage%3D3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markotan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomczuk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crysler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisennagel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gremminger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardino, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bone, R.</span><span> </span><span class="NLM_article-title">Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3727</span><span class="NLM_x">–</span> <span class="NLM_lpage">3731</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3727-3731&author=T.+Luauthor=T.+Markotanauthor=F.+Coppoauthor=B.+Tomczukauthor=C.+Cryslerauthor=S.+Eisennagelauthor=J.+Spurlinoauthor=L.+Gremmingerauthor=R.+M.+Sollauthor=E.+C.+Giardinoauthor=R.+Bone&title=Oxyguanidines.+Part+2%3A+Discovery+of+a+novel+orally+active+thrombin+inhibitor+through+structure-based+drug+design+and+parallel+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DT.%26aulast%3DMarkotan%26aufirst%3DT.%26aulast%3DCoppo%26aufirst%3DF.%26aulast%3DTomczuk%26aufirst%3DB.%26aulast%3DCrysler%26aufirst%3DC.%26aulast%3DEisennagel%26aufirst%3DS.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DGremminger%26aufirst%3DL.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DGiardino%26aufirst%3DE.%2BC.%26aulast%3DBone%26aufirst%3DR.%26atitle%3DOxyguanidines.%2520Part%25202%253A%2520Discovery%2520of%2520a%2520novel%2520orally%2520active%2520thrombin%2520inhibitor%2520through%2520structure-based%2520drug%2520design%2520and%2520parallel%2520synthesis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3727%26epage%3D3731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Walkowiak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmanowski, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strzykala, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bychowiec, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Songin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, K.-H.</span><span> </span><span class="NLM_article-title">Inhibition of endogenous pancreatic enzyme secretion by oral pancreatic enzyme treatment</span> <span class="citation_source-journal">Eur. J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=65-69&author=J.+Walkowiakauthor=H.+Witmanowskiauthor=K.+Strzykalaauthor=B.+Bychowiecauthor=T.+Songinauthor=K.+Borskiauthor=K.-H.+Herzig&title=Inhibition+of+endogenous+pancreatic+enzyme+secretion+by+oral+pancreatic+enzyme+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalkowiak%26aufirst%3DJ.%26aulast%3DWitmanowski%26aufirst%3DH.%26aulast%3DStrzykala%26aufirst%3DK.%26aulast%3DBychowiec%26aufirst%3DB.%26aulast%3DSongin%26aufirst%3DT.%26aulast%3DBorski%26aufirst%3DK.%26aulast%3DHerzig%26aufirst%3DK.-H.%26atitle%3DInhibition%2520of%2520endogenous%2520pancreatic%2520enzyme%2520secretion%2520by%2520oral%2520pancreatic%2520enzyme%2520treatment%26jtitle%3DEur.%2520J.%2520Clin.%2520Invest.%26date%3D2003%26volume%3D33%26spage%3D65%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Obourn, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frame, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. C.</span><span> </span><span class="NLM_article-title">Evidence that A8947 enhances pancreas growth via a trypsin inhibitor mechanism</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1006%2Ftaap.1997.8231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=9299603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADyaK2sXmt1WgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=1997&pages=116-126&author=J.+D.+Obournauthor=S.+R.+Frameauthor=T.+Shiuauthor=T.+E.+Solomonauthor=J.+C.+Cook&title=Evidence+that+A8947+enhances+pancreas+growth+via+a+trypsin+inhibitor+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence that A8947 enhances pancreas growth via a trypsin inhibitor mechanism</span></div><div class="casAuthors">Obourn, John D.; Frame, Steven R.; Chiu, Taisan; Solomon, Travis E.; Cook, Jon C.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">116-126</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">The objectives of this study were to investigate the mechanism(s) for the A8947 induction of pancreatic acinar cell hypertrophy and proliferation and to evaluate whether these pancreatic changes are reversible.  A8947 was fed to male Crl:CD BR rats for up to 28 days (0, 300, 10,000, 30,000 ppm) or 56 days (0, 30,000 ppm).  Rats were terminated on Test Days 7, 14, and 28 to assess the time course and dose response for the A8947-induced pancreatic changes, while rats terminated on Test Day 56 were used to assess the reversibility of the pancreas effects at 30,000 ppm A8947.  A8947 produced significant increases in pancreatic wt. and acinar cell proliferation and diffuse acinar cell hypertrophy in 7 days at 10,000 and 30,000 ppm dose levels.  By Day 14, abs. pancreas wts. in the 10,000 and 30,000 ppm groups were maximally increased and remained at these levels throughout the study.  In contrast, acinar cell proliferation in the 30,000 ppm group was still elevated at Test Day 14, but attenuated relative to the 7-day response, and returned to control levels by Test Day 28.  No effects were obsd. at 300 ppm after a 28-day exposure period, while complete reversibility of A8947-induced pancreatic effects was demonstrated at 30,000 ppm following a 1-mo recovery period (Test Day 56).  Cholecystokinin (CCK) levels were increased by A8947 and closely followed the time course for pancreatic changes.  MK-329, a specific CCKA receptor antagonist, completely ablated the ability of 30,000 ppm A8947 to increase pancreas wt. following 7 days of exposure.  A8947 did not bind the CCKA receptor in a receptor competition assay, negating any potential agonist mechanism.  A8947 did, however, inhibit trypsin in vitro, suggesting a mechanism of action similar to that of raw soy protein, in which trypsin inhibition in vivo results in increased CCK levels followed by pancreatic acinar cell hypertrophy and proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow6ER5r-41ybVg90H21EOLACvtfcHk0ljaDbD1JKTpWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmt1WgsLc%253D&md5=02d5f46ff084c90b554519f647c4e52f</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1006%2Ftaap.1997.8231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Ftaap.1997.8231%26sid%3Dliteratum%253Aachs%26aulast%3DObourn%26aufirst%3DJ.%2BD.%26aulast%3DFrame%26aufirst%3DS.%2BR.%26aulast%3DShiu%26aufirst%3DT.%26aulast%3DSolomon%26aufirst%3DT.%2BE.%26aulast%3DCook%26aufirst%3DJ.%2BC.%26atitle%3DEvidence%2520that%2520A8947%2520enhances%2520pancreas%2520growth%2520via%2520a%2520trypsin%2520inhibitor%2520mechanism%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D1997%26volume%3D146%26spage%3D116%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulichak, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, J. A.</span><span> </span><span class="NLM_article-title">Crystal structure of human α-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 Å resolution</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=1995&pages=198-203&author=Z.+Chenauthor=Y.+Liauthor=A.+M.+Mulichakauthor=S.+D.+Lewisauthor=J.+A.+Shafer&title=Crystal+structure+of+human+%CE%B1-thrombin+complexed+with+hirugen+and+p-amidinophenylpyruvate+at+1.6+%C3%85+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMulichak%26aufirst%3DA.%2BM.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DShafer%26aufirst%3DJ.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520human%2520%25CE%25B1-thrombin%2520complexed%2520with%2520hirugen%2520and%2520p-amidinophenylpyruvate%2520at%25201.6%2520%25C3%2585%2520resolution%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1995%26volume%3D322%26spage%3D198%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Sanderson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonough, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span> </span><span class="NLM_article-title">Azaindoles: Moderately basic P1 groups for enhancing the selectivity of thrombin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">–</span> <span class="NLM_lpage">798</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=795-798&author=P.+E.+Sandersonauthor=M.+G.+Stantonauthor=B.+D.+Dorseyauthor=T.+A.+Lyleauthor=C.+McDonoughauthor=W.+M.+Sandersauthor=K.+L.+Savageauthor=A.+M.+Naylor-Olsenauthor=J.+A.+Kruegerauthor=S.+D.+Lewisauthor=B.+J.+Lucasauthor=J.+J.+Lynchauthor=Y.+Yan&title=Azaindoles%3A+Moderately+basic+P1+groups+for+enhancing+the+selectivity+of+thrombin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanderson%26aufirst%3DP.%2BE.%26aulast%3DStanton%26aufirst%3DM.%2BG.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DMcDonough%26aufirst%3DC.%26aulast%3DSanders%26aufirst%3DW.%2BM.%26aulast%3DSavage%26aufirst%3DK.%2BL.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%2BM.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DYan%26aufirst%3DY.%26atitle%3DAzaindoles%253A%2520Moderately%2520basic%2520P1%2520groups%2520for%2520enhancing%2520the%2520selectivity%2520of%2520thrombin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D795%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Isaacs, R. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solinsky, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutrona, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span> </span><span class="NLM_article-title">Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 1: Weakly basic azoles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=338-342&author=R.+C.+A.+Isaacsauthor=M.+G.+Solinskyauthor=K.+J.+Cutronaauthor=C.+L.+Newtonauthor=A.+M.+Naylor-Olsenauthor=J.+A.+Kruegerauthor=S.+D.+Lewisauthor=B.+J.+Lucas&title=Structure-based+design+of+novel+groups+for+use+in+the+P1+position+of+thrombin+inhibitor+scaffolds.+Part+1%3A+Weakly+basic+azoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsaacs%26aufirst%3DR.%2BC.%2BA.%26aulast%3DSolinsky%26aufirst%3DM.%2BG.%26aulast%3DCutrona%26aufirst%3DK.%2BJ.%26aulast%3DNewton%26aufirst%3DC.%2BL.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%2BM.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520groups%2520for%2520use%2520in%2520the%2520P1%2520position%2520of%2520thrombin%2520inhibitor%2520scaffolds.%2520Part%25201%253A%2520Weakly%2520basic%2520azoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D338%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Isaacs, R. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solinsky, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutrona, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, E. A.</span><span> </span><span class="NLM_article-title">Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2062</span><span class="NLM_x">–</span> <span class="NLM_lpage">2066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2062-2066&author=R.+C.+A.+Isaacsauthor=M.+G.+Solinskyauthor=K.+J.+Cutronaauthor=C.+L.+Newtonauthor=A.+M.+Naylor-Olsenauthor=D.+R.+McMastersauthor=J.+A.+Kruegerauthor=S.+D.+Lewisauthor=B.+J.+Lucasauthor=L.+C.+Kuoauthor=Y.+Yanauthor=J.+J.+Lynchauthor=E.+A.+Lyle&title=Structure-based+design+of+novel+groups+for+use+in+the+P1+position+of+thrombin+inhibitor+scaffolds.+Part+2%3A+N-acetamidoimidazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsaacs%26aufirst%3DR.%2BC.%2BA.%26aulast%3DSolinsky%26aufirst%3DM.%2BG.%26aulast%3DCutrona%26aufirst%3DK.%2BJ.%26aulast%3DNewton%26aufirst%3DC.%2BL.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%2BM.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DLyle%26aufirst%3DE.%2BA.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520groups%2520for%2520use%2520in%2520the%2520P1%2520position%2520of%2520thrombin%2520inhibitor%2520scaffolds.%2520Part%25202%253A%2520N-acetamidoimidazoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2062%26epage%3D2066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Reiner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siev, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araldi, G.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamedova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K-S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradbury, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semple, J. E.</span><span> </span><span class="NLM_article-title">Non-covalent thrombin inhibitors featuring P3-heterocycles with P1-monocyclic arginine surrogates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1203</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1203-1208&author=J.+E.+Reinerauthor=D.+V.+Sievauthor=G.-L.+Araldiauthor=J.+J.+Cuiauthor=J.+Z.+Hoauthor=K.+M.+Reddyauthor=L.+Mamedovaauthor=P.+H.+Vuauthor=K-S.+S.+Leeauthor=N.+K.+Minamiauthor=T.+S.+Gibsonauthor=S.+M.+Andersonauthor=A.+E.+Bradburyauthor=T.+G.+Nolanauthor=J.+E.+Semple&title=Non-covalent+thrombin+inhibitors+featuring+P3-heterocycles+with+P1-monocyclic+arginine+surrogates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReiner%26aufirst%3DJ.%2BE.%26aulast%3DSiev%26aufirst%3DD.%2BV.%26aulast%3DAraldi%26aufirst%3DG.-L.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DHo%26aufirst%3DJ.%2BZ.%26aulast%3DReddy%26aufirst%3DK.%2BM.%26aulast%3DMamedova%26aufirst%3DL.%26aulast%3DVu%26aufirst%3DP.%2BH.%26aulast%3DLee%26aufirst%3DK-S.%2BS.%26aulast%3DMinami%26aufirst%3DN.%2BK.%26aulast%3DGibson%26aufirst%3DT.%2BS.%26aulast%3DAnderson%26aufirst%3DS.%2BM.%26aulast%3DBradbury%26aufirst%3DA.%2BE.%26aulast%3DNolan%26aufirst%3DT.%2BG.%26aulast%3DSemple%26aufirst%3DJ.%2BE.%26atitle%3DNon-covalent%2520thrombin%2520inhibitors%2520featuring%2520P3-heterocycles%2520with%2520P1-monocyclic%2520arginine%2520surrogates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1203%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schumacher, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heran, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbacher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Megill, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giancarli, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durham, S. K.</span><span> </span><span class="NLM_article-title">Thrombin inhibition compared with other antithrombotic drugs in rats</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1016%2F0049-3848%2892%2990031-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=1475778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADyaK3sXhsFOksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1992&pages=157-66&author=W.+A.+Schumacherauthor=C.+H.+Heranauthor=T.+E.+Steinbacherauthor=J.+R.+Megillauthor=J.+E.+Birdauthor=M.+R.+Giancarliauthor=S.+K.+Durham&title=Thrombin+inhibition+compared+with+other+antithrombotic+drugs+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombin inhibition compared with other antithrombotic drugs in rats</span></div><div class="casAuthors">Schumacher, W. A.; Heran, C. H.; Steinbacher, T. E.; Megill, J. R.; Bird, J. E.; Giancarli, M. R.; Durham, S. K.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-66</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    </div><div class="casAbstract">An aspirin-sensitive model of arterial thrombosis suitable for rapid evaluation of antithrombotic drugs was developed and characterized in anesthetized rats.  Carotid artery thrombi were formed in response to elec. stimulation and were occlusive in 84% of vehicle-treated rats.  Light and electron microscopy revealed these thrombi to be platelet-rich and fibrin-rich masses adherent to the injured vessel wall.  I.v. administration of aspirin (10 mg/kg), heparin (300 U/kg), a thromboxane (Tx) A2-receptor antagonist (SQ 29,548, 0.2 mg/kg + 0.2 mg/kg/h), or the thrombin inhibitor D-Ph alanyl-L-prolyl-L-arginyl chloromethyl ketone (PPACK, 52 μg/kg/min) decreased av. thrombus wt. by 35, 50, 57 and 94%, resp.  Each of these drugs also reduced the frequency of occlusion to <25%.  In contrast, thrombus wt. and vessel occlusion were not decreased by a serotonin antagonist (ketanserin, 3.0 mg/kg, i.v.), or after 14 days or oral dosing with either the calcium antagonist diltiazem (60 mg/kg) or SQ 33,351 (30 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBqEwKBuvDd7Vg90H21EOLACvtfcHk0liwwcxqnEk_Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhsFOksw%253D%253D&md5=adcff7547a31c16242948019144164f0</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1016%2F0049-3848%2892%2990031-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0049-3848%252892%252990031-5%26sid%3Dliteratum%253Aachs%26aulast%3DSchumacher%26aufirst%3DW.%2BA.%26aulast%3DHeran%26aufirst%3DC.%2BH.%26aulast%3DSteinbacher%26aufirst%3DT.%2BE.%26aulast%3DMegill%26aufirst%3DJ.%2BR.%26aulast%3DBird%26aufirst%3DJ.%2BE.%26aulast%3DGiancarli%26aufirst%3DM.%2BR.%26aulast%3DDurham%26aufirst%3DS.%2BK.%26atitle%3DThrombin%2520inhibition%2520compared%2520with%2520other%2520antithrombotic%2520drugs%2520in%2520rats%26jtitle%3DThromb.%2520Res.%26date%3D1992%26volume%3D68%26spage%3D157%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Berry, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecoffre, C.</span><span> </span><span class="NLM_article-title">Antithrombotic actions of argatroban in rat models of venous, ‘mixed’ and arterial thrombosis, and its effects on the tail transaction bleeding time</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">1209</span><span class="NLM_x">–</span> <span class="NLM_lpage">1214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1111%2Fj.1476-5381.1994.tb17126.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=7889274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADyaK2MXisFajtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1994&pages=1209-1214&author=C.+N.+Berryauthor=D.+Girardauthor=S.+Lochotauthor=C.+Lecoffre&title=Antithrombotic+actions+of+argatroban+in+rat+models+of+venous%2C+%E2%80%98mixed%E2%80%99+and+arterial+thrombosis%2C+and+its+effects+on+the+tail+transaction+bleeding+time"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Antithrombotic actions of argatroban in rat models of venous, 'mixed' [arteriovenous] and arterial thrombosis, and its effects on the tail transection bleeding time</span></div><div class="casAuthors">Berry, Christopher N.; Girard, Denise; Lochot, Sylvette; Lecoffre, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1209-14</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The antithrombotic action of argatroban, a synthetic thrombin inhibitor, was studied in the title 3 models of thrombosis in the rat, and in the tail transection bleeding time test.  Heparin was studied as a ref. anticoagulant.  In the model of venous thrombosis induced by thromboplastin followed by stasis of the abdominal vena cava, argatroban had an ED50 of 12 μg/kg, when administered as an i.v. bolus 5 min prior to the thromboplastin injection: the ED50 of heparin was 42 μg/kg.  When the two compds. were administered by continuous i.v. infusion, argatroban (ED50 = 1.5 μg/kg/min) had the same potency as heparin (ED50 = 1.2 μg/kg/min).  Argatroban was active in the arteriovenous shunt model, with an ED50 of 0.6 mg/kg when the compd. was given as a bolus.  The ED50 of heparin was 0.04 mg/kg under the same conditions.  The 2 compds. had ED50 values of 6 μg/kg/min (argatroban) and 3 μg/kg/min (heparin), when administered by continuous i.v. infusion.  When tested against occlusive arterial thrombus formation by elec. stimulation of the left carotid artery, both compds., given as either an i.v. bolus or a continuous infusion, led to dose-dependent increases in the duration of postlesion vessel patency.  The antithrombotic effects of argatroban were accompanied by only moderate changes in the coagulation parameters (thrombin time and activated partial thromboplatin time, APTT), whereas, even at a subthreshold dose of heparin, both the thrombin time and the APTT were >150 s.  Infusions of both compds. caused dose-dependent increases in the tail transection bleeding time, with the dose of argatroban that doubles the bleeding time (11 μg/kg) being 5 times greater than that of heparin (ED100 = 2.2 μg/kg/min).  These data show that, when administered as an i.v. infusion, argatroban is a potent antithrombotic agent in rat models of venous, 'mixed' and arterial thrombosis; this effect can be obtained with a lower degree of systemic anticoagulation than with heparin in the arterial model, and argatroban has a lower hemorrhagic potential than heparin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2c3pmCWsHqLVg90H21EOLACvtfcHk0liwwcxqnEk_Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXisFajtr4%253D&md5=a3055f4130afcb326ccacfba40480f0b</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1994.tb17126.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1994.tb17126.x%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DC.%2BN.%26aulast%3DGirard%26aufirst%3DD.%26aulast%3DLochot%26aufirst%3DS.%26aulast%3DLecoffre%26aufirst%3DC.%26atitle%3DAntithrombotic%2520actions%2520of%2520argatroban%2520in%2520rat%2520models%2520of%2520venous%252C%2520%25E2%2580%2598mixed%25E2%2580%2599%2520and%2520arterial%2520thrombosis%252C%2520and%2520its%2520effects%2520on%2520the%2520tail%2520transaction%2520bleeding%2520time%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D113%26spage%3D1209%26epage%3D1214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crain, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meade, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, A. M.</span><span> </span><span class="NLM_article-title">Nonpeptide factor Xa inhibitors II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=10991981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1ygu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=212-218&author=P.+C.+Wongauthor=E.+J.+Crainauthor=R.+M.+Knabbauthor=R.+P.+Meadeauthor=M.+L.+Quanauthor=C.+A.+Watsonauthor=R.+R.+Wexlerauthor=M.+R.+Wrightauthor=A.+M.+Slee&title=Nonpeptide+factor+Xa+inhibitors+II.+Antithrombotic+evaluation+in+a+rabbit+model+of+electrically+induced+carotid+artery+thrombosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide factor Xa inhibitors. II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis</span></div><div class="casAuthors">Wong, Pancras C.; Crain, Earl J.; Knabb, Robert M.; Meade, Raymond P.; Quan, Mimi L.; Watson, Carol A.; Wexler, Ruth R.; Wright, Matthew R.; Slee, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">212-218</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">SK549 (mol. wt. 546 Da) is a synthetic, selective inhibitor of human coagulation factor Xa (fXa) (Ki = 0.52 nM).  This study compared the antithrombotic effects of SK549 and a series of benzamidine isoxazoline fXa inhibitors with aspirin, DuP 714 (a direct thrombin inhibitor), recombinant tick anticoagulant peptide, or heparin in a rabbit model of elec. induced carotid arterial thrombosis.  Compds. were infused i.v. continuously from 60 min before elec. stimulation to the end of the expt.  Values of ED50 (dose that increases the carotid blood flow to 50% of the control) were 0.12 μmol/kg/h for SK549, 0.56 μmol/kg/h for aspirin, 0.14 μmol/kg/h for DuP 714, 0.06 μmol/kg/h for recombinant tick anticoagulant peptide, and >100 U/kg/h for heparin.  The EC50 (plasma concn. that increased blood flow to 50% of the control) for SK549 was 97 nM.  Unlike aspirin and heparin, SK549 was efficacious and, at 1.5 μmol/kg/h i.v. (n = 9), maintained carotid blood flow at 87±6% of control level for greater than 90 min.  Unlike heparin, SK549 inhibited ex vivo fXa activity but not ex vivo thrombin activity.  There was a highly significant correlation between Ki (fXa) and ED50 of a series of fXa inhibitors (r = 0.85, P <.001).  Therefore, these results suggest that SK549 is a novel, potent, and effective antithrombotic agent in a rabbit model of arterial thrombosis.  It is likely that SK549 exerts its antithrombotic effect through selective inhibition of fXa.  Furthermore, SK549 may be clin. useful for the prevention of arterial thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7m_8Krs2pdrVg90H21EOLACvtfcHk0ljy7iOMG70U9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1ygu74%253D&md5=52ed9fac0aeb3b953fd1a5825d03b5af</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DCrain%26aufirst%3DE.%2BJ.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DMeade%26aufirst%3DR.%2BP.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DWright%26aufirst%3DM.%2BR.%26aulast%3DSlee%26aufirst%3DA.%2BM.%26atitle%3DNonpeptide%2520factor%2520Xa%2520inhibitors%2520II.%2520Antithrombotic%2520evaluation%2520in%2520a%2520rabbit%2520model%2520of%2520electrically%2520induced%2520carotid%2520artery%2520thrombosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D295%26spage%3D212%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Giardino, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span> </span><span class="NLM_article-title">Antithrombotic properties of RWJ-50353, a potent and novel thrombin inhibitor</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1016%2FS0049-3848%2899%2900219-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=10706936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsFOjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2000&pages=83-93&author=E.+C.+Giardinoauthor=M.+J.+Costanzoauthor=J.+A.+Kauffmanauthor=Q.-S.+Liauthor=B.+E.+Maryanoffauthor=P.+Andrade-Gordon&title=Antithrombotic+properties+of+RWJ-50353%2C+a+potent+and+novel+thrombin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Antithrombotic Properties of RWJ-50353, a Potent and Novel Thrombin Inhibitor</span></div><div class="casAuthors">Giardino, E. C.; Costanzo, M. J.; Kauffman, J. A.; Li, Q. S.; Maryanoff, B. E.; Andrade-Gordon, P.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-93</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The antithrombotic, anticoagulant, and kinetic properties of RWJ-50353, a novel, reversible, active-site-directed thrombin inhibitor, were evaluated.  RWJ-50353 inhibited the catalytic activity of human α-thrombin with a Ki of 0.19±0.02 nM.  It showed a 16-fold selectivity relative to inhibition of trypsin and at least 330-fold selectivity relative to inhibition of other biol. important serine proteases.  In a gel-filtered platelet prepn., RWJ-50353 inhibited α-thrombin-induced aggregation with an IC50 of 32±6 nM.  In a canine arteriovenous shunt antithrombotic model, RWJ-50353 demonstrated a significant dose-related (0.1-1.0 mg/kg, i.v.) redn. in thrombus formation with 50% inhibition (ID50) obtained at 0.46±0.1 mg/kg.  In a rabbit deep vein thrombosis model, RWJ-50353 dose-dependently (0.1-1.0 mg/kg, i.v.) reduced thrombus formation with an ID50 of 0.25±0.03 mg/kg.  The antithrombotic activity in both of these models was assocd. with only mild prolongations in bleeding time and coagulation parameters.  These results demonstrate that RWJ-50353 is a potent, selective thrombin inhibitor that is an effective antithrombotic agent after i.v. administration in models of arterial and venous thrombosis and may be useful in the management of various thrombotic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDy7TwvOiotrVg90H21EOLACvtfcHk0ljy7iOMG70U9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsFOjt7s%253D&md5=1b8b77d6a55b157f4f59e9d5f10f4377</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0049-3848%2899%2900219-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0049-3848%252899%252900219-4%26sid%3Dliteratum%253Aachs%26aulast%3DGiardino%26aufirst%3DE.%2BC.%26aulast%3DCostanzo%26aufirst%3DM.%2BJ.%26aulast%3DKauffman%26aufirst%3DJ.%2BA.%26aulast%3DLi%26aufirst%3DQ.-S.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26atitle%3DAntithrombotic%2520properties%2520of%2520RWJ-50353%252C%2520a%2520potent%2520and%2520novel%2520thrombin%2520inhibitor%26jtitle%3DThromb.%2520Res.%26date%3D2000%26volume%3D98%26spage%3D83%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Barrett, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crocker, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damphousse, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heminway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazewatsky, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazaika, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, T. R.</span><span> </span><span class="NLM_article-title">Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with <sup>99m</sup>Tc</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc970001p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADyaK2sXhsFGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=155-160&author=J.+A.+Barrettauthor=A.+C.+Crockerauthor=D.+J.+Damphousseauthor=S.+J.+Heminwayauthor=S.+Liuauthor=D.+S.+Edwardsauthor=J.+L.+Lazewatskyauthor=M.+Kaganauthor=T.+J.+Mazaikaauthor=T.+R.+Carroll&title=Biological+evaluation+of+thrombus+imaging+agents+utilizing+water+soluble+phosphines+and+tricine+as+coligands+when+used+to+label+a+hydrazinonicotinamide-modified+cyclic+glycoprotein+IIb%2FIIIa+receptor+antagonist+with+99mTc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Biological Evaluation of Thrombus Imaging Agents Utilizing Water Soluble Phosphines and Tricine as Coligands When Used To Label a Hydrazinonicotinamide-Modified Cyclic Glycoprotein IIb/IIIa Receptor Antagonist with 99mTc</span></div><div class="casAuthors">Barrett, John A.; Crocker, Andrew C.; Damphousse, David J.; Heminway, Stuart J.; Liu, Shuang; Edwards, D. Scott; Lazewatsky, Joel L.; Kagan, Mikhail; Mazaika, Theresa J.; Carroll, Timothy R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-160</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hydrazinonicotinamide-functionalized cyclic glycoprotein IIb/IIIa (GPIIb/IIIa) receptor antagonist [cyclo(D-Val-NMeArg-Gly-Asp-Mamb(5-(6-(6-hydrazinonicotinamido)hexanamide))) (HYNICtide)] was labeled with 99mTc using tricine and a water sol. phosphine [trisodium triphenylphosphine-3,3',3''-trisulfonate (TPPTS); disodium triphenylphosphine-3,3'-disulfonate (TPPDS); or sodium triphenylphosphine-3-monosulfonate (TPPMS)] as coligands.  Three complexes, [99mTc(HYNICtide)(L)(tricine)] (1, L = TPPTS; 2, L = TPPDS; 3, L = TPPMS), were evaluated in the canine arteriovenous shunt (AV shunt) model and canine deep vein thrombosis imaging (DVT) model.  All three agents were adequately incorporated into the arterial and venous portions of the growing thrombus (7.8-9.9 and 0.2-3.7% ID/g, resp.) in the canine AV shunt model.  In the canine DVT model all three complexes had thrombus uptake that far exceeded the neg. control, [99mTc]albumin.  The findings indicate similar incorporation into a venous thrombus (% ID/g = 2.86 ± 0.4, 3.4 ± 0.9, and 3.38 ± 1.1 for complexes 1, 2, and 3, resp.) and similar blood clearance with a t1/2 of approx. 90 min.  Gamma camera scintigraphy allowed visualization of deep vein thrombosis in as little as 15 min with the thrombus/muscle ratios being 3.8 ± 0.8, 2.8 ± 0.4, and 3.0 ± 0.8 for complexes 1, 2, and 3, resp.  The visualization of the thrombus improved over time, and the thrombus/muscle ratios were 9.7 ± 1.9, 13.8 ± 3.6, and 9.4 ± 2 for complexes 1, 2, and 3, resp., at 120 min postinjection.  The administration of complexes 1-3 did not alter platelet function, hemodynamics, or the coagulation cascade.  Furthermore, complexes 1-3 did not significantly differ in their uptake into the growing thrombus, blood clearance, and target to background ratios.  Therefore, all three complexes have the capability to detect rapidly growing venous and arterial thrombi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY4h9ZUWNT2LVg90H21EOLACvtfcHk0ljy7iOMG70U9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsFGjtLs%253D&md5=5e4e19de4c5f9afabb3bebe791f65a5c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fbc970001p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc970001p%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DJ.%2BA.%26aulast%3DCrocker%26aufirst%3DA.%2BC.%26aulast%3DDamphousse%26aufirst%3DD.%2BJ.%26aulast%3DHeminway%26aufirst%3DS.%2BJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DD.%2BS.%26aulast%3DLazewatsky%26aufirst%3DJ.%2BL.%26aulast%3DKagan%26aufirst%3DM.%26aulast%3DMazaika%26aufirst%3DT.%2BJ.%26aulast%3DCarroll%26aufirst%3DT.%2BR.%26atitle%3DBiological%2520evaluation%2520of%2520thrombus%2520imaging%2520agents%2520utilizing%2520water%2520soluble%2520phosphines%2520and%2520tricine%2520as%2520coligands%2520when%2520used%2520to%2520label%2520a%2520hydrazinonicotinamide-modified%2520cyclic%2520glycoprotein%2520IIb%252FIIIa%2520receptor%2520antagonist%2520with%252099mTc%26jtitle%3DBioconjugate%2520Chem.%26date%3D1997%26volume%3D8%26spage%3D155%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Lorrain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechaire, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visconte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sainte-Marie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunven, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Connor, S. E.</span><span> </span><span class="NLM_article-title">Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1124%2Fjpet.102.044610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=12538808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVCgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2003&pages=567-574&author=J.+Lorrainauthor=L.+Milletauthor=I.+Lechaireauthor=S.+Lochotauthor=P.+Ferrariauthor=C.+Visconteauthor=M.+Sainte-Marieauthor=C.+Lunvenauthor=C.+N.+Berryauthor=P.+Schaefferauthor=J.-M.+Herbertauthor=S.+E.+O%27Connor&title=Antithrombotic+properties+of+SSR182289A%2C+a+new%2C+orally+active+thrombin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor</span></div><div class="casAuthors">Lorrain, J.; Millet, L.; Lechaire, I.; Lochot, S.; Ferrari, P.; Visconte, C.; Sainte-Marie, M.; Lunven, C.; Berry, C. N.; Schaeffer, P.; Herbert, J.-M.; O'Connor, S. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">567-574</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">N-[3-[[[(1S)-4-(5-Amino-2-pyridinyl)-1-[[4-difluoromethylene)-1-piperidinyl]carbonyl]butyl]amino]sulfonyl][1,1'-biphenyl]-2-yl]acetamide hydrochloride (SSR182289A) is a novel, potent, and selective thrombin inhibitor.  We have examd. the antithrombotic properties of SSR182289A administered by i.v. and p.o. routes in several different animal thrombosis models in comparison with ref. antithrombotic agents.  Oral administration of SSR182289A produced dose-related antithrombotic effects in the following models; rat venous thrombosis (ED50 0.9 mg/kg p.o.), rat silk thread arterio-venous (AV) shunt (ED50 3.8 mg/kg p.o.), rat thromboplastin-induced AV shunt (ED50 3.1 mg/kg p.o.), rat carotid artery thrombosis (ED200 5.9 mg/kg p.o.), and rabbit venous thrombosis (ED50 7.5 mg/kg p.o.).  Administered as an i.v. bolus, SSR182289A showed antithrombotic activity in the above models with ED50/ED200 values in the range of 0.2 to 1.9 mg/kg i.v. SSR182289A increased rat tail transection bleeding time at doses ≥10 mg/kg p.o.  In the rat thromboplastin-induced AV shunt model, SSR182289A 10 mg/kg p.o. produced marked antithrombotic effects at 30, 60, 120, and 240 min after administration.  Hence, SSR182289A demonstrates potent oral antithrombotic properties in animal venous, AV-shunt, and arterial thrombosis models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphIVi0E6pTNbVg90H21EOLACvtfcHk0lhcQg0nbKz1MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVCgtg%253D%253D&md5=40ee6cad6478dab6dd63b242b0a8357a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.044610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.044610%26sid%3Dliteratum%253Aachs%26aulast%3DLorrain%26aufirst%3DJ.%26aulast%3DMillet%26aufirst%3DL.%26aulast%3DLechaire%26aufirst%3DI.%26aulast%3DLochot%26aufirst%3DS.%26aulast%3DFerrari%26aufirst%3DP.%26aulast%3DVisconte%26aufirst%3DC.%26aulast%3DSainte-Marie%26aufirst%3DM.%26aulast%3DLunven%26aufirst%3DC.%26aulast%3DBerry%26aufirst%3DC.%2BN.%26aulast%3DSchaeffer%26aufirst%3DP.%26aulast%3DHerbert%26aufirst%3DJ.-M.%26aulast%3DO%2527Connor%26aufirst%3DS.%2BE.%26atitle%3DAntithrombotic%2520properties%2520of%2520SSR182289A%252C%2520a%2520new%252C%2520orally%2520active%2520thrombin%2520inhibitor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D304%26spage%3D567%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lu, T.; Tomczuk, B. T.; Markotan, T. P.</span> U.S. Patent 6,204,263 B1,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lu%2C+T.%3B+Tomczuk%2C+B.+T.%3B+Markotan%2C+T.+P.+U.S.+Patent+6%2C204%2C263+B1%2C+2001."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DT.%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the inhibition constant (K<sub>i</sub>) and the concentration of inhibitor which causes 50% inhibition (IC<sub>50</sub>) of an enzymatic reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm901802n&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm901802n&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28IC50%29+of+an+enzymatic+reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lhcQg0nbKz1MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528IC50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Webber, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewandowski, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schadt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettner, C. A.</span><span> </span><span class="NLM_article-title">Kinetic and crystallographic studies of thrombin with Ac-(D)Phe-Pro-boroArg-OH and its lysine, amidine, homolysine and ornithine analogs</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">3750</span><span class="NLM_x">–</span> <span class="NLM_lpage">3757</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=3750-3757&author=P.+C.+Webberauthor=S.-L.+Leeauthor=F.+A.+Lewandowskiauthor=M.+C.+Schadtauthor=C.-H.+Changauthor=C.+A.+Kettner&title=Kinetic+and+crystallographic+studies+of+thrombin+with+Ac-%28D%29Phe-Pro-boroArg-OH+and+its+lysine%2C+amidine%2C+homolysine+and+ornithine+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWebber%26aufirst%3DP.%2BC.%26aulast%3DLee%26aufirst%3DS.-L.%26aulast%3DLewandowski%26aufirst%3DF.%2BA.%26aulast%3DSchadt%26aufirst%3DM.%2BC.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DKettner%26aufirst%3DC.%2BA.%26atitle%3DKinetic%2520and%2520crystallographic%2520studies%2520of%2520thrombin%2520with%2520Ac-%2528D%2529Phe-Pro-boroArg-OH%2520and%2520its%2520lysine%252C%2520amidine%252C%2520homolysine%2520and%2520ornithine%2520analogs%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D34%26spage%3D3750%26epage%3D3757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Skrzypczak-Jankun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carperos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravichandran, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulinsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maraganore, J. M.</span><span> </span><span class="NLM_article-title">Structure of the hirugen and hirulog 1 complexes of α-thrombin</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">1379</span><span class="NLM_x">–</span> <span class="NLM_lpage">1393</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1991&pages=1379-1393&author=E.+Skrzypczak-Jankunauthor=V.+Carperosauthor=K.+G.+Ravichandranauthor=A.+Tulinskyauthor=M.+Westbrookauthor=J.+M.+Maraganore&title=Structure+of+the+hirugen+and+hirulog+1+complexes+of+%CE%B1-thrombin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkrzypczak-Jankun%26aufirst%3DE.%26aulast%3DCarperos%26aufirst%3DV.%26aulast%3DRavichandran%26aufirst%3DK.%2BG.%26aulast%3DTulinsky%26aufirst%3DA.%26aulast%3DWestbrook%26aufirst%3DM.%26aulast%3DMaraganore%26aufirst%3DJ.%2BM.%26atitle%3DStructure%2520of%2520the%2520hirugen%2520and%2520hirulog%25201%2520complexes%2520of%2520%25CE%25B1-thrombin%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1991%26volume%3D221%26spage%3D1379%26epage%3D1393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Brunger, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karplus, M.</span><span> </span><span class="NLM_article-title">Crystallographic R-factor refinement by molecular dynamics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">235</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1987&pages=458-460&author=A.+T.+Brungerauthor=J.+Kuriyanauthor=M.+Karplus&title=Crystallographic+R-factor+refinement+by+molecular+dynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunger%26aufirst%3DA.%2BT.%26aulast%3DKuriyan%26aufirst%3DJ.%26aulast%3DKarplus%26aufirst%3DM.%26atitle%3DCrystallographic%2520R-factor%2520refinement%2520by%2520molecular%2520dynamics%26jtitle%3DScience%26date%3D1987%26volume%3D235%26spage%3D458%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Bernstein, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koetzle, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, E. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brice, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennard, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimanouchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasumi, M.</span><span> </span><span class="NLM_article-title">The protein databank: A computer based archival file for macro-molecular structures</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1977&pages=535-542&author=F.+C.+Bernsteinauthor=T.+F.+Koetzleauthor=E.+F.+Meyerauthor=M.+D.+Briceauthor=J.+R.+Rodgersauthor=O.+Kennardauthor=T.+Shimanouchiauthor=M.+Tasumi&title=The+protein+databank%3A+A+computer+based+archival+file+for+macro-molecular+structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBernstein%26aufirst%3DF.%2BC.%26aulast%3DKoetzle%26aufirst%3DT.%2BF.%26aulast%3DMeyer%26aufirst%3DE.%2BF.%26aulast%3DBrice%26aufirst%3DM.%2BD.%26aulast%3DRodgers%26aufirst%3DJ.%2BR.%26aulast%3DKennard%26aufirst%3DO.%26aulast%3DShimanouchi%26aufirst%3DT.%26aulast%3DTasumi%26aufirst%3DM.%26atitle%3DThe%2520protein%2520databank%253A%2520A%2520computer%2520based%2520archival%2520file%2520for%2520macro-molecular%2520structures%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1977%26volume%3D112%26spage%3D535%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Sack, J. S.</span><span> </span><span class="NLM_article-title">CHAIN—A crystallographic modeling program</span> <span class="citation_source-journal">J. Mol. Graphics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">249</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm901802n&amp;key=10.1016%2FS0263-7855%2898%2980040-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=249&publication_year=1988&pages=224-225&author=J.+S.+Sack&title=CHAIN%E2%80%94A+crystallographic+modeling+program"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0263-7855%2898%2980040-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0263-7855%252898%252980040-4%26sid%3Dliteratum%253Aachs%26aulast%3DSack%26aufirst%3DJ.%2BS.%26atitle%3DCHAIN%25E2%2580%2594A%2520crystallographic%2520modeling%2520program%26jtitle%3DJ.%2520Mol.%2520Graphics%26date%3D1988%26volume%3D249%26spage%3D224%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LDX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LDX','PDB','3LDX'); return false;">PDB: 3LDX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T4U" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T4U','PDB','1T4U'); return false;">PDB: 1T4U</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QBV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QBV','PDB','1QBV'); return false;">PDB: 1QBV</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901802n&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-4%3Barticle%3Aarticle%3A10.1021%2Fjm901802n%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901802n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679983141b8f3c4c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
